Section 68

EurekaMag PDF full texts Chapter 67,148


Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A422 Outcomes of Stem Cell Transplantation for Myeloma in Thailand. Clinical Lymphoma and Myeloma 9: S66-S67
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A432 Long-Term Treatment with Lenalidomide in Previously Treated Subjects with Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S68-S69
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A435 Dex/Thal as Induction and Maintenance Treatment in Elderly Patients with Mm: A Randomized Trial. Clinical Lymphoma and Myeloma 9: S69-S70
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A448 Intermittent Dex/Thal as Pretransplantation and Maintenance Treatment in De Novo Mm: A Randomized Trial. Clinical Lymphoma and Myeloma 9: S71-S72
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A450 Alternating Vamp/ThaCyDex: An Effective Salvage Regimen in Relapsed Multiple Myeloma Patients. Clinical Lymphoma and Myeloma 9: S72-S73
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A453 Total Marrow Irradiation, Busulfan, and Cyclophosphamide Is Equivalent to Tandem Melphalan in Myeloma. Clinical Lymphoma and Myeloma 9: S73-S74
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A470 Phase Ii Trial of Mel/Dex + Bortezomib for Al Amyloidosis. Clinical Lymphoma and Myeloma 9: S74-S75
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A474 Single-Agent Cytarabine Effectively Mobilizes Stem Cells in Heavily Pretreated Myeloma Patients. Clinical Lymphoma and Myeloma 9: S75-S76
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A481 Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Smoldering or Indolent Myeloma. Clinical Lymphoma and Myeloma 9: S76-S77
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A498 Thalidomide + Dexamethasone After Asct Improves Pfs in Mm: A Brazilian Randomized Trial. Clinical Lymphoma and Myeloma 9: S78-S79
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A508 Treatment Response and Survival in Myeloma Renal Failure. Clinical Lymphoma and Myeloma 9: S79-S80
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A518 Dendritic cells Immunotherapy: A Phase Ii Clinical Trial. Clinical Lymphoma and Myeloma 9: S80-S81
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A530 Characterization of Bortezomib Resistance in Multiple Myeloma Cell Lines. Clinical Lymphoma and Myeloma 9: S81-S82
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A533 Rad001: Phase Ii Trial in Relapsed/Refractory Waldenstrm Macroglobulinemia, the Dfci Experience. Clinical Lymphoma and Myeloma 9: S82-S83
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A535 Phase Ii Trial of Bortezomib and Rituximab in Relapsed/Refractory Waldenstrm Macroglobulinemia. Clinical Lymphoma and Myeloma 9: S83-S84
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A546 Mrc Myeloma Ix: Preliminary Results from The Intensive Pathway Study. Clinical Lymphoma and Myeloma 9: S84-S85
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A574 Generic Bortezomib-Induced Severe Peripheral Neuropathy in Newly Diagnosed Multiple Myeloma Patients. Clinical Lymphoma and Myeloma 9: S86-S87
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A586 A Slow Pattern of Response in a Relapsed Multiple Myeloma Patient Treated with Lenalidomide. Clinical Lymphoma and Myeloma 9: S88-S89
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A609 Extended Follow-up Results of BiRd Therapy: Prolonged Responses Achieved. Clinical Lymphoma and Myeloma 9: S89-S90
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A618 Non-Frozen Autologous Peripheral Blood Stem Cells Transplantation in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S91-S92
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: A628 MicroRna Profile Identifies Distinct Clinically Relevant Subgroups in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S93-S94
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B026 Cs1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity via c-Maf Mediation. Clinical Lymphoma and Myeloma 9: S96-S97
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B033 Aurora-Kinase Inhibition for Tailored Risk-Adapted Treatment of Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S97-S98
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B037 Cal-101: A Selective Inhibitor of Pi3K p110D for the Treatment of Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S98-S99
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B050 Angiogenesis in Multiple Myeloma: Induction by Normal Plasma Cell and Aberrantly Expressed Genes. Clinical Lymphoma and Myeloma 9: S99-S100
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B081 Hevylite Detects Residual IgGk in IgG Heavy-chain Disease. Clinical Lymphoma and Myeloma 9: S100-S101
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B101 Quantification of Polymerising Serum Free Light Chains. Clinical Lymphoma and Myeloma 9: S101-S102
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B106 MicroRna Expression Profiling in Multiple Myeloma: Correlation with Genetic Abnormalities. Clinical Lymphoma and Myeloma 9: S102-S103
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B137 Pharmacogenetic Modeling for Prediction of Patient Outcomes in Myeloma. Clinical Lymphoma and Myeloma 9: S103-S104
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B145 Bmsc-induced Drug Resistance by Arresting Mm Cells at First Contact. Clinical Lymphoma and Myeloma 9: S104-S105
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B152 First Analysis of Hovon-65/Gmmg-Hd4 Randomized Phase Iii Trial Comparing Bortezomib, Doxorubicin, Dexamethasone (Pad) vs. Vad as Induction Treatment Prior to High-dose Melphalan (Hdm) in Patients with Newly Diagnosed Multiple Myeloma (Mm). Clinical Lymphoma and Myeloma 9: S105-S106
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B168 April Induces Proliferation of Primary Myeloma Cells Expressing Cyclin D2. Clinical Lymphoma and Myeloma 9: S106-S107
Boise, L.; Gutman, D. 2009: B176 Acquisition of a Multidrug Resistant Phenotype with a Proteasome Inhibitor. Clinical Lymphoma and Myeloma 9: S107-S108
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B195 Dna Dsbs Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity. Clinical Lymphoma and Myeloma 9: S109-S110
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B200 Targeted Drug Combinations in Poor Prognosis Multiple Myeloma: Therapeutic Implications. Clinical Lymphoma and Myeloma 9: S110-S111
Nair, J.; Carlson, L.; Boise, L.; Chanan-Khan, A.; Lee, K. 2009: B207 In the Crosshairs: Targeting Myeloma Cd28-B7 Interactions. Clinical Lymphoma and Myeloma 9: S112-S113
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B213 Integrin-linked Kinase as a Target in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S113-S114
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B216 Probing the Stem Cell in the 5T33 Multiple Myeloma Model. Clinical Lymphoma and Myeloma 9: S114-S115
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B226 High Hgf Levels are Associated with Response to Bortezomib. Clinical Lymphoma and Myeloma 9: S115-S116
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B234 Dasatinib and Dexamethasone Combination Therapy Targets Myeloma and the Tumor Microenvironment. Clinical Lymphoma and Myeloma 9: S116-S117
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B257 Vorinostat in Combination with Other Anti-Mm Agents. Clinical Lymphoma and Myeloma 9: S117-S118
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B267 Mek/Erk and Mevalonate Pathways Inhibition in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S118-S119
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B279 Panel of Potential Proteomic Biomarkers for Predicting Response to Thalidomide in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S119-S120
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B304 Does Toll-like Receptor 9 Signaling Play a Role in Myeloma Disease Progression?. Clinical Lymphoma and Myeloma 9: S121-S122
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B325 Immune Dysregulation in Mgus: Evidence that Mgus Is Not an Immunologically Inert State. Clinical Lymphoma and Myeloma 9: S123-S124
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B340 Molecular Classification of Newly Diagnosed Mm Patients Included in a Prospective Phase Iii Trial. Clinical Lymphoma and Myeloma 9: S124-S125
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B350 Sns-032, a Potent and Selective Cdk2, 7 and 9 Inhibitor, Demonstrates Preclinical Activity in Human Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S125-S126
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B357 Targeting Myeloma Bone Disease via Activin A Inhibition. Clinical Lymphoma and Myeloma 9: S126-S127
Bang, S.M.; Lee, J.; Shin, M.; Lee, J.; Seo, C.; Seo, J.; Park, K.; Yoon, S.; Lee, D.; Kim, H.; Kim, K.; Cho, S.; Kim, H.; Song, J.; Kim, J. 2009: B365 Molecular Cytogenetic Analysis of Waldenstrm Macroglobulinemia in Korea. Clinical Lymphoma and Myeloma 9: S127-S128
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B373 Frequency of Abnormal Serum Free Light-Chain Ratio in a French Cohort of Patients with Mgus. Clinical Lymphoma and Myeloma 9: S128-S129
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B387 Studies on c-Kit Protein Expression and c-Kit Gene in Mm Patients. Clinical Lymphoma and Myeloma 9: S129-S130
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B398 Suggestion of a Tool for Assessment of Plasma Cells in the Bone Marrow of Myeloma Patients. Clinical Lymphoma and Myeloma 9: S131-S132
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B405 Association of Genetic Variants with Fish-Based Karyotyping Status in Multiple Myeloma Patients. Clinical Lymphoma and Myeloma 9: S132-S133
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B414 Genes Mage-C1 and Mage-A3 Are Central to the Survival and Chemotherapy-Resistance of Myeloma Cells. Clinical Lymphoma and Myeloma 9: S133-S134
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B434 Hgf Inhibited Osteoblatogenenesis Via Regulation of Opn Mediated Mapk and Nf-kB Pathways in Mm. Clinical Lymphoma and Myeloma 9: S134-S135
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B446 Nk Cell Mediated Immunologic Responses Against Myeloma by B7-1(Cd80)/Il-2 Immune Gene Therapy. Clinical Lymphoma and Myeloma 9: S135-S136
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B457 At7519, a Multi-Cyclin Dependent Kinase Inhibitor, Induces Apoptosis in Multiple Myeloma via Gsk3B. Clinical Lymphoma and Myeloma 9: S137-S138
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B469 Unraveling the Synergism of Nab-Rapamycin and Perifosine Combination in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S138-S139
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B483 A Novel Small-Molecule Inhibitor Rgb 286638 Induces Apoptosis and Necrosis in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S139-S140
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B494 Quantitative Protein Expression-Based Classification of Mm. Clinical Lymphoma and Myeloma 9: S140-S141
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B507 Lethal and Bortezomib-Sensitizing Targets in Myeloma Identified by Genome-Scale Rnai Screening. Clinical Lymphoma and Myeloma 9: S141-S142
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B516 Nt-proBnp Levels in Myeloma Patients Without Evidence of Amyloidosis. Clinical Lymphoma and Myeloma 9: S142-S143
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B525 Regulation of Histone Deacetylase in Waldenstrm Macroglobulinemia. Clinical Lymphoma and Myeloma 9: S143-S144
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B528 Dual Pi3K and mTor Inhibition in Waldenstrm Macroglobulinemia. Clinical Lymphoma and Myeloma 9: S144-S145
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B538 In Vivo Imaging Model of Multiple Myeloma and its Cellular Interaction with the Bone Marrow Milieu. Clinical Lymphoma and Myeloma 9: S145-S146
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B540 The Effect of Insulin-Like Growth Factor-1 in Waldenstrm Macroglobulinemia. Clinical Lymphoma and Myeloma 9: S146-S147
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B552 the European Myeloma Stem cell Network (Mscnet). Clinical Lymphoma and Myeloma 9: S147-S148
Harding, S.; Drayson, M.; Mead, G.; Bradwell, A. 2009: B555 Prognostic Value of Free and Heavy/Light Chain Analysis. Clinical Lymphoma and Myeloma 9: S148-S149
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B562 Increasing Numbers of Most Mature Peripheral Blood B-Subsets are Observed in Monoclonal Gammopathies. Clinical Lymphoma and Myeloma 9: S150-S151
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B564 Various Growth Factors Regulate Mesenchymal Stem cell Differentiation Derived Human Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S151-S152
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B581 MicroRna Regulate Growth and Angiogenesis in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S153-S154
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B587 A Novel Genetic Polymorphism in the Dna Polymerase Kappa Gene May Play a Role in Multiple Myeloma. Clinical Lymphoma and Myeloma 9: S154-S155
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B596 Immunoglobulin Ratios: An Alternative to Immunofixation. Clinical Lymphoma and Myeloma 9: S156-S157
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B601 aCgh in Vk*Myc Mice Identifies Genetic Changes Shared with Human Mm. Clinical Lymphoma and Myeloma 9: S157-S158
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: B615 The Role of Rtk's in Waldenstrm Macroglobulinemia. Clinical Lymphoma and Myeloma 9: S158-S159
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2005: Differentiation of highly prevalent Is6110 single-copy strains of Mycobacterium tuberculosis from a rural community in South India with an ongoing Dots programme. Infection, Genetics and Evolution 5(1): 67-77
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2007: Left atrial volume: an important prognostic factor in patients with heart failure and left ventricular systolic dysfunction. European Journal of Heart Failure Suppls 6(1): 156-157
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2008: Effects of Darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure. European Journal of Heart Failure Supplements 7: 26-27
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2008: The Home-Hf Study: A multi-centre randomised controlled trial of home telemonitoring in a general heart failure population of elderly patients with co-morbidity. European Journal of Heart Failure Supplements 7: 152-153
Shepherd, J.; Barter, P. 2002: Lipid-lowering translating evidence into benefits. Atherosclerosis Suppls 2(4): 1-3
de Roos, N.M.; Schouten, E.G.; Scheek, L.M.; van Tol, A.; Katan, M.B. 2001: Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women. Atherosclerosis Suppls 2(2): 110-111
Durrington, P. 2002: Hdl in risk prediction and its direct and indirect involvement in atherogenesis. Atherosclerosis Suppls 3(4): 3-12
Cannon, C.P. 2003: The next step in cardiovascular protection. Atherosclerosis Suppls 4(5): 3-9
Wascher, T.C. 2003: Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes?. Atherosclerosis Suppls 4(5): 11-16
Shepherd, J. 2003: Preventing the next event in the elderly: the Prosper perspective. Atherosclerosis Suppls 4(5): 17-22
Nissen, S. 2003: 0Soa02-2 Seeing is believing: Imaging techniques to measure atherosclerosis progression. Atherosclerosis Suppls 4(2): 1-2
Mangelsdorf, D.; Kalaany, N.; Gauthier, K. 2003: 1Sy01-5 Nuclear receptors as the body's lipid sensors. Atherosclerosis Suppls 4(2): 3-4
Yamamoto, H.; Yonekura, H.; Watanabe, T.; Yamamoto, Y.; Sakurai, S.; Tanaka, N.; Li, H.; Myint, K.M.; Kim, C.-H.; Harashima, A. 2003: 1Fs01-6 Nurture vs nature in diabetic vasculopathy: Roles of advanced glycation endproducts and the receptor for them. Atherosclerosis Suppls 4(2): 5-6
Wang, Y. 2003: 1Fs02-4 Diet, physical activity, childhood obesity and risk of cardiovascular disease. Atherosclerosis Suppls 4(2): 6-7
Barter, P. 2003: 1Fs03-3 Global guidelines: National issues. Atherosclerosis Suppls 4(2): 7-8
Keech, A.; Best, J.; Scott, R.; Barter, P.; Forder, P.; Taskinen, M.-R.; Simes, R.J. 2003: 1Soa03-5 Field: Where do we stand? Significant lipid changes in a large-scale trial of fenofibrate to prevent cardiovascular disease in type 2 diabetes. Atherosclerosis Suppls 4(2): 10-11
Daemen, M. 2003: 1Ws02-5 Gene expression and plaque instability. Atherosclerosis Suppls 4(2): 13-14
Beisiegel, U.; Heeren, J. 2003: 1Ws03-5 Recycling of apoprotein E promotes cholesterol-efflux and generation of Hdl-E. Atherosclerosis Suppls 4(2): 14-15
Knobloch, K.; Lichtenberg, A.; Pichlmaier, M.; Mertsching, H.; Klima, U.; Haverich, A. 2003: 1P-0004 Sternal microcirculation after harvesting of the left internal mammary artery. Atherosclerosis Suppls 4(2): 19-20
Khazaei, M.; Nematbakhsh, M.; Dashti, G.H. 2003: 1P-0009 Estrogen attenuates fatty strak formation in coronary arteries in cholesterol-fed diabetic male rabbits. Atherosclerosis Suppls 4(2): 20-21
Ueda, Y.; Shimizu, M.; Ohtani, T.; Hirayama, A.; Kodama, K.; Mizote, I. 2003: 1P-0023 Amount of thrombus at culprit lesion of acute myocardial infarction is dependent on angioscopically determined coronary atherosclerosis. Atherosclerosis Suppls 4(2): 23-24
Koba, S.; Hirano, T.; Tsunoda, F.; Iso, Y.; Shibata, M.; Suzuki, H.; Geshi, E.; Katagiri, T. 2003: 1P-0027 Significance of small dense low-density lipoprotein phenotype and other risk factors in patients with various types of coronary heart diseases. Atherosclerosis Suppls 4(2): 24-25
Goracy, I.; Goracy, J.; Brykczynski, M.; Naruszewicz, M.; Ciechanowicz, A. 2003: 1P-0057 Polymorphisms C(-1562)T in the promoter of the matrix metalloproteinase-9 (Mmp-9), C677T of methylenetetrahydrofolate reductase (Mther), G298T of endothelial nitric oxide synthase (Enos), G455A of B-fibrinogen (B Fb) genes and coronary arteriosclerosis. Atherosclerosis Suppls 4(2): 31-32
Malyutina, S.; Gafarov, V.; Voevoda, M.; Maximov, V.; Ryabikov, A.; Novoselov, V. 2003: 1P-0061 Findings from autopsy in (sudden) cardiac death. Atherosclerosis Suppls 4(2): 32-33
Kanjuh, V.; Lalic, N.; Ostojic, M.; Lalic, K.; Beleslin, B.; Kanjuh, S.; Jotic, A. 2003: 1P-0066 Severity of coronary arterial stenotic changes correlates with increases in plasma insulin and plasminogen activator inhibitor 1 levels in patients with type 2 diabetes. Atherosclerosis Suppls 4(2): 33-34
Hirata, K.; Otsuka, R.; Amudha, K.; Sugioka, K.; Yoshikawa, J.; Homma, S.; Chim, L. 2003: 1P-0070 Coronary flow velocity reserve is reduced in pre-menopausal patients with systemic lupus erythematosus. Atherosclerosis Suppls 4(2): 34-35
Navai, L.; Anbari, M.A.; Kimiagar, M.; Shafighi, A. 2003: 1P-0079 A comparative study of prevalence of hypertension and body mass index in urban and rural areas of Tehran. Atherosclerosis Suppls 4(2): 36-37
Miura, K.; Soyama, Y.; Morikawa, Y.; Nishijo, M.; Nakanishi, Y.; Naruse, Y.; Kagamimori, S.; Nakagawa, H. 2003: 1P-0088 Four blood pressure indexes and the long-term risk of stroke in Japanese men and women: The Oyabe study. Atherosclerosis Suppls 4(2): 38-39
Jastrzebska, M.; Foltynska, A.; Goracy, I.; Widecka, K.; Ciechanowicz, A.; Chelstowski, K.; Naruszewicz, M. 2003: 1P-0097 The relationships between fibrinogen, plasminogen activator inhibitor-1 and their gene polymorphisms in patients with essential hypertension. Atherosclerosis Suppls 4(2): 40-41
Gotsis, A.; Bozia, P.; Labrou, A.; Savvopoulou, A.; Borghi, L.; Theodoridis, D.; Koutsogiannis, O.; Panagiotidou, A. 2003: 1P-0110 Dyslipidaemia and hypertension as aspects of metabolic syndrome X. Is the management sufficient?. Atherosclerosis Suppls 4(2): 43-44
Nagata, R.; Nishio, Y.; Sekine, O.; Maegawa, H.; Kashiwagi, A. 2003: 1P-0118 Single nucleotide polymorphism (-469 G to A) at the promoter region of sterol regulatory element binding protein-1c associates with hypertriglyceridemia induced by a diet high in fructose in mice. Atherosclerosis Suppls 4(2): 45-46
Christensen, J.H.; Krarup, H.B.; Toft, E.; Riahi, S.; Schmidt, E.B. 2003: 1P-0122 Body mass index, heart rate variability, and haptoglobin polymorphism in patients with coronary artery disease. Atherosclerosis Suppls 4(2): 46-47
Gertow, K.; Bellanda, M.; Sunnerhagen, M.; Eriksson, P.; Boquist, S.; Hamsten, A.; Fisher, R. 2003: 1P-0131 Genetic and structural evaluation of fatty acid transport protein-4 (Fatp4) in relation to markers of the insulin resistance syndrome. Atherosclerosis Suppls 4(2): 48-49
Jimbu, Y.; Igarashi, M.; Kimura, M.; Hirata, A.; Yamaguchi, H.; Kato, T.; Tominaga, M. 2003: 1P-0136 Effect of pioglitazone on atherogenic outcomes in patients with type 2 diabetes: Comparison with responder and non-responder groups. Atherosclerosis Suppls 4(2): 49-50
Nakamura, S.; Hirose, M.; Saito, E.; Miyauchi, T.; Kanazawa, A.; Hozawa, K.; Nakamura, H.; Yamamoto, K.; Makishima, N.; Nakamura, S.; Koyama, J. 2003: 1P-0145 Impact of diabetes mellitus on initial and long-term clinical results of long coronary lesions: Multicenter registry in Japan. Atherosclerosis Suppls 4(2): 51-52
Ohashi, H.; Oh, H.; Suzuma, K.; Suzuma, I.; Miyamoto, M.; Uemura, A.; Sugaya, T.; Fukamizu, A.; Takagi, H. 2003: 1P-0154 Angiotensin Ii plays as a survival factor in the retinal endothelial cells through type 1 receptor and Pi 3-kinase-Akt pathway. Atherosclerosis Suppls 4(2): 53-54
Kabakov, A.; Budagova, K.; Malyutina, Y.; Latchman, D. 2003: 1P-0171 Hsp70 or Hsp27 overexpressed in endothelial cells during post-ischemic reperfusion may protect from delayed apoptosis. Atherosclerosis Suppls 4(2): 57-58
Maemura, K.; Takeda, N.; Morita, H.; Imai, Y.; Hanada, T.; Nojiri, T.; Nagai, R. 2003: 1P-0176 Peripheral biological clock regulates circadian gene expression in vascular endothelial cells. Atherosclerosis Suppls 4(2): 58-59
Yokoi, T.; Fukuo, K.; Hotta, M.; Miyazaki, J.; Ichijo, H.; Ogihara, T. 2003: 1P-0180 High glucose upregulates plasminogen activator inhibitor-1 (Pai-1) expression through activation of apoptosis signal-regulating kinase 1 (Ask1) in endothelial cells. Atherosclerosis Suppls 4(2): 59-60
Wang, L. 2003: 1P-0186 Shear flow attenuates interleukin-6-induced Stat3 activation in endothelial cells. Atherosclerosis Suppls 4(2): 60-61
Nystr, H.; Lindblom, P.; Wickman, A.; Anderson, I.; Norlin, J.; Lindahl, P.; Bjarneg, M.; Fitzgerald, S.; Gan, L.-M.; Betsholtz, C.; Bergstr, G. 2003: 1P-0196 The Pdgf-B retention motif knockout mouse shows primary conduit vessel and renaldysfunction together with eccentric cardiac hypertrophy. Atherosclerosis Suppls 4(2): 62-63
Tambara, K.; Sakakibara, Y.; Sakaguchi, G.; Nakajima, H.; Premaratne, G.; Marui, A.; Yamamoto, M.; Tabata, Y.; Nishimura, K.; Komeda, M. 2003: 1P-0201 Local therapy with control-released basic fibroblast growth factor (bFgf) in the cardiac field. Atherosclerosis Suppls 4(2): 63-64
Kobayashi, K.; Yokote, K.; Maezawa, Y.; Kawamura, H.; Fujimoto, M.; Asaumi, S.; Mori, S.; Saito, Y. 2003: 1P-0205 Functional analysis about the role of Smad3-dependent transforming growth factor- signaling in neointimal hyperplasia. Atherosclerosis Suppls 4(2): 64-65
Ueshima, S.; Luttun, A.; Brusselmans, K.; Tiwa, M.; Herbert, J.-M.; Matsuo, O.; Collen, D.; Carmeliet, P.; Mooms, L. 2003: 1P-0210 Effects of endogenous placental growth factor on vascular permeability in pathological conditions. Atherosclerosis Suppls 4(2): 65-66
Bayansar, M.; Brundert, M.; Ewert, A.; Greten, H.; Rinninger, F. 2003: 1P-0219 Selective uptake of Hdl-associated cholesterolesters (Ce) by mouse peritoneal macrophages independent from scavenger receptor class B type (Sr-Bi). Atherosclerosis Suppls 4(2): 67-68
Lilia, H.; Suviolahti, E.; Perola, M.; Soro, A.; Taskinen, M.-R.; Peltonen, L.; Pajukanta, P. 2003: 1P-0228 A quantitative trait locus on chromosome 10p11 influences variation in plasma Hdl-C levels in Finnish dyslipidemic families. Atherosclerosis Suppls 4(2): 69-70
Kockx, M.; Wright, J.; Sloane, T.; Sviridov, D.; Fu, Y.; Chaddha, M.; Anantharamaiah, G.; Phillips, M.; Dean, R.; Rye, M.; Jessup, W.; Kritharides, L. 2003: 1P-0232 Apolipoprotein A-I-mediated secretion of apolipoprotein E has structural requirements distinct from those related to stimulation of cholesterol efflux. Atherosclerosis Suppls 4(2): 70-71
Nagata, M.; Yosino, J.; Inui, K.; Wakabayashi, T.; Kobayashi, T.; Kamiya, N. 2003: 1P-0236 Relationship between Helicobacter pylori, ischemic colitis and arterial stiffness. Atherosclerosis Suppls 4(2): 71-72
Sawayama, Y.; Ariyama, I.; Otaguro, S.; Hayashi, J. 2003: 1P-0241 Association between chronic Helicobacter pylori infection and ischemic stroke. Atherosclerosis Suppls 4(2): 72-73
Li, W.; Yuan, X.-M. 2003: 1P-0256 Role of lysosomal cathepsin in 7-oxysterol induced apoptosis. Atherosclerosis Suppls 4(2): 75-76
Zhuge, X.; Arai, H.; Xu, Y.; Kita, T.; Kobayashi, T.; Narumiya, S.; Yokode, M. 2003: 1P-0265 Role of monocyte-macrophage in atherosclerosis in thromboxane A2 receptor-deficient mice. Atherosclerosis Suppls 4(2): 77-78
Pu, J.; Wang, L.; Zhang, C.; Zeng, H. 2003: 1P-0269 Defibrase restored endothelial nitric oxide-mediated vasorelaxation in an atherosclerotic rabbit model. Atherosclerosis Suppls 4(2): 78-79
Yuan, X.-M.; Li, W. 2003: 1P-0274 Narmp 1 expressed in atherosclerotic lesions may be associated with 7-oxysterol induced apoptosis. Atherosclerosis Suppls 4(2): 79-80
Hellsten, A.; Li, W.; Jacobsson, L.S.; Blomqvist, H.; Olsson, A.G.; Yuan, X.-M. 2003: 1P-0288 Effects of -tocopherol and astaxanthin on plaque composition in atheroma of hyperlipidaemic rabbits. Atherosclerosis Suppls 4(2): 82-83
Boshtam, M.; Rafiei, M.; Sadeghi, K. 2003: 1P-0292 Vitamin E can reduce blood pressure in mild hypertensives. Atherosclerosis Suppls 4(2): 83-84
Djeric, M.; Ivanov, D.; Kojic-Damjanov, S.; Lepsanovic, L. 2003: 1P-0302 Importance of the serum levels of lipoprotein (a) in determining the risk of ischemic heart disease in longtime vegetarians. Atherosclerosis Suppls 4(2): 85-86
Fujiwara, H. 2003: 2Ws07-16 Granulocyte coloby-stimulating factor as a novel and non-invasive regeneration therapy against intractable arteriosclerosis obliterans and coronary heart disease. Atherosclerosis Suppls 4(2): 95-96
Higashiura, K. 2003: 2Ws08-5 Significance of insulin resistance to atherosclerosis. Atherosclerosis Suppls 4(2): 96-97
Merkel, M. 2003: 2Ws09-5 Homocysteine as a risk factor of cardiovascular disease. Atherosclerosis Suppls 4(2): 97-98
Maeda, N. 2003: 2Ws10-5 ApoE trapping: Is increased Ldlr always good for us?. Atherosclerosis Suppls 4(2): 98-99
Chung, I.-M.; Ueno, H.; Choi, D.; Jang, Y.; Pak, Y.; Kim, J.; Yang, W.-L. 2003: 2Ws12-4 Blockade of Tgf- by catheter-based gene transfer of a soluble Tgf- type Ii receptor inhibits in-stent neointima by decreased extracellular matrix accumulation and deposited proportionally more collagen in neointima. Atherosclerosis Suppls 4(2): 100-101
Yoon, C.; Kim, H.S.; Park, Y.B. 2003: 2Ht02-1 Adhesion molecules related with homing of endothelial progenitor cells and induction of homing by expression of the molecules by gene transfer. Atherosclerosis Suppls 4(2): 105-106
Kojic-Damjanov, S.; Djeric, M.; Kravarusic, J.; Dejanovic, J.; Lepsanovic, L. 2003: 2P-0322 Characteristics of lipid status of healthy young persons in Vojvodina. Atherosclerosis Suppls 4(2): 108-109
Pytlak, A.; Piotrowski, W. 2003: 2P-0326 Individual Cvd global risk and general practitioners management in Warsaw Monica Bis study. Atherosclerosis Suppls 4(2): 109-110
Wu, S.; Tan, J. 2003: 2P-0335 An epidemiological study about regularity of sex hormone changes in men and effects of Padam on lipid profile, glycometabolism, immune system and oxidation-antioxidation system. Atherosclerosis Suppls 4(2): 111-112
Tseng, C.H. 2003: 2P-0347 Determinants of all-cause mortality in type 2 diabetic patients in Taiwan: A 6-year prospective follow-up. Atherosclerosis Suppls 4(2): 114-115
Asao, K.; Nishimura, R.; Sarti, C.; Forsen, T.; Hyttinen, V.; Orchard, T.; Tuomilehto, J.; Tajima, N. 2003: 2P-0351 Mortality from cardiovascular diseases among individuals with type 1 diabetes in Japan, Finland, and Us. Atherosclerosis Suppls 4(2): 115-116
Nghiem, T.; Ta, T.T.M.; Kido, T.; Usuda, M.; Tani, M.; Nagano, M.; Kurata, H.; Nguyen, V.C.; Kondo, K. 2003: 2P-0355 The effect of the cholesteryl ester transfer protein gene and apolipoprotein E gene on plasma lipoprotein in Vietnamese. Atherosclerosis Suppls 4(2): 116-117
Kamijima, Y.; Ishii, I.; Yamagata, S.; Satho, N.; Yamada, Y.; Mochizuki, M.; Ueda, S. 2003: 2P-0359 Gender-specific efficacy of Hmg-CoA reductase inhibitors on the prevention of stroke: A meta-analysis of randomized, placebo-controlled, double-blind trials by gender. Atherosclerosis Suppls 4(2): 117-118
Raguz, M.; Raos, V.; Bergovec, M.; Mirat, J.; Vincelj, J.; iki, J. 2003: 2P-0368 Concentration of glucose, homocysteine and Lp(a) as a risk factor of coronary artery disease. Atherosclerosis Suppls 4(2): 119-120
Paximadas, S.; Pagoni, S.N.; Kosmidis, M.B.; Kanellas, K.A.; Moutafis, D.S.; Joakeimidis, N.K.; Gialernios, T.P. 2003: 2P-0377 Changes of homocysteine levels after administration of folic acid. Atherosclerosis Suppls 4(2): 121-122
Ezhov, M.; Naumov, V.; Afanasieva, M.; Pokrovsky, S. 2003: 2P-0382 Homocysteine and premature coronary heart disease. Atherosclerosis Suppls 4(2): 122-123
Russell, J.; Kelly, S.E.; Schaefer, S. 2003: 2P-0400 Insulin-sensitizing and cardiovascular effects of Ace inhibitors in the Jcr:La-cp rat. Atherosclerosis Suppls 4(2): 126-127
Chiba, T.; Kaneko, E.; Yui, K.; Kondo, K.; Shimokado, K. 2003: 2P-0409 Leptin-deficiency suppressed progression of atherosclerosis. Atherosclerosis Suppls 4(2): 128-129
AlMajali, K.; Cooper, M.; Adiseshiah, M.; Hurel, S.; Harry, P.; Urquhart, R.; Betteridge, D.J. 2003: 2P-0418 Effects of pioglitazone treatment on postprandial lipid metabolism in type 2 diabetes. Atherosclerosis Suppls 4(2): 130-131
Winkler, K.; Ruf, G.; Krane, V.; Wieland, H.; Ritz, E.; Wanner, C.; Iz, W.M. 2003: 2P-0423 Ldl subfraction profile at baseline in a double-blind clinical trial with atorvastatin in patients with type 2 diabetes on hemodialysis (Die Deutsche Diabetes Dialysis Study). Atherosclerosis Suppls 4(2): 131-132
Uehara, Y.; Rohrer, L.; Von Eckardstein, A. 2003: 2P-0435 The suppressive effect of acetoacetate on the expression of the Atp-binding cassette transporter A1 (Abca1) requires the E-box in the Abca1 promoter. Atherosclerosis Suppls 4(2): 134-135
Yoshida, H.; Tada, N. 2003: 2P-0439 Effect of Hmg CoA reductase inhibitor (statin) on Abca1 expression and Hdl-induced cholesterol efflux in macrophages. Atherosclerosis Suppls 4(2): 135-136
Lee, M.-H.; Patel, S.B. 2003: 2P-0444 Localization of Abcg5 and Abcg8 proteins in human liver. Atherosclerosis Suppls 4(2): 136-137
Neufeld, E.; Stonik, J.A.; Demosky, S.J.; Knapper, C.; Remaley, A.T.; Santamarina-Fojo, S.; Brewer, H.B. 2003: 2P-0451 The Abca1 transporter modulates late endocytic trafficking. Atherosclerosis Suppls 4(2): 138-139
Kruth, H.; Huang, W.; Zhao, B.; Zhang, W.-Y. 2003: 2P-0455 Pma activation of macrophages stimulates fluid-phase endocytic uptake of native Ldl generating foam cells. Atherosclerosis Suppls 4(2): 139-140
Hashida, K.; Fujita, M.; Kinoshita, M.; Maeda, T.; Maeda, Y.; Kudo, M.; Suda, T.; Hirota, D.; Taki, M.; Teramoto, T. 2003: 2P-0460 Role of sterol regulatory element binding protein-1 (Srebp-1) in hepatic regeneration after partial hepatectomy. Atherosclerosis Suppls 4(2): 140-141
Sun, Y.; Hu, D.; Huang, Y. 2003: 2P-0469 Angiotensin Ii type I receptor antagonist, irbesartan, prevents vascular cell adhesion molecule-1 expression in a rabbit model of early atherosclerosis. Atherosclerosis Suppls 4(2): 142-143
Honda, S.; Tomiyama, Y.; Kashiwagi, H.; Kiyoi, T.; Kato, H.; Kosugi, S.; Shiraga, M.; Kurata, Y.; Matsuzawa, Y. 2003: 2P-0478 Analysis of Arg-Gly-Asp-contact sites in the v subunit of integrin v3 employing single amino acid mutations. Atherosclerosis Suppls 4(2): 144-145
Oh, G.; Kim, J.; Nam, K.H. 2003: 2P-0482 Kr31378 ameliorates atherosclerosis by blocking recruitment and accumulation of monocytes in the hypercholesterolemic mice. Atherosclerosis Suppls 4(2): 145-146
Nakabe, N.; Naito, Y.; Shimozawa, M.; Manabe, H.; Katada, K.; Kokura, S.; Ichikawa, H.; Yoshida, N.; Okanoue, T.; Yoshikawa, T. 2003: 2P-0486 Azelnidipine, a novel ca-antagonist, reduces endothelial inflammatory response induced by oxysterol. Atherosclerosis Suppls 4(2): 146-147
Chen, A.; Li, L.; Fink, G.; Chu, Y.; Engelhardt, J.; Heistad, D. 2003: 2P-0492 Endothelin-1 stimulates arterial Vcam-1 expression via Nadph oxidase-derived superoxide in low renin hypertension. Atherosclerosis Suppls 4(2): 147-148
Yamagishi, M.; Higashikata, T.; Higashi, T.; Nagata, I.; Ueda-Ishibashi, H.; Sakamoto, A. 2003: 2P-0496 Altered expression of matrix metalloproteinase and tissue inhibitor of metallproteinase genes in human carotid plaque: Evidence from quantitative analysis using real-time Rt-Pcr method. Atherosclerosis Suppls 4(2): 148-149
Sherry, L.; Henry, B.; Shahid, M.; Long, C. 2003: 2P-0501 Characterisation of Par-4 receptor distribution in human atherosclerotic plaque tissue. Atherosclerosis Suppls 4(2): 149-150
Shiomi, M.; Ito, T.; Yamada, S.; Tamura, T.; Kawashima, S.; Fan, J. 2003: 2P-504 Development of an animal model for spontaneous myocardial infarction (Whhlmi rabbit). Atherosclerosis Suppls 4(2): 150-151
Shioi, A.; Kizu, A.; Jono, S.; Koyama, H.; Okuno, Y.; Nishizawa, Y. 2003: 2P-0509 Development of atherosclerotic calcification in ApoE-deficient mice. Atherosclerosis Suppls 4(2): 151-152
Knobloch, K.; Karck, M.; Bachmann, S.; Pichlmaier, M.; Lichtenberg, A.; Haverich, A. 2003: 2P-0519 Longterm results of uni- versus bilateral carotid thrombendarterectomy: A single center experience. Atherosclerosis Suppls 4(2): 153-154
Kitagawa, M. 2003: 2P-0524 Cerebral infarction and ischemic heart disease in type 2 diabetes mellitus patients. Atherosclerosis Suppls 4(2): 154-155
Yamashita, K.; Tasaki, H.; Suzuka, H.; Nihei, S.; Hirakawa, N.; Nakashima, Y. 2003: 2P-0534 Association of coronary atheorosclerosis with coronary flow velocity reserve evaluated by transthoracic Doppler echocardiography. Atherosclerosis Suppls 4(2): 156-157
Ryabikov, A.; Ryabikov, M.; Malyutina, S.; Staessen, J.A.; Nikitin, Y.. 2003: 2P-0543 Endothelial dysfunction: Non-invasive assessment and conventional determinants in a population. Atherosclerosis Suppls 4(2): 158-159
Kobayashi, H.; Suzuki, H.; Sato, F.; Yonemitsu, Y.; Nakashima, Y.; Seuishi, K. 2003: 2P-0552 Pitavastatin induces plaque stabilization in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis Suppls 4(2): 160-161
Beridze, M.; Kipshidze, N.; Kakauridze, N. 2003: 2P-0557 Atorvastatin's different doses lipid lowering, pleiotropic and plaque stability effects. Atherosclerosis Suppls 4(2): 161-162
Havekes, L.; Kleemann, R.; Emeis, J.; Fontijn, R.; Horrevoets, A.; Kooistra, T.; Princen, H. 2003: 2P-0562 Rosuvastatin reduces atherosclerosis development beyond and independently of its plasma cholesterol-lowering effect in Apoe3-Leiden transgenic mice. Evidence for anti-inflammatory effects of rosuvastatin. Atherosclerosis Suppls 4(2): 162-163
Yoshihara, D.; Matubara, C.; Nishioka, F.; Hirano, T.; Hiasa, Y.; Murakami, T. 2003: 2P-0566 Effect of bezafibrate on high-density lipoprotein (Hdl) concentrations, Hdl particle size distribution, and Hdl-core weight ratio in primary hypertriglyceridemics with Cetp TaqIb B2 allele. Atherosclerosis Suppls 4(2): 163-164
Yoshinaka, Y.; Kobayashi, H.; Kawamine, K.; Shibuya, K.; Sato, F. 2003: 2P-0580 Anti-atherosclerotic effect of the novel acyl-CoA: cholesterol acyltransferase inhibitor, K-10191, on high cholesterol-fed rabbits. Atherosclerosis Suppls 4(2): 166-167
Richter, W. 2003: 2P-0584 Effect of nilvadipine on serum lipoproteins in patients with hypertension. Atherosclerosis Suppls 4(2): 167-168
Fukumoto, Y.; Hirakawa, Y.; Abe, K.; Koike, G.; Mohri, M.; Shimokawa, H. 2003: 2P-0597 Intravenous administration of a Rho-kinase inhibitor, fasudil, reduces pulmonary vascular resistance in patients with pulmonary hypertension. Atherosclerosis Suppls 4(2): 170-171
Higashikata, T.; Miwa, K.; Kawashiri, M.; Katsuda, S.; Takata, M.; Inazu, A.; Koizumi, J.; Mabuchi, H. 2003: 2P-0606 Long-term effects of Ldl-apheresis treatment and morphologic changes of coronary atherosclerotic lesions in two brothers of homozygous patients with familial hypercholesterolemia. Atherosclerosis Suppls 4(2): 172-173
Chung, M.; Randinitis, E.; Calcagni, A.; Bramson, C.; Glue, P. 2003: 2P-0609 Biovailability of dual therapy: A fixed-dose combination tablet of amlodipine and atorvastatin. Atherosclerosis Suppls 4(2): 173-174
Shepherd, J.; Hunninghake, D.B.; Harris, S.; Hutchinson, H.; Pears, J. 2003: 2P-0613 Safety profile of rosuvastatin 1040 mg in an intergnational phase Ii/Iii clinical trial program. Atherosclerosis Suppls 4(2): 174-175
Celinska-Lowenhoff, M.; Undas, A.; Domagala, T.; Iwaniec, T.; Szczeklik, A. 2003: 2P-0617 Pleiotropic effects after a 3-day treatment with the lipid lowering drugs in patients with coronary artery disease. Atherosclerosis Suppls 4(2): 175-176
Mackness, M.; Durrington, P.; Mackness, B. 2003: 3Sy05-6 Paraoxonase: Biochemistry and contribution to atherosclerosis. Atherosclerosis Suppls 4(2): 177-178
Sobue, K. 2003: 3Sy07-4 Signal transduction and gene regulation in vascular smooth muscle cells. Atherosclerosis Suppls 4(2): 179-180
Silver, D. 2003: 3Fs06-6 Pdzk1 in hepatic Hdl metabolism. Atherosclerosis Suppls 4(2): 181-182
Abifadel, M.; Davignon, J.; Bernier, L.; Dubuc, G.; Boileau, C.; Prat, A.; Seidah, N.G. 2003: 3Fs07-5 Narc-1: A potential new target for drug therapy of hypercholesterolemia. Atherosclerosis Suppls 4(2): 182-183
Cubrilo, M. 2003: 3Ws17-1 Stroke risk factors: Recent evidence and new aspects. Atherosclerosis Suppls 4(2): 186-187
Humphries, S.E. 2003: 3Ws17-6 Genetic risk factors for stroke: Insights into patho-physiology from candidate gene approaches. Atherosclerosis Suppls 4(2): 187-188
Sukhova, G. 2003: 3Ws18-5 Role of elastolytic cathepsins in vascular remodeling. Atherosclerosis Suppls 4(2): 188-189
Imanaka, Y. 2003: 3Ws19-5 Macro and micro costing of atherosclerosis-related diseases in the Japanese health care system. Atherosclerosis Suppls 4(2): 189-190
Taskinen, M.-R. 2003: 3Ws20-6 Is liver the culprit of diabetic dyslipidemia?. Atherosclerosis Suppls 4(2): 190-191
Rigotti, A. 2003: 3Ws22-2 Functional role and regulation of hepatic scavenger receptor class B type I (Sr-Bi). Atherosclerosis Suppls 4(2): 191-192
Fujino, M.; Miura, S.; Matsuo, Y.; Tanigawa, H.; Kawamura, A.; Saku, K. 2003: 3P-0628 Differential effects of hydrophilic and lipophilic statins on cell proliferation and apoptosis. Atherosclerosis Suppls 4(2): 199-200
Nakano, T.; Nakashima, Y.; Yonemitsu, Y.; Sumiyoshi, S.; Sueishi, K. 2003: 3P-0642 Immunohistochemical expression of Vegf-C and D in the atherosclerotic intima of human coronary arteries. Atherosclerosis Suppls 4(2): 202-203
Kakisis, J.; Pradhan, S.; Cordova, A.; Liapis, C.; Sumpio, B. 2003: 3P-0655 Stat-3 activation in smooth muscle cells (Smc) subjected to cyclic strain. Atherosclerosis Suppls 4(2): 205-206
Yamamoto, K.; Sokabe, T.; Ohura, N.; Ando, J. 2003: 3P-0664 Turbulent shear stress upregulates urokinase plasminogen activator gene expression in coronary artery endothelial cells. Atherosclerosis Suppls 4(2): 207-208
Sato, H.; Sato, M.; Kurabayashi, M. 2003: 3P-0674 Fgf-2 signaling induces osteoblastic marker osteopontin gene expression and inhibits smooth muscle differentiation via Cbfa1 in rat aortic smooth muscle cells. Atherosclerosis Suppls 4(2): 209-210
Abe, M.; Hasegawa, K.; Wada, H.; Oda, T.; Yoshida, Y.; Kita, T. 2003: 3P-0679 Statins induce differentiated phenotype in human vascular smooth muscle cells through the inhibition of small Gtp-binding proteins. Atherosclerosis Suppls 4(2): 210-211
Meizi, J.; Bujo, H.; Yamazaki, H.; Shibasaki, M.; Takahashi, K.; Kanaki, T.; Saito, Y. 2003: 3P-0688 An Hmg-CoA reductase inhibitor inhibits the migration of smooth muscle cells through the Lr11-mediated urokinase receptor expression system in vitro. Atherosclerosis Suppls 4(2): 212-213
Yamakawa, T.; Tanaka, S.; Okuda, K.; Sekihara, H. 2003: 3P-0697 Induction of cyclooxygenase-2 by lysophosphatidylcholine in vascular smooth muscle cells: Involvement of p42/44 and p38Mapk pathway. Atherosclerosis Suppls 4(2): 214-215
Uchiyama, Y.; Tanaka, T.; Watanaba, Y.; Iwanari, H.; Jiang, S.-Y.; Naito, M.; Hamakubo, T.; Kodama, T. 2003: 3P-0715 Generation of monoclonal antibodies against nuclear hormone receptors using recombinant baculovirus displaying gp64-fusion proteins. Atherosclerosis Suppls 4(2): 218-219
Oishi, Y.; Manabe, I.; Ishihara, A.; Tsushima, K.; Fujiu, K.; Nishimura, G.; Nagai, R. 2003: 3P-0719 Potential role of Kruppel-like transcription factor5 (Klf5) in adipocyte differentiation. Atherosclerosis Suppls 4(2): 219-220
Kawamura, M.; Ogata, E.; Ashidate, K.; Hagiwara, K.; Matsushita, M.; Tohda, H.; Miyazaki, S.; Hirata, Y.; Teramoto, T. 2003: 3P-0728 Insulin enhances the clearance of modified low-density lipoprotein in vivo. Atherosclerosis Suppls 4(2): 221-222
Nagumo, A.; Ohni, M.; Kohno, Y.; Mizukawa, S.; Akishita, M.; Hata, Y.; Toba, K. 2003: 3P-0733 The incidence of midband lipoproteins in Pag disk electrophoresis and metabolic disorders in patients with normolipidemia. Atherosclerosis Suppls 4(2): 222-223
Yamazaki, H.; Aoki, T.; Maejima, T.; Tamaki, T.; Sato, F.; Saino, Y.; Kitahara, M.; Saito, Y. 2003: 3P-0738 Pitavastatin (Nk-104), an Hmg-CoA reductase inhibitor, is an efficient inducer of Ldl-receptor and reducer of cholesterol. Atherosclerosis Suppls 4(2): 223-224
Aoki, T.; Yamazaki, H.; Maejima, T.; Tamaki, T.; Sato, F.; Kitahara, M.; Saito, Y. 2003: 3P-0747 Effect of pitavastatin on sterol and bile acid excretion in guinea pigs. Atherosclerosis Suppls 4(2): 225-226
Kuwasako, T.; Hirano, K..; Sakai, N.; Ishigami, M.; Hiraoka, H.; Yamashita, S.; Matsuzawa, Y. 2003: 3P-0751 Postprandial hyperlipidemia and increased remnant lipoproteins in human genetic Cd36 deficiency. Atherosclerosis Suppls 4(2): 226-227
David-Couto, R.; Oliveira Dallan, L.A.; Ferreira Lisboa, L.A.; Takume Kawabe, L.; Almeida de Oliveira, S.; Cavalcante Maranh o, R. 2003: 3P-0756 Deposition of cholesterol from a lipid microemulsion in fragments of blood vessels excised from patients during coronary bypass surgery. Atherosclerosis Suppls 4(2): 227-228
Meyer, B.; Duvillard, L.; Owen, A.; Muriel, C.; Packard, C. 2003: 3P-0761 Characterization of intermediate density lipoprotein particles that do and do not bind to chondroitin sulphate. Atherosclerosis Suppls 4(2): 228-229
Rensen, P.; Goudriaan, J.; Teusink, B.; Willems van Dijk, K.; Havekes, L.; Voshol, P. 2003: 3P-0765 The Vldl receptor plays a crucial role in postprandial lipoprotein metabolism. Atherosclerosis Suppls 4(2): 229-230
Okazaki, M.; Sakurabayashi, I.; Nakajima, K.; Nakano, T. 2003: 3P-0774 Serum Rlp-cholesterol levels in hypertriglyceridemia associated with hyperalphalipoproteinemia. Atherosclerosis Suppls 4(2): 231-232
Ishida, T.; Hirata, K..; Kojima, Y.; Choi, S.; Cooper, A.; Quertermous, T.; Yokoyama, M. 2003: 3P-0779 Altered expression of endothelial cell-derived lipase in diseased vessel wall and its impact on Hdl metabolism. Atherosclerosis Suppls 4(2): 232-233
Kloer, H.U.; Hauenschild, A. 2003: 3P-0788 Severe chylomicronemia: Clinical epidemiology and recommendations for treatment. Atherosclerosis Suppls 4(2): 234-235
Shapira, I.; Schechner, V.; Justo, D.; Hershcovici, T.; Zeltser, D.; Beigel, I.; Berliner, S. 2003: 3P-0793 Comparative analysis between dextran sulfate adsorption and direct adsorption of lipoproteins (Dali) in their capability to reduce red blood cell adhesiveness/aggregation in the peripheral blood. Atherosclerosis Suppls 4(2): 235-236
Chen, C.; Cao, Y.; Hu, W. 2003: 3P-0798 A single base mutation (T to A) at position 190 in the apolipoprotein Cii promoter with apolipoprotein Cii deficiency. Atherosclerosis Suppls 4(2): 236-237
Kaito, K.; Abe, K.; Wada, M.; Sano, K.; Yoshitake, N.; Suzuki, H. 2003: 3P-0807 The effect of atorvastatin on Ldl particle size - A clue to atherosclerotic disease. Atherosclerosis Suppls 4(2): 238-239
Beil, F.U.; Buchwald, A.; Evans, D. 2003: 3P-0812 The 1131T> C polymorphism in apolipoprotein A5 (Apoa5) is associated with elevated plasma triglycerides only in overweight patients. Atherosclerosis Suppls 4(2): 239-240
Jones, P. 2003: 3P-0815 Comparison of the efficacy and safety of atorvastatin initiated at different starting doses. Atherosclerosis Suppls 4(2): 240-241
Kogushi, M.; Matsuoka, T.; Kobayashi, H.; Sato, N.; Suzuki, S.; Kawahara, T.; Kajiwara, A.; Hishinuma, I. 2003: 3P-0836 Biological characterization of Er129614-06, a novel, non-peptide protease-activated receptor-1 (Par-1) antagonist. Atherosclerosis Suppls 4(2): 245-246
Nordestgaard, B.; Bojesen, S.E.; Juul, K.; Schnohr, P.; Tybjærg-Hansen, A. 2003: 3P-0845 Platelet glycoprotein Iib/Iiia P1A2/P1A2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men. The Copenhagen City Heart Study. Atherosclerosis Suppls 4(2): 247-248
Aihara, K.; Azuma, H.; Akaike, M.; Fujimura, M.; Hashizume, S.; Yoshida, T.; Kato, M.; Yamaguchi, H.; Kato, S.; Matsumoto, T. 2003: 3P-0850 Lipopolysaccharide-induced thrombus formation in mice lacking vitamin D receptor. Atherosclerosis Suppls 4(2): 248-249
Tedeschi-Reiner, E.; Reiner, 2003: 3P-0860 Cortisol secretion and atherosclerosis of retinal arteries in men. Atherosclerosis Suppls 4(2): 250-251
Matsuyama, A.; Sakai, N.; Ishigami, M.; Hiraoka, H.; Kashine, S.; Nakamura, T.; Yamashita, S.; Matsuzawa, Y. 2003: 3P-0865 Minocycline for the treatment of Takayasu arteritis. Atherosclerosis Suppls 4(2): 251-252
Miyauchi, T.; Hirose, M.; Saito, E.; Nakamura, S.; Nakamura, S.; Hozawa, K.; Nakamura, H.; Yamamoto, K.; Makishima, N.; Koyama, J. 2003: 3P-0869 Initial and long-term clinical result of endoluminal stenting for obstructive lesions of the subclavian artery: Multicenter registry in Japan. Atherosclerosis Suppls 4(2): 252-253
Fukumoto, S.; Koyama, H.; Shoji, T.; Emoto, M.; Nishizawa, Y. 2003: 3P-0874 The mobilization of endothelial progenitor cells in accordance with arterial sclerosis. Atherosclerosis Suppls 4(2): 253-254
Raffai, R.; Loeb, S.; Weisgraber, K. 2003: 3P-0878 A mouse model to study the role of ApoE in atherosclerosis regression and plaque vulnerability in peripheral arterial disease. Atherosclerosis Suppls 4(2): 254-255
Zijta, F. 2003: 3P-0883 B- and M-mode ultrasound studies of arterial wall thickness and arterial wall stiffness in patients with Marfan syndrome and unaffected controls. Atherosclerosis Suppls 4(2): 255-256
Nomura, S.; Merched, A.; Oka, K.; Pastore, L.; Beaudet, A.; Chan, L. 2003: 3P-0887 Ldl receptor gene therapy protects against atherosclerosis in a mouse model of familial hypercholesterolemia. Atherosclerosis Suppls 4(2): 256-257
Nagata, H.; Nakano, H.; Nozaki, M. 2003: 3P-0892 Changes in hs-Crp and Tc/Hdl with transdermal vs. oral Hrt and atorvastatin aiming at primary prevention of cardiovascular diseases. Atherosclerosis Suppls 4(2): 257-258
Sawada, S.; Sato, K.; Yonemura, A.; Kusuhara, M.; Ohsuzu, F. 2003: 3P-0897 The effect of selective estrogen receptor modulators (Serms) on lipid metabolism. Atherosclerosis Suppls 4(2): 258-259
Tank, L.; Siddiq, A.; Bagger, Y..; Alexandersen, P.; Christiansen, C.; Larsen, P.J.; Froguel, P. 2003: 3P-0901 Single-nucleotide polymorphism (Snp) haplotypes in the adiponectin (Apm1) gene with relation to serum adiponectin, body fat distribution, and the severity of atherosclerosis in elderly women. Atherosclerosis Suppls 4(2): 259-260
Okada, T.; Murata, M.; Yamauchi, K.; Harada, K.; Iwata, F.; Hara, M.; Saito, E.; Miyashita, M.; Kuromori, Y. 2003: 3P-0905 Investigation of the new criteria of normal serum lipid levels in Japanese children: The nationwide study. Atherosclerosis Suppls 4(2): 260-261
Wiegman, A.; Hutten, B.A.; DeGroot, E.; Rodenburg, J.; Bakker, H.D.; Biller, H.R.; Sijbrands, E.J.G.; Kastelein, J.J.P. 2003: 3P-0913 Statin therapy in hypercholesterolemic children. Long-term efficacy and safety. Atherosclerosis Suppls 4(2): 262-263
Pasqualini, L.; Marchesi, S.; Siepi, D.; Liberatoscioli, L.; Gnasso, A.; Paris, L.; Lupattelli, G.; Cortese, C.; Mannarino, E. 2003: 3P-0917 Paraoxonase activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis Suppls 4(2): 263-264
Hirschi, K. 2003: 4Sy08-5 Vascular progenitors in adult tissues. Atherosclerosis Suppls 4(2): 265-266
Graier, W. 2003: 4Sy09-4 Ca2+ regulation of signal transduction in the endothelium. Atherosclerosis Suppls 4(2): 266-267
Saito, Y.; Kurabayashi, M.; Nagai, R. 2003: 4Ws25-4 Aging suppressor gene klotho and vascular endothelium. Atherosclerosis Suppls 4(2): 269-270
Ueshima, H. 2003: 4Ws27-1 Population differences in serum total cholesterol level and coronary heart disease. Atherosclerosis Suppls 4(2): 271-272
de Camargo Maranhao, M.F. 2003: 4Ws27-6 Geographical distribution of risk factors for atherosclerosis. Atherosclerosis Suppls 4(2): 272-273
Reddy, K.K.; Reddy, T.P.K.; Papa Rao, A.; Singh, R.B.; Rastogi, S.S.; Tomlinson, B. 2003: 4P-0923 Serum vitamins E, A and lipid peroxidation levels in Kurichias, an Indian tribal population. Atherosclerosis Suppls 4(2): 276-277
Usuda, M.; Sakurai, C.; Uto, H.; Tago, M.; Tani, M.; Kido, T.; Nghiem, T.N.; Miyake, Y.; Sakaida, K.; Kiyose, C.; Suzuki, E.; Kondo, K. 2003: 4P-0933 Effect of lemon flavonoids on resistance of Ldl to oxidation. Atherosclerosis Suppls 4(2): 278-279
DeRoos, B.; Duivenvoorden, I.; Teusink, B.; Pickard, K.; Havekes, L.M. 2003: 4P-0937 Effects of dietary fatty acids on lipoprotein metabolism and changes in hepatic protein levels in apolipoprotein E3-Leiden transgenic mice. Atherosclerosis Suppls 4(2): 279-280
Xu, J.-W.; Ikeda, K.; Yamori, Y. 2003: 4P-0946 Cyanidin-3-glucoside, a typical anthocyanin pigment, induces expression of endothelial nitric oxide synthase through Src-Erk1/2 signaling pathway. Atherosclerosis Suppls 4(2): 281-282
Mehalski, K.; Brand-Miller, J.; Blakesmith, S.; Kirby, A.; Pollicino, C.; Baghurst, K.; Record, S.; Hague, W.; Simes, J.; Nestel, P.; Tonkin, A.; Colquhoun, D. 2003: 4P-0950 Baseline diet glycemic load and glycemic index are determinants of Hdl cholesterol levels in patients with coronary heart disease: results from the Lipid study. Atherosclerosis Suppls 4(2): 282-283
Tsujimoto, M.; Adachi, H. 2003: 4P-0963 Structure and function of novel oxidized-Ldl receptors in endothelial cell. Atherosclerosis Suppls 4(2): 285-286
Gerry, A.B.; Leake, D.S. 2003: 4P-0967 Acidic pH protects against oxidised Ldl-induced apoptosis: possible role of Nf-kB. Atherosclerosis Suppls 4(2): 286-287
Tselepis, A.; Tsironis, L.D.; Mitsios, J.V.; Milionis, H.J.; Elisaf, M. 2003: 4P-0972 Lipoprotein(a) inhibits Paf-induced activation of human platelets in a manner independent of the endogenous Paf-acetylhydrolase activity. Atherosclerosis Suppls 4(2): 287-288
Nawawi, H.; Muid, S.; Osman, N.S.; Annuar, R.; Khalid, B.A.K.; Yusoff, K. 2003: 4P-0981 Enhanced oxidative stress and endothelial dysfunction in patients with familial hypercholesterolaemia. Atherosclerosis Suppls 4(2): 289-290
Shibata, Y.; Kume, N.; Arai, H.; Harauma, A.; Minami, M.; Hayashida, K.; Kamei, K.; Hara, S.; Kita, T.; Yokode, M. 2003: 4P-0990 Mulberry leaf extracts inhibit expression of lectin-like oxidized Ldl receptor-1 (Lox-1) in vascular endothelial cells. Atherosclerosis Suppls 4(2): 291-292
Harauma, A.; Ikeyama, K.; Kamei, K.; Arai, H.; Sano, H.; Murayama, T.; Takano, R.; Hara, S.; Kita, T.; Yokode, M. 2003: 4P-0993 Suppression of atherosclerosis by Mulberry leaf. Atherosclerosis Suppls 4(2): 292-293
Asgary, S.; Naderi, G.A.; Sattary, A.; Ghasemi, N. 2003: 4P-1002 The effect of cigarette smoke, nicotine and cotinine on red blood cell hemolysis and -Sh capacity. Atherosclerosis Suppls 4(2): 294-295
Kontush, A.; DeFaria, E.; Chantepie, S.; Chapman, M.J. 2003: 4P-1007 Anti-atherogenic activity of Hdl particle subspecies: Evidence for impaired antioxidative function in normocholesterolemic low Hdl states. Atherosclerosis Suppls 4(2): 295-296
Zhang, B.; Saku, K. 2003: 4P-1012 Quick and sensitive monitoring of oxidatively modified low density lipoprotein (Ldl) subfractions by capillary isotachophoresis (cItp). Atherosclerosis Suppls 4(2): 296-297
Shiotani, M.; Suzuki, S.; Nakatani, Y.; Itoh, F.; Kurosawa, T.; Hiraiwa, Y.; Ohkura, N.; Funato, M.; Hamakubo, T.; Kodama, T. 2003: 4P-1016 Na2003: as a novel Vldl-secretion inhibitor. Atherosclerosis Suppls 4(2): 297-298
Vijavakumar, R.S.; Nalini, N. 2003: 4P-1020 High cholesterol diet induced alterations in the enzymes of lipoprotein metabolism and modulation by treatment with piperine. Atherosclerosis Suppls 4(2): 298-299
Murano, T.; Shirai, K.; Sako, T.; Oikawa, S. 2003: 4P-1025 The recovery of dysfunctional Lpl (Asp204-Glu) activity by modification of substrate. Atherosclerosis Suppls 4(2): 299-300
Takata, K.; Mishima, Y.; Shirahama, H.; Umemoto, S.; Toyota, Y.; Hiraoka, A. 2003: 4P-1034 A novel nonsense mutation of cholesterol ester transfer protein gene and the clinical characterization of Japanese primary hyperalphalipoproteinemias. Atherosclerosis Suppls 4(2): 301-302
Hayashi, T.; Arockia, J.R.P.; Miyazaki, A.; Iguchi, A. 2003: 4P-1047 A new Hmg-CoA reductase inhibitor, pitavastatin retards remarkably the progression of high cholesterol induced atherosclerosis in rabbits Relevance of nitric oxide and superoxide anion. Atherosclerosis Suppls 4(2): 304-305
Kim, O.Y.; Goh, S.J.; Cha, B.R.; Wee, M.J.; Cho, H.; Jang, Y.; Lee, J.H. 2003: 4P-1056 Interrelationship between circulating C-reactive protein and oxidative stress in men. Atherosclerosis Suppls 4(2): 306-307
Woodman, R.; Playford, D.; Croft, K.; Watts, G. 2003: 4P-1060 Basal production of nitric oxide is increased in the microcirculation in type 2 diabetes despite endothelial dysfunction: association with oxidative stress and blood pressure. Atherosclerosis Suppls 4(2): 307-308
Jin, Z.; Liao, D.-F.; Berk, B. 2003: 4P-1065 Secreted heat shock protein 90-alpha is a novel mediator of oxidative stress via pro-inflammatory effects on vascular cells. Atherosclerosis Suppls 4(2): 308-309
Matsumoto, Y.; Hof, R.P. 2003: 4P-1070 Medial smooth muscle cells are replaced by host derived cells after carotid artery transplantation in transgenic mice expressing green fluorescent protein. Atherosclerosis Suppls 4(2): 309-310
Gavish, D.; Frieman, A.; Tanai, A.; Leibovitz, E.; Shargorodsky, M.; Zimlichman, R. 2003: 4P-1080 Decreased elasticity of large arteries and increased vascular resistance in patients suffering from systemic lupus erythematosus. Atherosclerosis Suppls 4(2): 311-312
Chen, Y.-H.; Lin, S.-J.; Chen, J.-W. 2003: 4P-1089 Activation of mononuclear cells and their adhesiveness to vascular endothelial cells under chronic oxidative stress in clinical and experimental atherosclerosis. Atherosclerosis Suppls 4(2): 313-314
Frostegard, J.; Pockley, A.G.; Georgiades, A.; Thulin, T.; Wu, R.; DeFaire, U. 2003: 4P-1098 Novel immunological risk factors for atherosclerosis. Atherosclerosis Suppls 4(2): 315-316
Kimura, S.; Sasaguri, T.; Tanimoto, A.; Kono, Y.; Sasaguri, Y. 2003: 4P-1103 Expression of macrophage-derived chemokine in U937 cells. Atherosclerosis Suppls 4(2): 316-317
Naruszewicz, M.; Bukowska, H.; Millo, B. 2003: 4P-1107 Increase in plasma propionate after chronic supplementation of diet with lactobacillus plantarum 299 v effect on inflammatory markers and adhesion molecules. Atherosclerosis Suppls 4(2): 317-318
Chiba, K.; Kito, K.; Shibutani, T.; Nishida, K.. 2003: 4P-1111 A small-molecule human Mcp-1 receptor (Ccr2B) antagonist with a highly species specificity. Atherosclerosis Suppls 4(2): 318-319
Beyzade, S.; Zhang, S.; Wong, Y.-K.; Day, I.; Eriksson, P.; Ye, S. 2003: 4P-1120 Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarctiona. Atherosclerosis Suppls 4(2): 320-321
P ll nen, P.; Karhunen, P.; Mikkelsson, J.; Laippala, P.; Ilveskoski, E.; Kunnas, T.; Perola, M.; Penttil, A.; Mattila, K.; Nikkari, S.; Syrj koski, K.; Lehtim ki, T. 2003: 4P-1124 Co-operative polymorphisms of matrix metalloproteinase 3 and 9 and area of coronary artery lesions related to risk of acute coronary events. Atherosclerosis Suppls 4(2): 321-322
Iehara, N.; Imai, H.; Ida, H.; Yamada, Y. 2003: 4P-1128 Modular cis-acting elements required for the 2(Iv) collagen promoter in tissue-specific transcription. Atherosclerosis Suppls 4(2): 322-323
Nakamura, S.; Hirose, M.; Saito, E.; Miyauchi, T.; Kanazawa, A.; Hozawa, K.; Nakamura, H.; Yamamoto, K.; Makishima, N.; Nakamura, S.; Koyama, J. 2003: 4P-1142 Stenting of coronary bifurcation lesions: Y-stening, T-stenting, single stenting, immediate and long-term results: Multicenter registry in Japan. Atherosclerosis Suppls 4(2): 325-326
Mori, T.; Hayashi, T.; Kitaura, Y. 2003: 4P-1146 In the state of increased oxidative stress, edarovone, a free radical scavenger, favorably blunted vascular injury response. Atherosclerosis Suppls 4(2): 326-327
Masuda, M.; Takahashi, H. 2003: 4P-1155 Measurement of soluble FcRiiiaM derived from macrophages in plasma as a novel marker for atherosclerosis. Atherosclerosis Suppls 4(2): 328-329
Shi, G.-Y.; Liu, S.-L.; Chen, Y.-W.; Shi, C.-S.; Wu, M.-H.; Wu, L. 2003: 4P-1164 Effect of pravastatin on the aortic gene expression of ApoE-deficient mice fed with a hypercholesterolemic diet. Atherosclerosis Suppls 4(2): 330-331
Kang, D.-H.; Park, J.-E.; Yoo, E.-S.; Lee, I.-K.; Johnson, R.J. 2003: 4P-1173 Uric acid induced the expression of C-reactive protein (Crp) in vascular smooth muscle cells (Vsmc) via Map kinase-dependent and angiotensin Ii-mediated pathway. Atherosclerosis Suppls 4(2): 332-333
Malyszko, J.; Mysliwiec, M.; Hryszko, T. 2003: 4P-1182 Simvastatin affects hemostasis, endothelial function and Cd40L in capd patients. Atherosclerosis Suppls 4(2): 334-335
Kanbay, M.; Yildirir, A.; Muderrisoglu, H.; Colak, T.; Karakayali, H.; Haberal, M. 2003: 4P-1186 Effects of immunosuppressive therapy on blood lipid profile after renal transplantation. Atherosclerosis Suppls 4(2): 335-336
Zhao, H.; Chen, Q.; Hao, A.-Z.; Zou, X.-M.; Tong, P.; Chan, J.; Tomlinson, B. 2003: 4P-1195 Prescription frequency of herbal medicines in Chinese patients with type 2 diabetes mellitus. Atherosclerosis Suppls 4(2): 337-338
Asgary, S. 2003: 4P-1200 Amirkabiria odoratissima, an anti-inflammatory drug, prevents development of fatty streak. Atherosclerosis Suppls 4(2): 338-339
Cortellaro, M.; Arquati, M.; Gualdoni, A.; Rossi, E. 2003: 4P-1204 Multiorgan atherosclerotic disease in a young patient affected by hyperhomocysteinemia with multiple heterozygous mutations. Atherosclerosis Suppls 4(2): 339-340
Burazor, I.; Burazor, M.; Tasic, G. 2004: W01.9 Infectious agents, inflammation and acute coronary syndromes: Coxackie B virus, acute phase proteins and their potentional role in atherosclerosis. Atherosclerosis Suppls 5(1): 2-3
Cipolletta, C.; Trimble, E. 2004: W01.13 Comparative study of the pharmacological effects of troglitazone, mevinolin and Ly379196 on Ldl receptor, Vldl receptor and macrophage scavenger receptor, Cd36, in macrophage-derived-monocytes. Atherosclerosis Suppls 5(1): 3-4
Derosa, G.; Scalise, F.; Avanzini, M.; Piccinni, M.; Bertone, G.; Mugellini, A.; Geroldi, D.; Perlini, S.; Palladini, G.; Fogari, R. 2004: W01.17 Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event. Atherosclerosis Suppls 5(1): 4-5
Gentile, M.; Rubba, F.; Mattiello, A.; Celentano, E.; Galasso, R.; Ciardullo, A.; de Magistris, M.S.; Del Pel Pezzo, M.; Rubba, P.; Panico, S. 2004: W01.22 Insulin levels and Hs-Crp in a group of mediterranean women: Findings from progetto atena. Atherosclerosis Suppls 5(1): 5-6
Bukarica, L.G.; Novakovic, A.; Stojnic, N.; Kanjuh, V.; Heinle, H. 2004: W01.27 The mechanism of endothelium independent vasorelaxation induced by wine polyphenol resveratrol. Atherosclerosis Suppls 5(1): 6-7
Kowalski, J.; Blazyzyk, J.; Pawlicki, L.; Irzmanski, R.; Petecka, E.; Kowalczyk, E.; Ceglinski, T.; Lewinski, A.; Kedziora, J. 2004: W01.32 Carvedilol inhibits lipid peroxidation in patients with stable angina. Atherosclerosis Suppls 5(1): 7-8
Chan, W.L.; Pejnovic, N.; Hamilton, H.; Popadic, D.; Poggi, A.; Vun Liew, T. 2004: W01.45 Interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 Nkt and Cd4+ T cells: Implication for atherosclerosis disease progression. Atherosclerosis Suppls 5(1): 10-11
Naruszewicz, M.; Zapolska-Downar, D.; Nowicka, G.; Bukowska, H.; Siennicka, A. 2004: W01.54 Acrylamide from processed foodNew potential risk factor for plaque rupture. Atherosclerosis Suppls 5(1): 12-13
Olofsson, P.; Wågsäter, D.; Hansson, G.; Sirsjö, A. 2004: W01.59 Cytomegalovirus inducible gene 5 is induced in human and rodent vascular inflammation and atherosclerosis. Atherosclerosis Suppls 5(1): 13-14
Philippidis, P.; Nadra, I.; Evans, B.; Taylor, K.; Haskard, D.; Landis, C. 2004: W01.68 Hemoglobin scavenging human macrophages elicit haptoglobin phenotype dependent anti-inflammatory responses with potential atheroprotective implications. Atherosclerosis Suppls 5(1): 15-16
Pörn-Ares, I.; Saido, T.; Andersson, T.; Ares, M. 2004: W01.72 Oxidized Ldl induces calpain-dependent cell death and ubiquitination of caspase-3 in Hmec-1 endothelial cells. Atherosclerosis Suppls 5(1): 16-17
Scazzocchio, B.; Vari, R.; DiBenedetto, R.; D'Archivio, M.; Giovannini, C.; Masella, R. 2004: W01.76 Biophenols reduce oxLdl uptake by macrophage scavenger receptors. Atherosclerosis Suppls 5(1): 17-18
Toborek, M.; Henni, B. 2004: W01.85 Unsaturated fatty acid-induced inflammatory environments in human endothelial cells. Atherosclerosis Suppls 5(1): 19-20
Wosik-Erenbek, M. 2004: W01.97 Correlation between positive family history of cardiovascular disease and inflammatory factors for children and adolescents. Atherosclerosis Suppls 5(1): 22-23
Cignarella, A.; Minici, C.; Brusadelli, A.; Bolego, C.; Gaion, R.; Maggi, A.; Puglisi, L. 2004: W01.107 Estrogen receptor expression is altered in the aorta during diabetes and inflammation. Atherosclerosis Suppls 5(1): 24-25
Marques, F.; Sousa, J.C.; de Oliveira, H.F.C.; Sousa, N.; João Saraiva, M.; Almeida Palha, J. 2004: W02.117 The absence of transthyretin influences mouse fat and glucose metabolism. Atherosclerosis Suppls 5(1): 26-27
Sanguino, E.; Alegret, M.; Laguna-Egea, J. 2004: W01.121 Sex-relaetd differential effect of in aged rats. Atherosclerosis Suppls 5(1): 27-28
López-Ruiz, A.; Martinez-Triguero, M.; Casado, M.; Jarabo, M.; Díaz, M.; López-Gutierrez, A.; Casañ, R.; Morillas, C.; Hernandez Mijares, A. 2004: W01.125 Lipoprotein lipase variant N291S is associated with hypertriglyceridemia in familial combined hyperlipidemia. Atherosclerosis Suppls 5(1): 28-29
Ramji, D.; Foka, P.; Irvine, S.; Hughes, T.; Rogers, S.; Singh, N.; Greenow, K.; Evans, S.; Harvey, E.; Ali, S. 2004: W01.129 Signal transduction pathways and transcriptional control mechanisms involved in the cytokine-mediated regulation of key genes in macrophages implicated in foam cell formation and atherosclerosis. Atherosclerosis Suppls 5(1): 29-30
Irvine, S.A.; Foka, P.; Ramji, D.P. 2004: W04.138 Transcriptional regulation of macrophage lipoprotein lipase gene expression by transforming growth factor-beta. Atherosclerosis Suppls 5(1): 31-32
Llampayas, O.; Vilahur, G.; Llorente-Cortés, V.; Badimon, L. 2004: W04.141 Regulation of the monocyte cyclooxigenase-2 mRna by inflammatory mediators and lipids. Atherosclerosis Suppls 5(1): 32-33
Pistamaltzian, N.; Regli, A.; Drosos, T.; Caroni, C.; Kosioni, E.; Ligoura, P.; Zografos, P.; Konstantinidis, I. 2004: W04.146 Correlation between Il-1, Il-6 and Hdl serum levels. Atherosclerosis Suppls 5(1): 33-34
van der Vleuten, G.; Veerkamp, M.; van Tits, L.; Toenhake, H.; den Heijer, M.; Stalenhoef, A.; de Graaf, J. 2004: W04.150 Leptin levels in subjects with familial combined hyperlipidemia. Atherosclerosis Suppls 5(1): 34-35
Öörni, K.; Sneck, M.; Kovanen, P. 2004: W05.154 Decrease in pH enhances aggregation of modified Ldl particles and the binding of Ldl to human arterial proteoglycans. Atherosclerosis Suppls 5(1): 35-36
Minoretti, P.; Emanuele, E.; Visai, L.; Speziale, P.; Icaro-Cornaglia, A.; Peros, E.; Montagna, L.; Geroldi, D.; D'Angelo, A. 2004: W05.158 Binding of lipoprotein(a) to laminin: In vivo and in vitro evidences. Atherosclerosis Suppls 5(1): 36-37
Ferré, R.; Guardiola, M.; Negredo, E.; Ribalta, J.; Salazar, J.; Girona, J.; Clotet, B.; Masana, L. 2004: W06.167 Cetp activity is not influenced by Efavirenz. Atherosclerosis Suppls 5(1): 38-39
Hauer, A.; Uyttenhove, C.; de Vos, P.; Stroobant, V.; Renauld, J.; van Berkel, T.; van Snick, J.; Kuiper, J. 2004: W07.179 Vaccination against interleukin 12 attenuates atherosclerosis in Ldl receptor deficient mice. Atherosclerosis Suppls 5(1): 41-42
Tziakas, D.; Chalikias, G.; Stakos, D.; Hatzinikolaou, H.; Papadopoulou, E.; Kortsaris, A.; Chatscras, D. 2004: W07.184 Serum activity of proinflammatory cytokines in patients with unstable angina or non persistent St elevation myocardial infarction. Effects of short term atorvastatin administration. Atherosclerosis Suppls 5(1): 42-43
Calpe, L.; Escolà, J.; Ribas, V.; Blanco, F. 2004: W08.192 Genes regulated by phytosterol-treatment in a murine model of dyslipemia and atherosclerosis. Atherosclerosis Suppls 5(1): 44-45
Larigauderie, G.; Furman, C.; Lasselin, C.; Copin, C.; Fruchart, J.; Rouis, M. 2004: W08.196 Role of adipophilin on lipid accumulation in human macrophages. Atherosclerosis Suppls 5(1): 45-46
Cohn, J.; Patterson, B.; Uffelman, K.; Davignon, J.; Steiner, G. 2004: W09.200 Insulin resistance is associated with increased Vldl triglyceride and Vldl apoC-Iii production. Atherosclerosis Suppls 5(1): 46-47
Barrett, H.; Ji, J.; Johnson, A.; Serone, A.; Loehrer, F.; Watts, G. 2004: W09.204 Fenofibrate increases Hdl Lpai-Aii production in men with the metabolic syndrome. Atherosclerosis Suppls 5(1): 47-48
Farvid, M.; Ng, W.; Chan, D.; Barrett, H.; Watts, G. 2004: W09.217 Association between plasma adiponectin levels and adipose tissue compartments in men. Atherosclerosis Suppls 5(1): 50-51
Gotis, A.K.; Boxia, P.I.; Labrou, A.D.; Karagkiozaki, V.C.; Borghi, L.F.; Karakiriou, M.K.; Koutsogiannis, O.E.; Savvopoulou, A.G.; Kyrkoudis, A.I.; Panagiotidou, A.E. 2004: W09.221 Metabolic syndrome X in hypertensive patients. From guidelines to clinical practice. Atherosclerosis Suppls 5(1): 51-52
Hassancin, D. 2004: W09.225 Post heart protection study; which lipid guidelines to adopt for diabetics?. Atherosclerosis Suppls 5(1): 52-53
Mäki-Torkko, N.; Juonala, M.; Rönnemaa, T.; Viikari, J.; Raitakari, O. 2004: W09.234 Metabolic syndrome in Finnish young adults: Prevalence and association to carotid artery intima-media thickness. The cardiovascular risk in young Finns study. Atherosclerosis Suppls 5(1): 54-55
Milionis, H.; Liberopoulos, E.; Tzouvaras, V.; Bairaktari, E.; Goudevenos, J.; Seferiadis, K.; Elisaf, M. 2004: W09.243 Metabolic syndrome in elderly patients suffering a first-ever acute ischemic stroke. Atherosclerosis Suppls 5(1): 56-57
Pirro, M.; Savarese, G.; Mannarino, M.; Siepi, D.; Schillaci, G. 2004: W09.248 Effects of the metabolic syndrome on arterial stiffness in hypertensive subjects. Atherosclerosis Suppls 5(1): 57-58
Stollenwerk, M.; Schiopu, A.; Nordin Fredrikson, G.; Diehtl, W.; Nilsson, J.; Ares, M. 2004: W10.269 Very low density lipoprotein potentiates tumor necrosis factor expression in macrophages. Atherosclerosis Suppls 5(1): 62-63
Stein, R.; Peelman, F.; Tavernier, J.; Rosseneu, M. 2004: W11.274 Regulation of the Abca1 transporter activity by protein kinase Ck2. Atherosclerosis Suppls 5(1): 63-64
Hirano, T.; Ito, Y. 2004: W12.296 A novel and simple method for quantification of small dense Ldl and its clinical significance. Atherosclerosis Suppls 5(1): 68-69
Koulouris, S.; Marousis, P.; Karabinos, I.; Triantafyllou, K.; Melpidou, A.; Papageorgakis, N.; Vassiliki, K.; Zoulien, Z.; Pitsavos, C.; Lekakis, J. 2004: W12.300 Saturated fat administration in healthy volunteers is associated with postprandial endothelial dysfunction which is totally reversed by the concomitant intake of red wine. Atherosclerosis Suppls 5(1): 69-70
Sakai, N.; Hibuse, T.; Ohashi, K.; Uchida, Y.; Matsuzawa, Y.; Yamashita, S. 2004: W12.309 Novel Elisa for Apo B-48 revealed chylomicron remnants (Cr) are accumulated in the serum of diabetic patients despite normolipidemia. Atherosclerosis Suppls 5(1): 71-72
Bighetti, E.J.B.; Amaral, M.E.C.; Berti, J.A.; Casquero, A.C.; Boschero, A.C.; Oliveira, H.C.F. 2004: W13.318 Lipemic and glycemic responses to ciprofibrate treatment in genetic dyslipidemic mice. Atherosclerosis Suppls 5(1): 73-74
DeCastellarnau, C.; Casala, C.; Casaroli, R.; Reina, M.; Vilar, S. 2004: W13.322 Effect of different Ldls on endothelial cell barrier function. Atherosclerosis Suppls 5(1): 74-75
Lindén, D.; William-Olsson, L.; Rhedin, M.; Asztély, A.; Clapham, J.; Schreyer, S. 2004: W13.327 Overexpression of mitochondrial glycerol-3-phosphate acyltransferase in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. Atherosclerosis Suppls 5(1): 75-76
Mel'nichenko, A.; Aksenov, D.; Sobenin, I.; Panasenko, O.; Orekhov, A. 2004: W13.331 Different types of enzymatic modification cause aggregation of low density lipoprotein and intracellular cholesterol accumulation. Atherosclerosis Suppls 5(1): 76-77
Whitfield, A.; Crawford, G.; Robertson, K.; Barrett, P.; Hegele, R.; Tran, K.; Yao, Z.; van Bockxmeer, F.; Burnett, J. 2004: W13.340 A novel non-truncating Apob gene mutation, L343V, causes familial hypobetalipoproteinaemia. Atherosclerosis Suppls 5(1): 78-79
Eden, E.; Tosi, I.; Naoumova, R.; Soutar, A. 2004: W14.344 A novel missense mutation in Pcsk9 co-segregates with hypercholesterolaemia in patients from two families of english descent. Atherosclerosis Suppls 5(1): 79-80
Dembinska-Kiec, A.; Niedbal, S.; Malczewska-Malec, M.; Glab, G.; Zdzienicka, A.; Wybranska, I.; Kwasniak, M.; Leszczynska-Golabek, I. 2004: W14.353 The genetic background of obesity treatment efficacy the different results in beta 2-adrenergic receptor Gln27Glu carriers. Atherosclerosis Suppls 5(1): 81-82
Frederiksen, J.; Juul, K.; Grande, P.; Jensen, G.B.; Schroeder, T.V.; Tybærg-Hansen, A.; Nordestgaard, B. 2004: W14.357 Methylenetetrahydrofolate reductase C677T, moderate hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism. Atherosclerosis Suppls 5(1): 82-83
Gylling, H.; Hallikainen, M.; Pihlajamäki, J.; Ågren, J.; Laakso, M.; Miettinen, T. 2004: W14.361 Polymorphism in the Abcg5 and Abcg8 genes and cholesterol and glucose metabolism in mild hypercholesterolemia. Atherosclerosis Suppls 5(1): 83-84
Kaplan, D.; Schreiber, R.; Oliveira, H.; Cruz, M.; Tentor, J.; Harada, L.; Castilho, L.; Nakamura, R.; de Faria, E. 2004: W14.366 Genetics of cholesteryl ester transfer protein in a Brazilian population. Atherosclerosis Suppls 5(1): 84-85
Nissen, P.; Andersen, P.; Jensen, L.; Larsen, L.; Stenderup, A.; Nielsen, G.; Damgaard, D.; Soerensen, V.; Larsen, M.; Faergeman, O. 2004: W14.383 Validation of single strand conformation polymorphism (Sscp) analysis in the detection of mutations in genes such as that coding for the Ldl receptor. Atherosclerosis Suppls 5(1): 88-89
Tarugi, P.; Lancellotti, S.; di Leo, E.; Calandra, S. 2004: W14.392 Familial hypobetalipoproteinemia with no truncated forms of apolipoprotein B detectable in plasma. Atherosclerosis Suppls 5(1): 90-91
Voorbij, H.; van Himbergen, T.; de Graaf, J.; Hattori, H.; Kastelein, J.; van Tits, L.; Stalenhoef, A.; Roest, M. 2004: W14.396 The effects of paraoxonase on cholesterol lowering by simvastatin and atorvastatin. Atherosclerosis Suppls 5(1): 91-92
Hermida, R.; Ayala, D.; Calvo, C.; Dominguez, M.; Covelo, M.; Mojon, A.; Fernandez, J.; Fontao, M.; Soler, R.; Lopez, J. 2004: W15.400 Differences in the seasonal variation of plasma fibrinogen between dipper and nondipper hypertensive patients. Atherosclerosis Suppls 5(1): 92-93
Calebras, C.; Irurita, M.; Fuentes, J.; Lopez, L.; Deniz, C.; Martinez Saavedra, M.; Chirino, K.; Nieto, V.; Diaz Cremades, J. 2004: W15.409 Is hyperhomocystinemia a distinctive feature in young patients with myocardial infarction?. Atherosclerosis Suppls 5(1): 94-95
Herman, Z.; Okopien, B.; Krysiak, R.; Stachura-Kulach, A.; Kulach, A. 2004: W15.418 Extralipid effects of atorvastatin in patients with hypercholesterolemia. Atherosclerosis Suppls 5(1): 96-97
Kuhlmann, C.; Schäfer, M.; Lüdders, D.; Schaefer, C.; Most, A.; Backenköhler, U.; Neumann, T.; Tillmanns, H.; Erdogan, A. 2004: W15.422 Ca2+-activated K+ channels contribute to lysophosphatidylcholine induced endothelial dysfunction. Atherosclerosis Suppls 5(1): 97-98
Motyka, M.; Hartwich, J.; Skrzcczynska, J.; Bzowska, M.; Malczewska-Malec, M.; Pryjma, J.; Dembinska-Kiec, A. 2004: W15.427 Lipoprotein composition related to metabolic syndrome as parameters influencing platelet adhesion. Atherosclerosis Suppls 5(1): 98-99
Sánchez-Gómez, S.; Vilahur, G.; Padro, T.; Badimon, L. 2004: W15.431 Ffr-rFviia by blocking blood-borne tissue factor inhibits thrombosis triggered by ruptured vessel wall. Atherosclerosis Suppls 5(1): 99-100
Appeldoorn, C.; Bonnefoy, A.; Lutters, B.; Daenens, K.; van Berkel, T.; Hoylaerts, M.; Biessen, E. 2004: M.444 Gallic acid is a potent antagonist of P-selectin: Implications for the French paradox. Atherosclerosis Suppls 5(1): 102-103
Ben-Avi, L.; Durst, R.; Shpitzen, S.; Leitersdorf, E.; Meiner, V. 2004: M.460 Apo E genotyping: Accurate, simple, high throughput method using Abi Prism snapshot multiplex system. Atherosclerosis Suppls 5(1): 106-107
Betteridge, D.; Gibson, M. 2004: M.464 Effect of rosuvastatin and atorvastatin on Ldl-C and Crp levels in patients with type-2 diabetes: Results of the andromeda study. Atherosclerosis Suppls 5(1): 107-108
Brotons, C.; Fornasini, M.; Casanovas, J.; Iruela, A.; Vinyeta, R.; Martínez, M.; Bartés, A. 2004: M.473 Use of lipid lowering drugs according to cholesterol value and absolute cardiovascular risk. Atherosclerosis Suppls 5(1): 109-110
Calvo, C.; Hermida, R.; Ayala, D.; Dominguez, M.; Covelo, M.; Lopez, J. 2004: M.477 Ambulatory blood pressure pattern in patients with resistant hypertension as a function of the circadian time of antihypertensive therapy. Atherosclerosis Suppls 5(1): 110-111
Caparevic, Z.; Begovic, D.; Petrovic, D.; Spasic, S.; Cvetkovic, R. 2004: M.481 Oxidized Ldl in middle-aged type 2 diabetes patients without coronary heart disease. Atherosclerosis Suppls 5(1): 111-112
Cheng, X.; Kuzuya, M.; Sasaki, T.; Kanda, S.; Shibata, T.; Nakamura, K.; Ushiyama, M.; Di, Q.; Shi, G.; Iguchi, A. 2004: M.486 Cysteine protease-cathepsins and vascular remodeling after balloon-injury. Atherosclerosis Suppls 5(1): 112-113
Davies, G.; Yin, D.; Alemao, E.; Nocea, G.; Casado, M.; Veltri, E.; Cook, J. 2004: M.497 The economic assessment of lipid lowering therapy with ezetimibe vs atorvastatin titration in Spain. Atherosclerosis Suppls 5(1): 114-115
de Waal, T.; Zijta, F.; Stok, W.; de Groot, E.; Kastelein, J.; Karemaker, J. 2004: M.501 M-mode ultrasound imaging of arterial wall movement and arterial wall thickness of distal carotid arteries in atherosclerosis studies in healthy adults. Atherosclerosis Suppls 5(1): 115-116
Fauler, G.; März, W.; Abletshauser, C.; Erwa, W.; Löser, R. 2004: M.510 Fluvastatin Er formulation reduces cholesterol biosynthesis independent of daytime of administration. Atherosclerosis Suppls 5(1): 117-118
Frikke-Schmidt, R.; Nordestgaard, B.; Tybjærg-Hansen, A. 2004: M.514 High throughput genotyping using the Abi prism 7900Ht sequence detection system. Atherosclerosis Suppls 5(1): 118-119
Hermida, R.; Calvo, C.; Ayala, D.; Dominguez, M.; Covelo, M.; Lopez, J. 2004: M.530 Elevated ambulatory pulse pressure in patients with type 2 diabetes mellitus. Atherosclerosis Suppls 5(1): 122-123
Hollman, G.; Ek, A.; Olsson, A. 2004: M.534 Achievement of treatment goals. Atherosclerosis Suppls 5(1): 123-124
Jukema, J.; Liem, A.; Dunselman, P.; van der Sloot, J.; Lok, D.; Zwinderman, A. 2004: M.542 Ldl-C/Hdl-C ratio in patients with coronary artery disease and low Hdl-C: The radar study. Atherosclerosis Suppls 5(1): 125-126
Karabinos, I.; Koulouris, S.; Papageorgakis, N.; Gregoriadou, A.; Melpidou, A.; Karahalios, T.; Kranodis, A.; Zoulten, Z.; Exadaktylo, N. 2004: M.551 Alpha-1 antitrypsine: Distinct role in inflammatory process and its prognostic significance patients with unstable angina. Atherosclerosis Suppls 5(1): 127-128
Karakitsos, D.; Patrianakos, A.; DeGroot, E.; Parthenakis, F.; Stratigis, S.; Vardaki, E.; Ganotakis, E.; Daphnis, E.; Vardas, P. 2004: M.555 Assessing pulse wave velocity and biophysical properties of the aorta in patients with end-stage renal disease. Atherosclerosis Suppls 5(1): 128-129
Kiortsis, D.; Tsouli, S.; Xydis, V.; Lourida, E.; Argyropoulou, M.; Efremidis, S.; Evangelou, A.; Tselepis, A.; Elisaf, M. 2004: M.559 Correlation of autoantibody titers against various forms of oxidized Ldl with carotid intima media thickness (Imt) in hyperlipidemic patients. Atherosclerosis Suppls 5(1): 129-130
Koulouris, S.; Tryantafillou, K.; Karabinos, I.; Kranidis, A.; Melpidou, A.; Papageorgakis, N.; ElAli, M.; Theororidis, T.; Zoulien, Z.; Kokkinou, V. 2004: M.563 Carotid vs femoral atherosclerosis: Which can better predict coronary artery disease?. Atherosclerosis Suppls 5(1): 130-131
Laszlo, M.; Gyozo, D.; Erzsebet, N.; Ferenc, E.; Andras, K. 2004: M.568 The evaluation of short and long term administration of drugs improving life expectancy in patients with myocardial infarction. Atherosclerosis Suppls 5(1): 131-132
Liu, P.; Tsai, W.; Lin, C.; Hsu, C.; Chen, J. 2004: M.572 Invasive measurements of pulse wave velocity correlate with the degree of echocardiographic aortic valve calcification and its severity in aged patients with degenerative aortic valve stenosis. Atherosclerosis Suppls 5(1): 132-133
Mallén, M.; Martín, B.; Castillo, S.; Pueyo, M.; Pocoví, M. 2004: M.576 A complete genetic diagnostic method for familial hypercholesterolaemia. Atherosclerosis Suppls 5(1): 133-134
Marquez, M.; Yepez, C.; Rosalia, S.; Torres, M.; Rincon, M.; Muñoz, M.; Leal, M.; Oviedo, R. 2004: M.580 Antioxidant vitamins (A, E and C) in the risk profile of cardiovascular disease in dyslipidemic patients. Atherosclerosis Suppls 5(1): 134-135
McMahon, R.; Woodside, J.; Young, I. 2004: M.589 Pulse wave velocity in young adults is independent of plasma homocysteine. Atherosclerosis Suppls 5(1): 136-137
Melnichenko, A.; Sobenin, I.; Pryanishnikov, V.; Orekhov, A. 2004: M.593 Anti-atherosclerotic effects of garlic powder time-released tablets. Atherosclerosis Suppls 5(1): 137-138
Núñez, I.; Gilabert, R.; Pérez-Heras, A.; Serra, M.; Casals, E.; Deulofeu, R.; Ros, E. 2004: M.602 A walnut diet improves endothelial function in hypercholesterolemic subjects: A randomized crossover trial. Atherosclerosis Suppls 5(1): 139-140
Ose, L.; Bays, H.; Fraser, N.; Quinto, K.L.; Reyes, R.; Sapre, A.; Tribble, D.; Donahue, S.R. 2004: M.606 Efficacy and safety of ezetimibe/simvastatin combination tablet compared with simvastatin alone in patients with primary hypercholesterolemia. Atherosclerosis Suppls 5(1): 140-141
Otto, A.; Fontaine, D.; Fontaine, J.; Berkenboom, G. 2004: M.610 Long-term rosuvastatin treatment protects against nitrate-induced oxidative stress. Atherosclerosis Suppls 5(1): 141-142
Pietzsch, J.; Bergmann, R.; Wuest, F.; Pawelke, B.; van den Hoff, J. 2004: M.619 Assessment of metabolism of native and oxidized low density lipoprotein in vivo: Insights from animal positron emission tomography (micropet) studies. Atherosclerosis Suppls 5(1): 143-144
Quax, P.; Pires, N.; van Vlijmen, B.; Havekes, L.; Jukema, W. 2004: M.624 Novel mouse model for rapid screening of anti-restenotic drugs using a drug eluting perivascular device. Atherosclerosis Suppls 5(1): 144-145
Rallidis, L.; Hamodraka, E.; Sinos, L.; Zolindaki, M.; Foulidis, V.; Velissaridou, A. 2004: M.628 Patients who continue to smoke after a myocardial infarction constitute a subgroup that requires a special attention. Atherosclerosis Suppls 5(1): 145-146
Rodriguez-Acebes, S.; de la Cueva, P.; Fernandez, C.; Lasuncion, M.; Martínez-Botas, J.; Gomez-Coronado, D. 2004: M.633 Comparison of the effects of cholesterol and desmosterol on the cell cycle of a Dhcr24-deficient cell line. Atherosclerosis Suppls 5(1): 146-147
Schmidt, C.; Fagerberg, B.; Wikstrand, J.; Hulthe, J. 2004: M.650 Non-stenotic echolucent plaques in the carotid arteries in clinically healthy, 58-year old men predict cardiovascular events. Atherosclerosis Suppls 5(1): 150-151
Todorova, B.; Alabakovska, S.; Labudovic, D.; Tosheska, K. 2004: M.664 Ldl subclasses distribution in different ethnic groups in Macedona. Atherosclerosis Suppls 5(1): 153-154
Tsimihodimos, V.; Irene, G.; Tselepis, A.; Bairaktari, E.; Elisaf, M. 2004: M.669 Effect of fenofibrate on Ldl subfractions in patients with combined dyslipidemia. Atherosclerosis Suppls 5(1): 154-155
Villalba, F.; Espino, A.; Cordobés, J.; González, M.; Alvarez-Lacayo, C.; Jiménez, A.; López-Chozas, J. 2004: M.673 Dipper behaviour and blood pressure with different antihypertensive medications. Atherosclerosis Suppls 5(1): 155-156
Vohnout, B.; Lietava, J.; Blazicek, P.; Dukat, A. 2004: M.678 Relationship of calculated Ldl-C with Apob levels in subjects with normal and elevated levels of triglycerides. Atherosclerosis Suppls 5(1): 156-157
Wijeratne, S.; Iversen, A.; Hall, S.; Hall, S. 2004: M.686 Carotid ultra sound examination as a diagnostic and motivational tool in vascular risk factor clinics. Atherosclerosis Suppls 5(1): 158-159
Zamaklar, M.; Trifunovic, D.; Lalic, K.; Rajkovic, N. 2004: M.690 Unbalanced lipid peroxidation as risk factor for coronary artery disease in type 2 diabetics. Atherosclerosis Suppls 5(1): 159-160
Benbow, U.; Newby, A.C. 2005: W01-O-002 Endothelial monocyte derived activating polypeptide-Ii (Emap-H): A new inducer of matrix metalloproteinase-1 (Mmp-1) in cells of the atherosclerotic plaques. Atherosclerosis Suppls 6(1): 1-2
Favar, E.; Adorni, M.P.; Zimetti, F.; Zanotti, I.; Bernini, F. 2005: W01-P-007 Lercanidipine reduces free cholesterol-induced cytotoxicity. Atherosclerosis Suppls 6(1): 3-4
Pain, S.; Pussinen, P.J.; Sinisalo, J.; Manila, K.; Ahlberg, J.; Valtonen, V.; Nieminen, M.S.; Asikainen, S. 2005: W01-P-011 Serum Lps and antibodies to periodontal bacteria associate with recurrent cardiovascular events. Atherosclerosis Suppls 6(1): 4-5
Vaulin, N.; Pokrovskaya, E.; Gratsiansky, N. 2005: W01-P-015 Gemfibrozil in patients with acute coronary syndrome does not exhibit favourable rapid pleiotropic effects. Atherosclerosis Suppls 6(1): 5-6
Ordovas, J.M. 2005: W02-Is-002 Genetics, diet and healthy aging: The importance of cardiovascular disease prevention. Atherosclerosis Suppls 6(1): 6-7
Bobkova, D.; Bohuslavova, R.; Poledne, R.; Adamkova, V.; Hubacek, J.A. 2005: W02-P-001 Apoaiv variant Gln360His influences thechange in plasma cholesterol concentrations in response to population dietary change in an 8 year follow-up. Atherosclerosis Suppls 6(1): 7-8
Moreno, J.A.; López-Miranda, J.; Pérez-Martinez, P.; Moreno, R.; Gómez, P.; Lozano, A.; Cortés, B.; Fernández de la Puebla, R.A.; Delgado, J.; Fuentes, F.; Pérez-Jiménez, F. 2005: W02-P-009 The apolipoprotein E gene promoter 219G/T polymorphism determines insulin sensitivity in response to dietary fat in healthy young people. Atherosclerosis Suppls 6(1): 9-10
Tzirkalli, M.; Dedoussis, G.; Zambartas, C. 2005: W02-P-013 Tnf- -308G> a polymorphism is not a risk factor for coronary disease (Cid) in a Greek-Cypriot cohort. Atherosclerosis Suppls 6(1): 10-11
Benardi, F.; Scanavini, D. 2005: W03-Is-002 Molecular abnormalities in endothelial cell-plasma protein interactions. Atherosclerosis Suppls 6(1): 11-12
Blann, A.D.; Chong, A.Y.; Freestone, B.; Lip, G.Y.H. 2005: W03-P-001 Increased circulating endothelial cells in acute congestive heart failure: Comparison. Atherosclerosis Suppls 6(1): 12-13
Isler Butun, I.; Domaniç, N.; Ekmekçi, H.; Sömmez, H.; Çiftçi, O.; Gürel, C.; Ulutin, T.; Kökoglu, E.; Vural, V.A. 2005: W03-P-005 Evaluation of nitric oxide, platelet fibronectin and platelet aggregation levels in coronary heart disease. Atherosclerosis Suppls 6(1): 13-14
Toutouza, M.; Vasiliadou, C.; Antoniades, C.; Tousoulis, D.; Giotsas, N.; Koukoura, M.; Pitsavos, C.; Stefanadis, C. 2005: W03-P-012 Lipoproteins affect endothelial function and thrombosic mechanisms in young individuals. Atherosclerosis Suppls 6(1): 15-16
Dobsak, P.; Nagasaka, M.; Siegeloval, J.; Kohzuki, M.; Imachi, K.; Jancik, J.; Eicher, J.C.; Wolf, J.E. 2005: W04-O-001 Promotion of angiogenesis and blood supply restoration in ischemic skeletal muscle of rat after low-voltage electrical stimulation. Atherosclerosis Suppls 6(1): 16-17
Djuric, T.; Zivkovic, M.; Mecanin, S.; Caranovic, O.; Stankovic, A.; Alavantic, D. 2005: W04-P-002 Association of Mmp-3 5A/6A and Nos3 G894T polymorphisms with hypertension and serum Hdl cholesterol level. Atherosclerosis Suppls 6(1): 17-18
Blanco-Colio, L.M.; Rodriguez-Vita, J.; Sanchez-Lopez, E.; Esteban, V.; Egido, J.; Ruiz-Ortega, M. 2005: W04-P-006 Hmg-Coa reductase inhibitors, via Rhoproteins, decrease angiotensin H-induced connective tissue growth factor in vascular smooth muscle cells. Atherosclerosis Suppls 6(1): 18-19
James, R.; Guernier, S.; Deakin, S. 2005: W05-O-002 Gene-statin interactions: The influenceof paraoxonase-1 promoter polymorphism C-107T on up-regulation of gene expression by simvastatin. Atherosclerosis Suppls 6(1): 19-20
Bohuslavova, R.; Hubacek, J.A.; Kadlecová, M.; Zicha, J.; Kunes, J. 2005: W06-P-001 Apolipoprotein Av expression in Prague hypertriglyceridemic rats. Atherosclerosis Suppls 6(1): 22-23
Hubacek, J.A.; Zeng, W.; Škodová, Z.; Vrablik, M.; Talmud, P.J. 2005: W06-P-008 Apoav variant Ala315> Val has no effect on plasma triacylglycerols in a Czech male cohort. Atherosclerosis Suppls 6(1): 24-25
Aran, S.; Tunçkale, A.; Tavsanoglu, S.; Dirican, A. 2005: W07-P-002 Serum Hdl-C levels of turkish patients with glucose abnormalities. Atherosclerosis Suppls 6(1): 26-27
Idzior-Walus, B.; Sieradzki, J.; Kostner, G.; Małecki, M.; Klupa, T.; Wesołowska, T.; Walust, M.; Naruszewicz, M. 2005: W07-P-006 Familial lecithin-cholesterol acyltransferase deficiency: Characteristics of the carriers of a new Lcat gene mutation from a polish family. Atherosclerosis Suppls 6(1): 27-28
Watanabe, H.; Soro-Paavonen, A.; Taskinen, M.-R. 2005: W07-P-010 Characteristics of the Hdl-C particle size in low Hdl-C family members. Atherosclerosis Suppls 6(1): 28-29
Vaverková, H.; Novotný, D.; Karásek, D.; Jackuliaková, D.; Halenka, M.; Budíková, M. 2005: W08-O-003 Adiponectin and its association with metabolic syndrome, inflammatory markers and dyslipidemic phenotypes. Atherosclerosis Suppls 6(1): 29-30
Cymerys, M.; Kopczyński, J.; Dytfeld, J.; Bryl, W.; Miczke, A.; Łuczak, M.; Pupek-Musialik, D.; Bogdański, P. 2005: W08-P-004 Lipoprotein (A) and apolipoprotein B Relationship with other risk factors for atherosclerosis in patients with metabolic syndrome. Atherosclerosis Suppls 6(1): 30-31
Kopecky, J.; Brauner, P.; Matejkova, O.; Mustard, K.J.; Flachs, P.; Thomason-Hughes, M.; Rossmeisl, M.; Hardie, D.G. 2005: W08-P-012 Possible involvement of Amp-activated protein kinase in adipocytes in regulation of adiposity. Atherosclerosis Suppls 6(1): 32-33
Saban-Ruiz, J.; Bernal, E.; Sanchez, O.; Masquez, J.; Monge, B.; Fernandez, E.; Coca, D.; Sanchez-Largo, E.; Trueba, A.; Fabregate, R. 2005: W08-P-028 B-type natriuretic peptide and endothelin in high cardiovascular risk patients without target-organ damage. Atherosclerosis Suppls 6(1): 36-37
Airman, T.J. 2005: W09-Is-001 What can genetics offer in understanding the pathogenesis of coronary heart disease?. Atherosclerosis Suppls 6(1): 38-39
Pires, N.M.; Monraats, P.S.; Schepers, A.; de Vries, M.R.; van Bockel, J.H.; Quax, P.H.; Jukema, J.W. 2005: W09-O-003 Tumor necrosis factor-alpha plays a. Atherosclerosis Suppls 6(1): 39-40
Chang, N.C.; Lint, M.S.; Lee, T.M. 2005: W09-P-004 Effect of pravastatin on sympathetic innervation in hyperlipidemic rabbits. Atherosclerosis Suppls 6(1): 40-41
Matsumoto, M.; Sata, M.; Soma, M.; Nagai, R. 2005: W09-P-009 Oral administration of eicosapentanoic acid reduces and stabilizes atherosclerotic lesions in apoE-deficient mice. Atherosclerosis Suppls 6(1): 41-42
Nachtigal, P.; Semecký, V.; Pospíšlová, N.; Pospechová, K.; Jamborová, G.; Solichová, D.; dánský, P. 2005: W09-P-013 Atorvastatin and its effects on the endothelial expression of Vcam-1 and Icam-1 in Apoe Ko mouse model of atherosclerosis. Atherosclerosis Suppls 6(1): 42-43
Pomaro, D.; Ihara, S.; Pinto, L.; Ueda, I.; Casarini, D.; Santos, A.; Ebihara, F.; Izar, M.; Helfenstein, T.; Fonseca, F. 2005: W09-P-017 High glucose levels abolish antiatherosclerotic benefits of ace inhibition in alloxan-induced diabetes in rabbits. Atherosclerosis Suppls 6(1): 43-44
Shaham, M.; Meir, K.; Weiss, L.; Reich, S.; Zeira, M.; Butbul, E.; Leitersdorf, E. 2005: W09-P-022 The role of sterol 27-iiydroxylase inatherosclerosis: Bone marrow transplantations in genetically modified mice. Atherosclerosis Suppls 6(1): 44-45
Vinagre, C.; DeAngelis, K.; Irigoyen, C.; Maranhao, R. 2005: W09-P-026 Exercise training increases skeletal muscle Ldl uptake. Atherosclerosis Suppls 6(1): 45-46
Ishida, T.; Hirata, K.; Kojima, Y.; Tanaka, H.; Okada, T.; Quertermous, T.; Yokoyama, M. 2005: W10-O-001 Endothelial lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis Suppls 6(1): 46-47
Berrougui, H.; Cloutier, M.; Khalil, A. 2005: W10-P-002 Ageing and cardiovascular diseases,implication of Hdl and paraoxonase in reverse cholesterol transport. Atherosclerosis Suppls 6(1): 47-48
Carettoni, D.; Arioli, P.; Belland, B.; Red˦lli, L. 2005: W10-P-006 Hts assay development for cardiovascular-relevant lipases. Atherosclerosis Suppls 6(1): 48-49
de Faria, E.C.; Tentor, J.; Harada, L.; Nakamura, R.; Gidlund, M.; Castilho, L.N.; Schreiber, R. 2005: W10-P-010 Different metabolic behaviors in the fasting and the post-alimentary periods clarify the association of lipemia with atherosclerosis markers. Atherosclerosis Suppls 6(1): 49-50
Heeren, J.; Ragozine, S.; Niemeier, A.; Laatsch, A.; Merkel, M.; Beisiegel, U. 2005: W10-P-014 Knockdown of hepatic Abca1 decreases plasma Hdl cholesterol levels and influences postprandial lipemia in mice. Atherosclerosis Suppls 6(1): 50-51
Kastelern, J.J.P.; Bots, M.L.; Riley, W.A.; Evans, G.W.; Meijer, R.; Revkin, J.H.; Raszewska, J.; Shear, C.L.; Thuren, T. 2005: W10-P-018 Design of a study comparing torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis in patients with familial hypercholesterolemia. Atherosclerosis Suppls 6(1): 51-52
Lee-Rueckert, M.; Metso, J.; Jauhiainen, M.; Kovauen, P.T. 2005: W10-P-022 Chymase treatment of Hdl3 increased their ability to transfer cholesterol esters and phospholipids mediated by plasma lipid transfer proteins. Atherosclerosis Suppls 6(1): 52-53
Notot, A.T.W.; Mathiesen, E.B.; Hansen, J.B. 2005: W10-P-025 Delayed postprandial clearance of chylomicrons and decreased lipoprotein lipase (Lpl) activity in persons with echolucent carotid plaques. Atherosclerosis Suppls 6(1): 53-54
Vasiliadou, C.; Toutouza, M.; Antoniades, C.; Tousoulis, D.; Koumalos, N.; Giotsas, N.; Pitsavos, C.; Stefanadis, C. 2005: W11-O-003 Ace I/D genetic polymorphism affects the expression of interleukin-6, P-selectin and oxidative stress status during the acute phase of myocardial infarction. Atherosclerosis Suppls 6(1): 56-57
Javorsky, M.; Kozárová, M.; Šalagovic, J.; Tkác, I. 2005: W11-P-005 Relationship among urinary albumin excretion rate, lipoprotein lipase Pvuii polymorphism and plasma fibrinogen in type 2 diabetic patients. Atherosclerosis Suppls 6(1): 57-58
Minchenko, O.; Minchenko, D.; Opentanova, I. 2005: W11-P-009 Upregulation of the transcript level of P-selectin in the heart of C57Bl/6 (wild-type), Ldl-receptor and apoE knockout mice in response to Lps. Atherosclerosis Suppls 6(1): 58-59
Tremblay, N.; Chamberland, A.; Audet, M.; Gilbert, B.; Vohla, M.C.; Gaudet, D.; Laprise, C. 2005: W11-P-013 Analysis of genes associated with obesity in a population of French Canadian forest workers. Atherosclerosis Suppls 6(1): 59-60
Rosengrent, B.; Umaerust, M.; Jönsson-Rylandert, A.-C.; Peilot, H.; Mattsson Hultén, L.; Rodriguez-Lee, M.; Hurt-Camejo, E. 2005: W12-Is-002 Differences in secretory phospholipaseA2 type Iia and V enzymes function in lipoprotein metabolism and possible contribution to atherosclerosis. Atherosclerosis Suppls 6(1): 60-61
Aksenovt, D.; Melnichenko, A.; Suprun, I.; Sobenin, I.; Panasenko, O.; Orekhov, A. 2005: W12-P-002 Apob-100 Antigen structure of naturally occurring modified and enzymatically modified low density lipoprotein. Atherosclerosis Suppls 6(1): 61-62
Bláha, V.; Solichová, D.; Cenohorský, D.; Hyšpler, R.; Vyroubal, P.; Musil, F.; Zadká, Z. 2005: W12-P-006 The impact of abnormalities of fatty acid metabolism in nonagenarians with coronary artery disease. Atherosclerosis Suppls 6(1): 62-63
Frostegard, J.; Svenungsson, E.; Wu, R.; Gunnarsson, I.; Lundberg, I.; Klareskog, L.; Hörkkö, S.; Witztum, J. 2005: W12-P-018 Lipid-peroxidation is enhanced in Sle patients and associated with arterial and renal disease manifestations. Atherosclerosis Suppls 6(1): 65-66
Gorchakova, T.; Suprun, I.; Sobenin, I.; Orekhov, A. 2005: W12-P-023 The suppression of the inflammatory cytokines expression by natural substances. Atherosclerosis Suppls 6(1): 66-67
Grzybowska, J.; Kiec-Wilkt, B.; Piatkowskat, E.; Polust, A.; Kristiansen, K.; Dembinska-Kiec, A. 2005: W12-P-026 Influence of ciglitazone on endothelial cells differentiation and on Bfgf and Vegf-dependent tubulogenesis. Atherosclerosis Suppls 6(1): 67-68
Irurita, M.; Culebra, C.; Diaz Cremades, J.; Irurita, J.; Fuente, J.; Deniz, C.; Martinez Saavedra, M.T.; Chirino, R.; Molina, I.; Nieto, V. 2005: W12-P-030 Role of homocystinemia in the pathogenesis and outcome of premature myocardial infarction. Atherosclerosis Suppls 6(1): 68-69
Lankin, V.; Arzamastseva, N.; Tikhaze, A.; Nedosugova, L.; Konovalova, G.; Lisina, M.; Ageev, F. 2005: W12-P-034 Ldl modification during atherosclerosis and diabetes. Atherosclerosis Suppls 6(1): 69-70
Mayer, C.M.; Gruben, H.J.; Land, E.M.; Scharnag, H.; März, W. 2005: W12-P-038 Statin induced inhibition of Crp expression in primary human hepatocytes. Atherosclerosis Suppls 6(1): 70-71
Negrusz-Kawecka, M.; Poreba, R.; Mazurek, W.; Halawa, B. 2005: W12-P-045 Endothelial function in patients with unstable angina. Atherosclerosis Suppls 6(1): 72-73
Patrignani, P.; DiFebbo, C.; Tacconelli, S.; Moretta, V.; Baccante, G.; Sciulli, M.G.; Antonucci, I.; Stuppia, L.; Porreca, E. 2005: W12-P-049 Cyclooxygenase-2-derived prostacyclin restrains platelet thromboxane biosynthesis in toll-like receptor 4 polymorphisms. Atherosclerosis Suppls 6(1): 73-74
Perunicic-Pekovic, G. 2005: W12-P-053 Markers of inflammation-related parameters of malnutrition in hemodialysis patients. Atherosclerosis Suppls 6(1): 74-75
Poston, R.N.; Marshall, M.; Aiken, A.; Fennes, A.; Louis, H. 2005: W12-P-057 Cd14 dependent adhesion of monocytes to oxidised Ldl and Hsp60 via lipid rafts. Atherosclerosis Suppls 6(1): 75-76
Rodriguez, J.A.; Nespereira, B.; Perez-Ilzarbe, M.; Eguinoa, E.; Paramo, J.A. 2005: W12-P-061 Hypercholesterolemic Ldl increase endothelial Vegf and Vegfr-2 expression by inducing Hif-1alpha and superoxide production. Atherosclerosis Suppls 6(1): 76-77
Serest, I.; Harangi, M.; Erdei, A.; Audikovszky, M.; Debreczeni, L.; Kovacsay, A.; Illyes, L.; Pados, G.; Paragh, G. 2005: W12-P-065 Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome. Atherosclerosis Suppls 6(1): 77-78
Van Antwerpen, P.; Zouaoui Boudjeltia, K.; Legssyer, I.; Babar, S.; Moreau, P.; Moguilevsky, N.; Vanhaeverbeek, M.; Ducobu, J.; Never, J. 2005: W12-P-080 Comparative assessment of the inhibiting effect of captopril and of 4 antagonists of the angiotensin converting enzyme on Ldl oxidation by the myeloperoxidase. Atherosclerosis Suppls 6(1): 81-82
Weiss, N.; Postea, O.; Kroet, E.; Keller, C. 2005: W12-P-084 Stereo-specific and redox-sensitive stimulation of monocyte adhesion to endothelial cells by homocysteine. Atherosclerosis Suppls 6(1): 82-83
Zhdanov, S. 2005: W12-P-088 Immune inflammation and development of early atherosclerotic lesions in the aorta and pulmonary artery. Atherosclerosis Suppls 6(1): 83-84
Hernández-Vargas, P.; Ortiz-Munoz, G.; López-Franco, O.; Sanju n, G.; Suzuki, Y.; Ortega, L.; Egido, J.; Gómez-Guerrero, C. 2005: W13-O-001 Fc receptor deficiency reduces macrophage accumulation and plaque formation in apoE knock-out mice. Atherosclerosis Suppls 6(1): 84-85
Bruckdorfer, K.R.; Grimsditch, D.C.; Fagg, R.S.; Lloyd, A.; Howlett, K.M.; Benson, G.M. 2005: W13-P-002 Elevated haematocrit and reduced neutrophil counts in athero-susceptible C57Bl apoE-/-compared with athero-resistant C3H apoE-/-mice. Atherosclerosis Suppls 6(1): 85-86
Dreux, A.; Lamb, D.J.; Modjtahedi, H.; Ferns, G.A.A. 2005: W13-P-006 Expression and function of the epidermal growth factor receptor (Egfr) on human monocytes. Atherosclerosis Suppls 6(1): 86-87
Kuhlmann, C.R.W.; Reinhold, L.; Schaefer, C.A.; Most, A.K.; Tillmanns, H.; Erdogan, A. 2005: W13-P-010 Angiogenic effects of Sdf-1-alphadepend on K+ channels, Ca2+ and No. Atherosclerosis Suppls 6(1): 87-88
Papadopoulou, C.; Taylor, P.R.; Poston, R.N. 2005: W13-P-014 Antibodies to Il-8, Gro-alpha, Mcp-1 and their receptors Cxcr2 and Ccr2 inhibit the adhesion of U937 cells to human atherosclerotic plaques. Atherosclerosis Suppls 6(1): 88-89
Shiraki, R.; Inoue, N.; Otsui, K.; Honjo, T.; Takahashi, M.; Hirata, K.; Kawashima, S.; Yokoyama, M. 2005: W13-P-018 Toll-like receptor 4 expression on peripheral blood monocytes predicts the risk of coronary artery disease in patients with low C-reactive protein. Atherosclerosis Suppls 6(1): 89-90
Yoon, Y.W.; Kwon, H.M.; Hwang, K.C.; Choi, E.Y.; Hong, B.K.; Kim, D.S.; Kim, H.S. 2005: W13-P-026 The potential role of advanced glycation end products (Ages) in vascular smooth muscle cell proliferation and restenosis in diabetic vasculopathy. Atherosclerosis Suppls 6(1): 91-92
Tornvall, P.; Held, C.; Ericsson, C.-G.; Silveira, A.; Hamsten, A.; Bennermo, M. 2005: W14-P-006 Genotype-specific increase in plasma concentrations of activated coagulation factor Vii in response to experimental inflammation. A link between infection and acute myocardial infarction. Atherosclerosis Suppls 6(1): 94-95
Claudel, T.; Elzinga, B.M.; Bloks, V.; Staels, B.; Voshol, P.J.; Kuipers, F. 2005: W15-Is-002 Role of farnesoid X receptor (Fxr) in control of plasma lipid levels. Atherosclerosis Suppls 6(1): 95-96
Bertolotti, M.; Anzivino, C.; Gabbi, C.; Tenedini, E.; Tagliafico, E.; Ricchi, M.; Carulli, L.; Loria, P.; Carubbi, F.; Carull, N. 2005: W15-P-001 Role of nuclear receptors in the molecular regulation of cholesterol homeostasis in cultured human hepatocytes. Atherosclerosis Suppls 6(1): 96-97
Lestavel, S.; Duval, C.; Touches, V.; Tailleux, A.; Carriere, V.; Fruchart, J.C.; Staels, B.; Clavey, V. 2005: W15-P-005 Regulation of genes encoding intestinal cholesterol transporters by nuclear receptors in human Caco-2/Tc7 enterocytes. Atherosclerosis Suppls 6(1): 97-98
Stein, E.A.; Melezinkova, H.; LeMaulf, F.; Gold, A. 2005: W16-O-003 Efficacy and safety of rosuvastatin 40 Mg in patients with severe type Iia and Iib hypercholesterolaemia. Atherosclerosis Suppls 6(1): 99-100
Bakhai, A.; Allan, S.; Davies, G.M.; Alemao, E.; Thilo, K.; Parker, L.; Yin, D.; Drummond, M. 2005: W16-P-002 Physician perceived barriers to optimal management of hyperlipidemia. Atherosclerosis Suppls 6(1): 100-101
Beigel, Y.; Beigel, R.; Barenboim, E.; Azaria Sofer, B.; Goldstein, L.; Shechter, M. 2005: W16-P-006 The efficacy and safety of statins for primary prevention of atherosclerosis in military air crew personnel. Atherosclerosis Suppls 6(1): 101-102
Bobadilla, J.F.; Gómez-Gerique, J.A.; Del Castillo, A.; Rubio-Terres, C. 2005: W16-P-010 Impact of the comercialized statins on the primary prevention of cardiovascular complications in Spain. Atherosclerosis Suppls 6(1): 102-103
Cabello, R.; Perona, J.S.; Montero, E.; Osada, J.; Ruiz-Gutierrez, V. 2005: W16-P-013 Postprandial lipid response of the orujo olive oil: Similarities and possible advantages compared with refined olive oil. Atherosclerosis Suppls 6(1): 103-104
Davies, A.; Kingslake, S. 2005: W16-P-017 Cost-effectiveness of primary prevention of Cvd from the Uk Nhs perspective: A comparison of men and women with type 2 diabetes. Atherosclerosis Suppls 6(1): 104-105
Díaz-Peromingo, J.A.; Albán-Salgado, A.; Sánchez-Leira, J.; García-Suárez, F.; Padín-Paz, E.; Saborido-Froján, J.; Iglesias-Gallego, M.; Fernández-Ameneiros, M.J. 2005: W16-P-021 Effect of low dose of atorvastatin on hyperhomocysteinemic patients with associated combined hyperlipidemia. Atherosclerosis Suppls 6(1): 105-106
Fait, T.; Vrablik, M.; Kostirova, M. 2005: W16-P-025 Changes of plasma atherosclerosis risk factors' levels caused by estrogen replacement therapy. Atherosclerosis Suppls 6(1): 106-107
Fonseca, F.A.H.; Marotti, M. 2005: W16-P-029 Comparison of the efficacy and tolerability of rosuvastatin with atorvastatin in patients with hypercholesterolaemia: The discovery penta study. Atherosclerosis Suppls 6(1): 107-108
Gupta, M.; Constance, C. 2005: W16-P-033 Direct statin comparison of Ldl-Cvalues: An evaluation of rosuvastatin therapy (discovery Canada). Atherosclerosis Suppls 6(1): 108-109
Chaiseva, L.; Pleskachoff, S.; Jugessur, R.; Ivanchenko, D. 2005: W16-P-037 Lipid metabolism in elderly patients suffering from hypertension drugs therapy. Atherosclerosis Suppls 6(1): 109-110
Kallend, D.; Faergeman, O.; Chitra, R. 2005: W16-P-041 Comparison of the efficacy of rosuvastatin versus other statins in achieving 2003 European Ldl-C goals. Atherosclerosis Suppls 6(1): 110-111
Koroleva, O.; Drinitsina, S.; Pokrovskaya, M.; Nikitina, N.; Azizova, O.; Zateychshikov, D. 2005: W16-P-048 Dependent the dose an activity of atorvastatin on oxidizability and atherogenic of serum of a blood in patients with early coronary artery disease. Atherosclerosis Suppls 6(1): 112-113
Martínez-Martín, F.J.; Rodriguez Rosas, H.; PeiróMartinez, I.; Soriano, P.; de Pablos Velasco, P.L. 2005: W16-P-052 Addition of ezetimibe to the treatment of type 2 diabetic patients with hyperlipidaemia, uncontrolled with statin treatment. Atherosclerosis Suppls 6(1): 113-114
Nikitina, N.; Korennaya, V.; Myasoedova, V.; Khalilov, E.; Sobenin, I.; Orekhov, A. 2005: W16-P-059 Antiatherogenic effects of phytoestrogens in postmenopausal women. Atherosclerosis Suppls 6(1): 115-116
Ose, L.; Stender, S.; Rotonda, J.; Shah, A.; Maccubbin, D.; Tribble, D.; Velhi, E.; Mitchel, Y. 2005: W16-P-063 The lipid-altering effects of Inegy-Tm are consistent across gender, race, age, and baseline Ldl-C levels. Atherosclerosis Suppls 6(1): 116-117
Panagiotakos, D.; Pitsavos, C.; Antonoulas, A.; Zompolos, S.; Kogias, I.; Mantas, I.; Sumvopodis, P.; Stefanadis, C. 2005: W16-P-066 The effect of adherence to the Mediterranean diet on the severity and prognosis of acute coronary syndromes: The Greek study of Acs (the Greecs). Atherosclerosis Suppls 6(1): 117-118
Rajagopalan, S.; Alemao, E.; Yin, D. 2005: W16-P-071 Cv morbidity among Chd patients in Germany. Atherosclerosis Suppls 6(1): 118-119
Richter, D.J.; Goumas, G.; Athanasias, D.; Karabinos, H.; Marousis, P.; Avgerodimos, P.; Papadopoulos, A.; Marinakis, A.; Toutouzas, P.; Voridis, E. 2005: W16-P-074 Duration of first visit to a lipid unit can affect patient's compliance. Atherosclerosis Suppls 6(1): 119-120
Schmitz, G.; Orsó, E.; Bandulik, S.; Boettcher, A.; Binder, M.; Werner, T.; Liebisch, G.; Kramer, W. 2005: W16-P-078 Aminopeptidase N (Cd13) acts as aco-receptor for the enterocytic micellar cholesterol absorption through deep tubular invaginations. Atherosclerosis Suppls 6(1): 120-121
Sobenin, I.; Myasoedova, V.; Orekhov, A. 2005: W16-P-082 Antiatherogenic potency of phytoestrogen-rich plants: The viewpoint for clinical implications. Atherosclerosis Suppls 6(1): 121-122
Pitha, J.; Lejskova, M.; Zecova, S.; Kovar, J.; Stavek, P.; Poledne, R. 2005: W17-O-004 Influence of cardiovascular risk factors on different vascular beds in women. Atherosclerosis Suppls 6(1): 125-126
Chow, W.S.; Tso, A.W.K.; Shiu, S.W.M.; Wong, Y.; Ai, V.H.G.; Tan, K.C.B. 2005: W17-P-008 Phospholipid transfer protein activity and endothelial dysfunction in type 2 diabetes. Atherosclerosis Suppls 6(1): 127-128
Marian, I.; Marian, A.; Ardelean, L.; Chiorescu, R.; Blaga, S. 2005: W17-P-012 Relation between carotid intima-mediathickness and lipid profile at patients with metabolic syndrome. Atherosclerosis Suppls 6(1): 128-129
Rapaee, R.; Muid, S.; Nawawi, H.; Khalid, B.A.K.; Yusoff, K. 2005: W17-P-016 Treatment with atorvastatin improved luminal diameter of brachial artery in patients with hypercholesterolemia. Atherosclerosis Suppls 6(1): 129-130
Troseid, M.; Hjerkinn, E.M.; Seljeflot, I.; Klemsdal, T.O.; Bergengen, L.; Breivik, L.; Arnesen, H. 2005: W17-P-020 Comparison of biochemical, functional and structural measurements of arterial wall properties in elderly men. Atherosclerosis Suppls 6(1): 130-131
Kolovou, D.; Anagnostopoulou, K.; Pavlidis, A.; Salpea, K.; Pilatis, N.; Iraklianou, S.; Papadopoulou, E.; Sorondila, K.; Cokkinos, D. 2005: T01-P-014 Postprandial lipaemia in men with metabolic syndrome and healthy men. Atherosclerosis Suppls 6(1): 136-137
Sasaki, J. 2005: T01-P-026 Prevalence of coronary events and cerebral infarction in male patients with the metabolic syndrome: The Kyushu lipid intervention study (Klis). Atherosclerosis Suppls 6(1): 139-140
Kowalski, J.; Pawlicki, L.; Ceglinski, T.; Irzmanski, R.; Kedziora, J.; Lewinski, A. 2005: T02-P-007 Estimation of antioxidative effect of carvedilol in patients after myocardial infarction. Atherosclerosis Suppls 6(1): 142-143
Narbute, I.; Erglis, A.; Kalnins, U. 2005: T02-P-011 Transradial approach for coronary procedures The experience of Latvian Centre of Cardiology. Atherosclerosis Suppls 6(1): 143-144
Costa, R.; Izar, M.; Santos, A.; Pinto, L.; Ihara, S.; Las Casas, A.; Relvas, W.; Dabella, M.; Fonseca, F. 2005: T03-P-003 Drip paper-filtered and boiled and cotton-filtered coffee reduce lipid peroxidation and anthropometric parameters in primary hypercholesterolemia. Atherosclerosis Suppls 6(1): 146-147
Ficker, E.S.; Vinagre, C.G.; Chacra, A.P.M.; Neves, V.C.; Negrao, C.E.; Oliveira, M.E.F.; Maranhao, R.C. 2005: T03-P-007 Exercise-training accelerates low-density lipoprotein metabolism in hypercholesterolemia. Atherosclerosis Suppls 6(1): 147-148
Blaha, V.; Solichova, D.S. 2005: T03-P-019 Changes of cholesterol metabolism in nonagenarians. Atherosclerosis Suppls 6(1): 150-151
Yu, R.H.Y.; Hot, S.C.; Ho, S.S.Y.; Woo, J.L.F.; Woo, K.S.; Ahuja, A.T. 2005: T03-P-023 Distribution and prevalence of subclinical atherosclerosis as determined by carotid intima media thickness and plaque index in early postmenopausal Chinese women in Hong Kong. Atherosclerosis Suppls 6(1): 151-152
Andrianova, I.; Sobenin, I.; Orekbov, A. 2005: T04-P-004 Direct atherogenic effect of homocysteine in cultured human intimal cells. Atherosclerosis Suppls 6(1): 152-153
Buyukozturk, K.; Ilerigelen, B.; Kabakci, G.; Koylan, N.; Kozan, O. 2005: T04-P-008 The impact of hs-crp on risk evaluation in hypertensive patients: Lessons learned from iceberg study. Atherosclerosis Suppls 6(1): 153-154
de Faria, E.; Dalpino, F.; Sodré, F.; Oliveira, H.C. 2005: T04-P-012 High prevalence of different types ofdyslipidemia in individuals from an urban area of the state of Sao Paulo, Brazil. Atherosclerosis Suppls 6(1): 154-155
Filippatos, T.D.; Gazi, I.; Kiortsis, D.N.; Elisaf, M.S.; Tselepis, A.D. 2005: T04-P-016 Plasma Paf-Acetylhydrolase (Lp-Pla2) activity as a marker of small-dense Ldl in subjects at median cardiovascular risk. Atherosclerosis Suppls 6(1): 155-156
Jegere, S.; Erglis, A.; Kumsars, I.; Narbute, I.; Sondore, D.; Dinne, I.; Kalnins, U. 2005: T04-P-020 Riga ncb and Riga I Ncb Studies: The Effect of Barotrauma reduction on neointimal proliferation after regular and direct stenting. Atherosclerosis Suppls 6(1): 156-157
Kirmizis, D.; Tsiandoulass, A.; Koutoupa, E.; Pangalou, M.; Rozi, P.; Protopappa, M.; Barboutis, K. 2005: T04-P-024 Serum apolipoprotein al (Apoa1) levels are strong predictors of atherosclerotic cardiovascular disease in patients on chronic haemodialysis. Atherosclerosis Suppls 6(1): 157-158
Krstacic, A.; Krstacic, G.; Gamberger, D.; Car, Z. 2005: T04-P-028 Stroke patient models based on supervised inductive machine learning. Atherosclerosis Suppls 6(1): 158-159
Malek, F.; Malkova, J.; Pokorny, R. 2005: T04-P-031 Effect of maternal diet during pregnancy on insulin levels and birth weight of neonates. Atherosclerosis Suppls 6(1): 159-160
Normen, L.; Horm, M.; Lear, S.; Harris, M.; Montaner, J.; Bondy, G. 2005: T04-P-035 Pancreatitis frequency in Hiv-positive and Hiv-negative patients with hypertriglyceridemia. Atherosclerosis Suppls 6(1): 160-161
Sayar, N.; Terzi, S.; Akbulut, T.; Ergelen, M.; Bilsel, T.; Ciloglu, F.; Yesilcimen, K. 2005: T04-P-039 The role of plasma homocysteine levelon collateral status in single-vessel chronic total occlusion. Atherosclerosis Suppls 6(1): 161-162
Tomás, M.; Manresa, J.M.; Zamora, A.; Fitó, M.; Covas, M.I.; Alcántara, M.; Latorre, G.; Sentí, M.; Marrugat, J. 2005: T04-P-043 Interrelationship of classical and emergent risk factors with genetic variants relevant to coronary heart disease. Atherosclerosis Suppls 6(1): 162-163
Vlachogiannis, E.; Liavvas, C.H.; Koukoulidou, Z.; Dougalis, A.; Mousiolis, A.; Daskalopoulou, E. 2005: T04-P-047 Risk factors for atherosclerosis in patients with obstructive sleep apnea syndrome. Atherosclerosis Suppls 6(1): 163-164
Saban-Ruiz, J.; Bernal, E.; Sanchez, O.; Sanchez-Largo, E.; Ugalde, A.; Fernadez, E.; Coca, D.; Fabregate, R.; Villar, L.M.; Marquez, J. 2005: T05-P-004 Association between C-Reactive protein and metabolic/haemodynamic parameters. Atherosclerosis Suppls 6(1): 164-165
Damas, S.A.; Ficker, E.S.; Silveira, M.F.; Vinagre, C.G.; Ianni, B.M.; Mady, C.; Maranhao, R.C. 2005: T06-P-003 Plasma kinetics of a lipid emulsion resembling low-density lipoprotein in morbid obesity. Atherosclerosis Suppls 6(1): 165-166
Jauhiainen, M.; Setälä, N.; Ehnholm, C.; Metso, J.; Tervo, T.; Eriksson, O.; Holopainen, J. 2005: T06-P-007 Phospholipid transfer protein (Pltp) is present in human tear fluid. Atherosclerosis Suppls 6(1): 166-167
Meshkov, A.; Stambolsky, D.; Nikitina, L.; Abdullaev, S.; Bochkov, V.; Tkachuk, V.; Kukharchuk, V.; Malyshevt, P. 2005: T07-P-008 Genetic risk factors for coronary heart disease in patients with familial hypercholesterolemia. Atherosclerosis Suppls 6(1): 172-173
Kinoshita, S.; Tsuji, E. 2006: Mo-P5:307 Effect of vitamin E supplementation on immune responses to prolonged exercise. Atherosclerosis Suppls 7(3): 113-114
Berbée, J.F.P.; Schippers, E.F.; Van Der Hoogt, C.C.; Kitchens, R.L.; Van Dissel, J.T.; Bakker-Woudenberg, I.A.J.M.; Havekes, L.M.; Rensen, P.C.N. 2006: Tu-P7:194 Apolipoprotein Ci stimulates the inflammatory response to lipopolysaccharide in mice and humans. Atherosclerosis Suppls 7(3): 227-228
Gerry, A.B.; Leake, D.S. 2006: Tu-P8:327 Mouse, but not human, macrophages activate Nfkappab P50 homodimers in response to low extracellular Ph to limit Tnf-alpha induced cytokine secretion. Atherosclerosis Suppls 7(3): 256-257
Religa, P.; Grudzinska, M.; Wolmer, N.; Bojakowski, K.; Nozynski, J.; Zakliczynski, M.; Zembala, M.; Gaciong, Z.; Soderberg-Naucler, C. 2006: Tu-P10:477 Vascular chimerism of human cardiac allograft is the result of inflammatory response. Atherosclerosis Suppls 7(3): 289-290
Batuca, J.; Delgado Alves, J. 2006: We-P11:271 Humoral response against high density lipoproteins (Hdl) in normal population. Atherosclerosis Suppls 7(3): 405-406
Garrett, B.; Superko, A.; McGovern, M.; Superko, R. 2006: Th-P16:337 Nicotinic acid: A woman's drug. Atherosclerosis Suppls 7(3): 567-568
Chaduneli, E.; Chagunava, K.; Tsiskarishvili, D. 2006: Th-P16:410 Beneficial effects of simvastatin (Vasilip) on thrombogenic response an lipid profile in subjects with Chd. Atherosclerosis Suppls 7(3): 583-584
Moreno, J.A.; Pérez-Jiménez, F.; Pérez-Martínez, P.; Cortés, B.; García-Salas, M.; Ruano, J.; Gallego, A.; López-Miranda, J. 2006: Th-P17:419 The apolipoprotein E gene promoter (491 A/T) polymorphism determines triacylglycerol plasma concentration in response to dietary fat. Atherosclerosis Suppls 7(3): 585-586
Potter, K.; Hankey, G.J.; Green, D.J.; Arnolda, L.F. 2007: Wo1-Or-6 Long-Term Treatment with Folic Acid, Vitamin B6 and B12 does not Improve Vascular Structure or Function: A Randomized Controlled Trial. Atherosclerosis Suppls 8(1): 1-2
Pauletto, P.; Puato, M.; Zanardo, M.; Rattazzi, M.; Winnicki, M.; Longo, D.; Dorigatti, F.; Palatini, P. 2007: Wo8-Or-5 a 5-Year Perspective Study on Ultrasound Carotid Intima-Media Thickness in Grade I Hypertensives. Atherosclerosis Suppls 8(1): 8-9
Hodson, L.; Fielding, B.A.; Milne, R.W.; Karpe, F.; Frayn, K.N. 2007: Wo9-Or-5 Insulin Resistance Reduces the Contribution of Systemic Plasma Non-Esterified Fatty Acids into Very Low-Density Lipoprotein Triacylglycerol. Atherosclerosis Suppls 8(1): 9-10
Pettersson, C.; Fogelstrand, L.; Rosengren, B.; Stahlman, S.; Hurt-Camejo, E.; Fagerberg, B.; Wiklund, O. 2007: Wo10-Or-5 increased Lipolysis by Secretory Phospholipase A2 Group V of Lipoproteins from Subjects with type 2 Diabetes and the Metabolic Syndrome. Atherosclerosis Suppls 8(1): 10-11
Fornage, M.; Carr, J.J.; Jacobs, D.R.; Loria, C.M.; Steffen, L.M.; Williams, O.D. 2007: Wo12-Or-4 Association of Alox15 Gene Polymorphisms with Prevalence and Progression of Coronary Artery Calcification: The Cardia Study. Atherosclerosis Suppls 8(1): 12-13
Pejnovic, N.; Vratimos, A.; Lee, S.H.; Popadic, D.; Takeda, K.; Hamilton, H.; Liew, T.V.; Akira, S.; Chan, W.L. 2007: Wo13-Or-4 increased Atherosclerotic Lesions and Th17 cells in Interleukin-18 Deficient Apolipoprotein E-Knockout Mice Fed High-Cholesterol Diet. Atherosclerosis Suppls 8(1): 13-14
Asmis, R. 2007: Wo14-Or-4 Thiol Oxidative Stress in Macrophage Injury and Atherosclerotic Lesion Development in Ldl Receptor-Deficient Mice. Atherosclerosis Suppls 8(1): 14-15
Fasano, T.; Cefalu', A.B.; DiLeo, E.; Noto, D.; Pollaccia, D.; Bocchi, L.; Valenti, V.; Guardamagna, O.; Averna, M.; Tarugi, P. 2007: Wo15-Or-4 a Novel Loss of Function Mutation of Pcsk9 Gene in Caucasians with low Plasma Ldl-Cholesterol. Atherosclerosis Suppls 8(1): 15-16
Panayiotou, A.; Georgiou, N.; Nicolaides, A.N.; Tyllis, T.; Griffin, M.; Martin, R.; Bond, D.; Tziakouri, C.H.; Panayiotou, C.; Fessas, C.H. 2007: Wo16-Or-4 Association Of Serum Homocysteine, Folate And Mthfr C677T Genotypes With Early Atherosclerosis. Results From The Cyprus Study. Atherosclerosis Suppls 8(1): 16-17
Hodis, J.; Farghali, H. 2007: Po1-17 effect of Troglitazone and its Blocker (Sr-202) on Nitric Oxide Production and Lipolysis in Adipocyte Culture. Atherosclerosis Suppls 8(1): 22-23
Marinou, K.; Hodson, L.; Frayn, K.N.; Karpe, F.; Fielding, B.A. 2007: Po1-21 Sources of Fatty Acids for 3-Hydroxybutyrate Production Differ during Short-Term Fasting in Men and Women. Atherosclerosis Suppls 8(1): 23-24
Andersson, L.; Ericson, J.; Bostrom, P.; Rutberg, M.; Li, L.; Magnusson, B.; Olofsson, S.O. 2007: Po2-25 the Mechanism of the Assembly of Cytosolic Lipid Droplets. Atherosclerosis Suppls 8(1): 24-25
Vikstedt, R.; Metso, J.; Ye, D.; Hildebrand, R.; Van Berkel, T.; Ehnholm, C.; Jauhiainen, M.; Van Eck, M. 2007: Po2-29 Deficiency of Macrophage Phospholipid Transfer Protein Protects against Atherosclerotic Lesion Development. Atherosclerosis Suppls 8(1): 25-26
Muilu, M.J.; Nuutinen, S.; Metso, J.; Pussinen, P.; Enholm, C.; Jauhiainen, M. 2007: Po2-42 Development and Application of a Novel Mouse Apoe Elisa Method. Atherosclerosis Suppls 8(1): 28-29
Pospisilova, N.; Nachtigal, P.; Jamborova, G.; Pospechova, K.; Solichova, D.; Andrys, C.; Zdansky, P.; Semecky, V. 2007: Po2-55 Apoe/Ldl Receptor-Double-Knockout Mice: An Animal Model for the Study of Statins effects in Atherogenesis. Atherosclerosis Suppls 8(1): 31-32
Korth, R.M. 2007: Po3-59 Smoking, Borderline Ldl Levels and Renal small Vessel Disease of Women with Overweight. Atherosclerosis Suppls 8(1): 32-33
Bakunts, H.; Yegyan, L. 2007: Po3-68 Immune Complexes and Lipid Spectrum in Patients with Stroke. Atherosclerosis Suppls 8(1): 34-35
van Schalkwijk, D.B.; Freidig, A.P.; van Ommen, B.; van der Greef, J. 2007: Po3-77 Particle Profiler: A Model Analysis of Lipoprotein Delipidation. Atherosclerosis Suppls 8(1): 36-37
Brouwers, M.; van Greevenbroek, M.; de Graaf, J.; Georgieva, A.; van der Kallen, C.; ter Avest, E.; Stehouwer, C.; Stalenhoef, A.; de Bruin, T. 2007: Po3-81 Parabolic relation between Plasma Triglycerides and Ldl-Cholesterol in Familial Combined Hyperlipidemia: The Multiple-Type Hyperlipidemia Explained?. Atherosclerosis Suppls 8(1): 37-38
Tsimihodimos, V.; Gazi, I.; Kalogirou, M.; Tselepis, A.D.; Elisaf, M. 2007: Po3-85 Evaluation of the Ability of Simple Lipid Measures to Predict the Presence of Small, Dense Ldl Particles. Atherosclerosis Suppls 8(1): 38-39
Kopprasch, S.; Ansurudeen, I.; Pietzsch, J.; Graessler, J.; Bornstein, S.R. 2007: Po4-94 Native and Oxidized low Density Lipoprotein Modulate Adrenal Steroidogenesis via Extracellular Signal-Regulated Kinase. Atherosclerosis Suppls 8(1): 40-41
Busto, R.; Sanchez-Wandelmer, J.; Davalos, A.; Pastor, O.; Lasuncion, M.A. 2007: Po4-103 Inhibition of Cholesterol Biosynthesis Affects Lipid Raft/Caveolae and Signal Transduction in Adipogenesis. Atherosclerosis Suppls 8(1): 42-43
Dedoussis, G.; Panagiotakos, D.B.; Pitsavos, C.; Chrysohoou, C.; Stefanadis, C. 2007: Po5-107 The Interaction Between Adherence To The Mediterranean Diet And Methylenetetrahydrofolate Reductase C677T Mutation On Homocysteine Concentrations. Atherosclerosis Suppls 8(1): 43-44
Conti, B.; Montali, A.; Valiante, S.; Gaudio, C.; Panetta, G.; Pergolini, A.; Antonini, R.; Violi, F.; Campagna, F.; Arca, M. 2007: Po5-111 C242T Polymorphism Of Nadph Oxidase P22Phox Gene Predicts Major Cardiovascular Events (Mace) In High-Risk Individuals. Atherosclerosis Suppls 8(1): 44-45
Sazonova, M.A.; Budnikov, Y.Y.; Khasanova, Z.B.; Postnov, A.Y.; Sobenin, I.A.; Orekhov, A.N. 2007: Po5-115 Direct Quantitative Assessment of Mutant Allele in Mitochondrial Genome in Atherosclerotic Lesion of Human Aorta. Atherosclerosis Suppls 8(1): 45-46
Cefalu', A.B.; DiLeo, E.; Martini, S.; Vigna, G.; Noto, D.; Magnolo, L.; Barbagallo, C.M.; Tarugi, P.; Averna, M.R. 2007: Po5-119 Mutations in the Cetp Gene in Italian Subjects with Hyperalphalipoproteinemia. Atherosclerosis Suppls 8(1): 46-47
Ariza, M.J.; Hornos, A.; Rioja, J.; Requena, G.; Roman-Garcia, J.; Valdivielso, P.; Sanchez-Chaparro, M.A.; Gonzalez-Santos, P. 2007: Po5-123 Association Of Lpl Variants, D9N And N291S, And Apo E Polymorphisms With Hypertriglyceridemia In A Mediterranean Spanish Working Population. Atherosclerosis Suppls 8(1): 47-48
Bacci, S.; Zhang, Y.Y.; Boonyasrisawat, W.; Nolan, D.; Duffy, J.; Morini, E.; Turchi, F.; Salvemini, L.; Mangiacotti, D.; Mastroianno, S.; Menzaghi, C.; Prudente, S.; Doria, A.; Trischitta, V. 2007: Po5-126 Combined Effect Of K121Q Of Enpp1 (Pc-1) And Q84R Of Trib3 On Age At Myocardial Infarction In Type 2 Diabetic Patients. Atherosclerosis Suppls 8(1): 48-49
Zambon, A.; Mercurio, D.; Zarantonello, G.; Leon, A.; Vianello, D.; Battistin, L.; Cagnin, A.C. 2007: Po5-147 Association Of Paraoxonase 1 Poly- Morphism With Alzheimer'S Disease And Increased Plasma Levels Of Oxidized Ldl. Atherosclerosis Suppls 8(1): 53-54
van den Berg, T.M.; Rietveld, A.P.; van Zaanen, H.C.T.; Chaves, F.J.; Real, J.T.; Carmena, R.; Elte, J.W.F.; Castro Cabezas, M. 2007: Po5-151 Angiotensin Ii and Ace Polymorphisms in relation to Fasting and Postprandial Lipids and Determinants of the Metabolic Syndrome. Atherosclerosis Suppls 8(1): 54-55
Kuznetsova, T.Y.; Dudanov, I.P.; Gavrilov, D.V.; Balatski, A.V.; Makarevich, P.I.; Parfjonova, E.V.; Samokhodskaja, L.M. 2007: Po5-155 Polymorphism Glu298Asp Of Endothelial Nitric Oxide Synthase Gene And Its Influence On Incidence Of Atherosclerosis In Patients With Arterial Hypertension. Atherosclerosis Suppls 8(1): 55-56
Hoefle, G.; Muendlein, A.; Saely, C.H.; Risch, L.; Rein, P.; Koch, L.; Schmid, F.; Aczel, S.; Marte, T.; Langer, P.; Drexel, H. 2007: Po5-159 The 11377 C>G Promoter Variant Of The Adiponectin Gene, Prevalence Of Coronary Atherosclerosis, And Incidence Of Vascular Events In Men. Atherosclerosis Suppls 8(1): 56-57
Karabina, S.A.; Maouche, S.; Gora, S.; Lambeau, G.; Cambien, F.; Ninio, E. 2007: Po6-163 Profiling of Macrophage Gene Expression in Response to Ldl Particles Modified by Human Group X Secreted Phospholipase A2. Atherosclerosis Suppls 8(1): 57-58
Garcia-Fuentes, E.; Garcia- Almeida, J.M.; Garrido-Sanchez, L.; Garcia-Arnes, J.; Bermudez-Silva, F.J.; Garcia-Serrano, S.; Rodriguez de Fonseca, F.; Soriguer, F. 2007: Po6-167 Cb1 Cannabinoid Receptors Regulate the Fatty Acid Metabolism in Morbidly Obese Persons. Atherosclerosis Suppls 8(1): 58-59
Krapivner, S.; Popov, S.; Chernogubova, E.; Hellenius, M.L.; Fisher, R.; Hamsten, A.; van't Hooft, F. 2007: Po6-176 Human Evidence for the Involvement of Insig-2 in the Adipose Tissue Metabolism. Atherosclerosis Suppls 8(1): 60-61
Davalos, A.; de la Pena, G.; Castilla, P.; Sanchez-Martin, C.C.; Martin-Sanchez, C.; Lasuncion, M.A. 2007: Po7-179 Grape Juice Polyphenols Downregulate Nicotinamide Adenine Dinucleotide Phosphate Oxidase Subunit Expression in Circulating Blood cells. Atherosclerosis Suppls 8(1): 61-62
Tomlinson, B.; Lui, S.S.H.; Hu, T.M.; Chu, T.T.W.; Poon, E.; Baum, L.; Ko, G.T.C. 2007: Po7-183 Effects Of Cyp2D6 Polymorphism On Response To Rosuvastatin In Chinese Patients. Atherosclerosis Suppls 8(1): 62-63
Nik Tavakoli, N.; Harris, A.K.; Bao, S.; Hambly, B.D. 2007: Po8-195 Interferon-Gamma Contributes to Neointimal Proliferation following Arterial Angioplasty in a Mouse Model. Atherosclerosis Suppls 8(1): 65-66
Derosa, G.; Cicero, A.F.G.; DAngelo, A.; Celentano, C.; Fiorenza, A.M.; Salvadeo, S.A.T.; Pricolo, F.; Ferrari, I.; Gravina, A.; Fogari, R. 2007: Po9-200 Inflammation Markers and Mmps in Nondiabetic and Diabetic Subjects during Ogtt. Atherosclerosis Suppls 8(1): 66-67
Heikkila, H.M.; Latti, S.; Leskinen, M.J.; Hakala, J.K.; Kovanen, P.T.; Lindstedt, K.A. 2007: Po9-204 Activated Mast cells Induce Endothelial cell Apoptosis by a Combined Action of Chymase and Tnf-Alpha. Atherosclerosis Suppls 8(1): 67-68
Haversen, L.; Noren, K.; Ullstrom, C.; Wiklund, O. 2007: Po9-217 Palmitate Induces Proinflammatory Cytokine Secretion in Human Macrophages via Activation of P38 and Jnk Kinases. Atherosclerosis Suppls 8(1): 70-71
Gargiulo, S.; Gamba, P.; Sottero, B.; Leonarduzzi, G.; Kadl, A.; Robbesyn, F.; Leitinger, N.; Poli, G. 2007: Po9-221 Pro-Inflammatory effect of Oxysterols: Up-Regulation of Mcp-1 in Macrophage cells. Atherosclerosis Suppls 8(1): 71-72
Dimitiou, A.A.; Stathopoulos, P.; Tsikaris, B.; Tselepis, A.D. 2007: Po9-225 Inhibition of Platelet Activation by Peptide Analogues of the Intracellular Domain of Beta 3 Subunit of the Platelet Integrin Receptor. Atherosclerosis Suppls 8(1): 72-73
Chlopicki, S.; Csanyi, G.; Franczyk, M.; Gajda, M.; Jawien, J.; Walski, M.; Wojnar, L.; Pisulewski, P. 2007: Po9-229 Impairment of no and Upregulation of Cox-2/Pgi2 and Edhf Pathways in Apoe/Ldlr / Mice; Relationship with Development of Atherosclerotic Plaques. Atherosclerosis Suppls 8(1): 73-74
Jyrkkänen, H.K.; Hurttila, H.; Kansanen, E.; Ylä-Herttuala, S.; Levonen, A.L. 2007: Po9-234 Nrf2 Down-Regulates Thioredoxin Interacting Protein (Txnip) Expression. Atherosclerosis Suppls 8(1): 74-75
Kummu, O.; Ruskoaho, H.; Kesaniemi, Y.A.; Horkko, S. 2007: Po9-242 Presence of Igg Antibodies to Carbamylated Proteins Are Related to Antibodies Binding to Apoptotic cells. Atherosclerosis Suppls 8(1): 76-77
Horke, S.; Witte, I.; Wilgenbus, P.; Krueger, M.; Strand, D.; Foerstermann, U. 2007: Po9-246 Human Paraoxonase 2: An Endogenous Enzyme as Defense System against Vascular Oxidative Stress and Endoplasmic Reticulum Stress-Induced Apoptosis. Atherosclerosis Suppls 8(1): 77-78
Garcia-Gonzalez, M.J.; Dominguez-Rodrigez, A.; Abreu-Gonzalez, P. 2007: Po9-250 Diurnal Variations of Soluble Cd40 Ligand Serum Levels in Patients with St-Segment Elevation Myocardial Infarction. Atherosclerosis Suppls 8(1): 78-79
Saban-Ruiz, J.; Sanchez, O.; Fabregate, R.; Fabregate, M.; DeLaTorre, N.; Coca-Robinot, D.; Campoy, J. 2007: Po9-261 high Sensitivity C-Reactive Protein Levels and Micromacrovascular Elasticity. Atherosclerosis Suppls 8(1): 81-82
Oksaharju, A.; Lappalainen, J.; Puolakkainen, M.; Pussinen, P.J.; Kovanen, P.T.; Lindstedt, K.A. 2007: Po9-269 Proatherogenic Bacteria Induce an Inflammatory Response in Cultured Mast cells. Atherosclerosis Suppls 8(1): 83-84
Tsoukatos, D.C.; Moussis, V.; Panopoulou, C.P.; Christofidou, E.D.; Koussisis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S. 2007: Po10-276 the Role of Paf-Acetylhydrolase in the Development of Atherosclerosis. Atherosclerosis Suppls 8(1): 85-86
Van Antwerpen, P.; Zouaoui Boudjeltia, K.; Dufrasne, F.; Legssyer, I.; Babar, S.; Moreau, P.; Moguilevsky, N.; Prevost, M.; Neve, J.; Ducobu, J. 2007: Po10-284 Inhibition Of The Mpo/H2O2/Chloride Dependent Ldl Oxidation Assessed By In Vitro, Elisa And Cell Tests. Atherosclerosis Suppls 8(1): 87-88
Rashtchizadeh, N.; Ettehad, S.; DiSilvestro, R.; Dehnad, A.; Mesgari, M.; Vatankhah, A.M. 2007: Po10-293 Co-Supplementation of Copper and Zinc Has a different effect on Atherosclerosis in Iron-Overload Hypercholesterolemic Rabbits. Atherosclerosis Suppls 8(1): 89-90
Stintzing, S.; Ocker, M.; Hahn, E.G.; Herold, C.; Barbera, L.; Aigner, T.; Neureiter, D. 2007: Po11-301 Expression of Cytokeratins inside Atherosclerotic Lesions of different Anatomic Regions. Atherosclerosis Suppls 8(1): 91-92
Shenhar-Tsarfaty, S.; Ben-Assayag, E.; Ofek, K.; Bova, I.; Shopin, L.; Berliner, S.; Shapira, I.; Bornstein, N.M.; Soreq, H. 2007: Po11-305 Association of Serum Paraoxonase with Carotid Atherosclerosis. Atherosclerosis Suppls 8(1): 92-93
Thompson, A.R.; Cooper, J.A.; Humphries, S.E.; Dasmohpatra, M.; Hafez, H.; Jones, G.; VanRij, A. 2007: Po11-309 Arterial Wall Remodelling and the Ras. Implicated in Aaa Disease. Atherosclerosis Suppls 8(1): 93-94
DiFrancesco, A.; Fazia, M.L.; Iezzi, A.; Cuccurullo, C.; DeCesare, D.; Dannenberg, A.J.; Mezzetti, A.; Cipollone, F. 2007: Po11-313 Suppression of 15-Hydroxyprostaglandin Dehydrogenase as a Basis of Atherosclerotic Plaque Instability in Humans. Atherosclerosis Suppls 8(1): 94-95
Sarndahl, E.; Bergstrom, I.; Patcha, V.; Nijm, J.; Lundqvist Setterud, H.; Jonasson, L. 2007: Po12-317 Activation State of Neutrophils in Patients with Stable Coronary Artery Disease. Atherosclerosis Suppls 8(1): 95-96
Liisanantti, M.K.; Lehto, T.; Huusko, T.; Eskelinen, S.; Sormunen, R.; Vuoristo, J.; Savolainen, M.J. 2007: Po12-322 effects of Phosphatidylethanol on Endosomes in Cultured Human Endothelial cells. Atherosclerosis Suppls 8(1): 96-97
Przewlocki, T.; Kablak-Ziembicka, A.; Tracz, W.; Kopec, G.; Rubis, P.; Kozanecki, A.; Kostkiewicz, M.; Podolec, P. 2007: Po13-336 Patients with Coronary and Supraaortic Artery Atherosclerotic Disease Have a high Prevalence of Renal Artery Stenosis. Atherosclerosis Suppls 8(1): 99-100
Nylaede, M.; Kroese, A.J.; Morken, B.; Stranden, E.; Sandbaek, G.; Lindahl, A.K.; Arnesen, H.; Seljeflot, I. 2007: Po13-339 Beneficial effects of 1-Year Optimal Medical Treatment with and without Additional Pta on Inflammation in Patients with Pad. Atherosclerosis Suppls 8(1): 100-101
Giampietro, O.; Antelmo, O.; Manzini, S.; Rossi, L.; Matteucci, E. 2007: Po13-344 Cardiochek Pa Cholesterol-Testing Device Compared to Diagnostic Laboratory Method. Atherosclerosis Suppls 8(1): 101-102
Lahoz, C.; Mantilla, M.T.; Taboada, M.; Soler, B.; Martín-Jadraque, L.; Tranche, S.; Lopez-Rodriguez, I.; Monteiro, B.; Mostaza, J.M. 2007: Po13-348 Evidence-Based Cardiovascular Therapies and Therapeutic Goals in Patients with Coronary Disease and Chronic Kidney Disease Attended in Primary Care. Atherosclerosis Suppls 8(1): 102-103
Masin, V.; Blaha, M.; Maly, R.; Blaha, V.; Zajic, J.; Zimova, R.; Maly, J.; Zadak, Z. 2007: Po13-352 Verification of a Computer Controlled Model for Ldl-Apheresis Optimization in Clinical Practice. Atherosclerosis Suppls 8(1): 103-104
Dani, G.Y.; Vendrey, R.; Nagy, E.; Sziklai, G.Y.; Hajdara, I.; Mark, L.; Katona, A. 2007: Po13-356 Main Features of the Care of Patients with Multiplex Cerebral Infarction. Atherosclerosis Suppls 8(1): 104-105
Vukovic, I.; Arsenijevic, N.; Lackovic, V. 2007: Po14-360 Immunocytochemical and Ultrastructural Analysis of Aortic Wall Remodeling. Atherosclerosis Suppls 8(1): 105-106
Viikari, L.A.; Raitakari, O.T.; Viikari, J.; Huupponen, R. 2007: Po14-372 Adiponectin and Carotid Imt in 24-39 Years Old Finns. Atherosclerosis Suppls 8(1): 108-109
Yildirim, N.; Tekin, N.S.; Dogan, S.M.; Tekin, I.O.; Aydin, M.; Dursun, A.; Gursurer, M.; Bozboga, S. 2007: Po14-376 Myocardial Functional And Textural Findings Of The Right Ventricle And Their Association With Cellular Adhesion Molecules In Behcet'S Disease. Atherosclerosis Suppls 8(1): 109-110
Pojskic, B.; Macic-Dzankovic, A. 2007: Po14-380 Carotid Dilatation and Cholesterolemia at Hypertensive Patients as Predictor for Stroke. Atherosclerosis Suppls 8(1): 110-111
Garcia Diaz, J.D.; Lopez de Guzman, A.; Diez, M.I.; Perez, A.; Albarran, F. 2007: Po14-395 Prevalence of Subclinical Peripheral Atherosclerosis in Rheumatoid Arthritis Patients. Atherosclerosis Suppls 8(1): 114-115
Duran, X.; Vilahur, G.; Badimon, L. 2007: Po15-400 Vascular Smooth Muscle cell Survival is Preserved by in Vivo no Donor Treatment. Atherosclerosis Suppls 8(1): 115-116
Törmälä, R.M.; Appt, S.; Clarkson, T.B.; Groop, P.H.; Rönnback, M.; Ylikorkala, O.; Mikkola, T.S. 2007: Po15-404 Equol Production Capability is Associated with Favorable Endothelial Function in Postmenopausal Women using Tibolone. Atherosclerosis Suppls 8(1): 116-117
Khazaei, M.; Nematbakhsh, M.; Ahmadi, H.; Masjedi, M. 2007: Po15-408 the effect of Aspirin on Serum Vascular Endothelial Growth Factor and Nitric Oxide Concentrations in High-Cholesterol Fed Rabbits. Atherosclerosis Suppls 8(1): 117-118
Blum, A.; Mashiach Eizenberg, M.; Tatour, S.; Kryuger, K.; Vigder, F.; Laster, Z.; Front, E. 2007: Po15-412 Periodontal Care may Improve Endothelial Dysfunction. Atherosclerosis Suppls 8(1): 118-119
Karasek, D.; Vaverkova, H.; Halenka, M.; Budikova, M.; Novotny, D. 2007: Po15-416 Brachial Endothelial Function in Subjects with Familial Combined Hyperlipidemia and its Relationships to Carotid Artery Intima-Media Thickness. Atherosclerosis Suppls 8(1): 119-120
Rusnakova, H.; Pittrova, H.; Cechura, M.; Rajdl, D.; Trefil, L.; Simandlova, H.; Pekna, R.; Racek, J. 2007: Po15-421 Assymetric Dimethylarginine in Patients with Severe Peripheral Artery Disease. Atherosclerosis Suppls 8(1): 120-121
Olivos, C.; Valenzuela, A.; Arteaga, A.; Margozzini, P.; Olea, R.; Maiz, A.; Rigotti, A.; Ferreccio, C.; Aguilera, X.; Gonzalez, C. 2007: Po16-425 Cardiovascular Risk, Cholesterol Goal Attainment, and Lipid-Lowering Eligibility in Chile. Findings from the First National Health Survey. Atherosclerosis Suppls 8(1): 121-122
Paramo, J.A.; Rodriguez, J.A.; Martinez, S.; Angos, V.; Beloqui, O.; Orbe, J. 2007: Po16-430 Association of Smoking, Metalloproteinases and Cardiovascular Risk Factors in Healthy Middle-Aged Subjects. Atherosclerosis Suppls 8(1): 122-123
Hartwich, J.; Goralska, J.; Zawilinska, B.; Siedlecka, D.; Dolecki, J.; Drozdz, W.; Dembinska-Kiec, A. 2007: Po16-434 Redox Ranking of Plasma Ischemia Modified Albumin (Ima), Hscrp and Chlamydophila Pneumoniae Seropositivity. Longitudinal Study in Pvd Patients. Atherosclerosis Suppls 8(1): 123-124
Yan, P.; Zhang, Q.; Alemao, E.; Yin, D. 2007: Po16-438 Lipid Management and Ldl-C Goal Attainment in Clinical Practice in Singapore. Atherosclerosis Suppls 8(1): 124-125
Bazzino, O.; Davies, G.M.; Alemao, E.; Yin, D.; Cook, J.R. 2007: Po16-442 Modeling Reductions in Cholesterol and Cardiovascular Events in Cohort of Argentinean Patients Switched from Statin Monotherapy to Ezetimibe/Simvastatin. Atherosclerosis Suppls 8(1): 125-126
Voller, H.; Bestehorn, K.; Jannowitz, C.; Reibis, R.; Wegscheider, K. 2007: Po16-446 Sustained Suboptimal Secondary Prevention of Coronary Artery Disease in type 2 Diabetes: An Analysis of 41300 Patients over 3 Years. Atherosclerosis Suppls 8(1): 126-127
Kumagae, S.; Adachi, H.; Enomoto, M.; Satoh, A.; Fukami, A.; Otsuka, M.; Shigetoh, Y.; Furuki, K.; Imaizumi, T. 2007: Po16-459 Tgf-Beta1 is a Marker for left Ventricular Hypertrophy in Hypertensive Subjects in a General Population. Atherosclerosis Suppls 8(1): 129-130
Liberopoulos, E.N.; Elisaf, M.S. 2007: Po16-464 Control of Cardiovascular Risk Factors in Outpatients with Atherothrombosis in Greece. Atherosclerosis Suppls 8(1): 130-131
Patel, J.V.; Lim, H.S.; Gunarathne, A.; Tracey, I.; Hughes, E.A.; Lip, G.Y.H. 2007: Po16-468 Ethnic Differences in Rates of Incident Myocardial Infarction in Patients with Hypertension Are Explained by an Excess of Diabetes. Atherosclerosis Suppls 8(1): 131-132
Boeriu, E.; Cucuruz, M.; Lesovici, M.; Marc, M.; Pop, L.; Serban, M. 2007: Po16-471 Lifestyle Screening Study in Teens Predictor for Atherosclerosis. Atherosclerosis Suppls 8(1): 132-133
Cabrera Sierra, M.; Sainz Gutierrez, J.C.; Calvo Bonacho, E.; Sanchez Chaparro, M.A.; Fernandez-Labandera, C.; Sevian Carroquino, R.; Ruiz Moraga, M.; Roman Garcia, J.; Fernandez Meseguer, A.; Garcia Garcia, A.; Gomez Martinez, P.; Lopez Serrano, S.; Rueda Vicente, J.; Gelpi Mendez, J.A.; Barrera Caballero, E. 2007: Po16-476 Dislipemia Prevalence in a Labor Population. Ibermutuamur Cardiovascular Investigation Plan. Atherosclerosis Suppls 8(1): 133-134
Arai, H. 2007: Po17-488 high Cardio-Ankle Vascular Index (Cavi) can Predict the Development of Carotid Atherosclerosis. Atherosclerosis Suppls 8(1): 136-137
Kablak-Ziembicka, A.; Przewlocki, T.; Tracz, W.; Kopec, G.; Pieniazek, P.; Kozanecki, A.; Rzeznik, D.; Stompor, T.; Sulowicz, W. 2007: Po17-495 Value of Doppler Ultrasonography in Renal Artery Stenosis Recognition. Atherosclerosis Suppls 8(1): 138-139
Poppert, H.; Esposito, L.; Wolf, O.; Zimmer, C.; Heider, P. 2007: Po17-499 Mri Based Classification of Carotid Stenosis: A Promising Tool for Detection of Unstable Lesions. Atherosclerosis Suppls 8(1): 139-140
Szmit, S.; Zagrodzka, M.; Jaroń, B.; Cholewa, M.; Opolski, G. 2007: Po17-503 Comparison of Coronary Artery Disease Risk Factors and Atherosclerosis Progression with Exercise Tolerance in Patients with Diabetes Mellitus 2. Atherosclerosis Suppls 8(1): 140-141
Sampi, M.; Ukkola, O.; Paivansalo, M.; Ruskoaho, H.; Kesaniemi, Y.A.; Horkko, S. 2007: Po19-519 Plasma Il-5 Levels Are Associated with Antibodies to Oxidized Ldl and Subclinical Atherosclerosis in Humans. Atherosclerosis Suppls 8(1): 144-145
Mostaza, J.; DelaPena, A.; Gonzalez-Sarmiento, E.; Vega-Rollan, F.; Rodilla, E.; Mangas, A.; Linares, J.; Carrasco, F. 2007: Po19-523 Relationship between Ankle-Brachial Index and Chronic Renal Disease in Hypertensive Subjects with no Known Cardiovascular Disease. Atherosclerosis Suppls 8(1): 145-146
Beraia, M.V.; Todua, F.I. 2007: Po19-527 Role of the Arterial Stenosis in an Atherosclerosis. Atherosclerosis Suppls 8(1): 146-147
Kucur, M.; Isman, F.K.; Karadag, B.; Vural, V.A.; Tavsanoglu, S. 2007: Po19-531 Association of Human Cartilage Glycoprotein-39 Levels with the Extent of Coronary Artery Disease in Patients Undergoing Coronary Angiography. Atherosclerosis Suppls 8(1): 147-148
Schillaci, G.; Pirro, M.; Pucci, G.; Mannarino, M.R.; Gemelli, F.; Lupattelli, G.; Mannarino, E. 2007: Po19-539 Inverse relation between Serum Cholesterol Concentration and left Ventricular Function in Young Hypertensive Patients. Atherosclerosis Suppls 8(1): 149-150
Dvorakova, J.; Kolinova, M.; Hyanek, J.; Matoska, V. 2007: Po19-552 Risk Factors of Atherosclerosis and Coagulation Disorders in Patients Treated for Epilepsy. Atherosclerosis Suppls 8(1): 152-153
Takeoka, H.; Furusyo, N.; Toyoda, K.; Murata, M.; Ohnishi, H.; Maeda, S.; Sawayama, Y.; Sagara, Y.; Kashiwagi, S.; Hayashi, J. 2007: Po19-560 Blood-Borne Virus and Atherosclerosis. Atherosclerosis Suppls 8(1): 154-155
Skoglund, C.; Wetterö, J.; Sjöwall, C.; Skogh, T.; Tengvall, P.; Bengtsson, T. 2007: Po19-565 the Regulatory Role of C-Reactive Protein (Crp) on Platelet Activation. Atherosclerosis Suppls 8(1): 155-156
Rallidis, L.S.; Zolindaki, M.; Vikelis, M.; Moustogiannis, G.; Liakos, G.; Kremastinos, D.T. 2007: Po19-569 high Levels of Fibrinogen Are Associated with Poor Short-Term Prognosis in Patients with Acute Ischaemic Stroke. Atherosclerosis Suppls 8(1): 156-157
Jarabo-Bueno, M.M.; Lopez-Ruiz, A.; Banyuls-Morant, C.; Yanini, J.; Martinez-Triguero, M.L.; Hernandez-Mijares, A. 2007: Po19-573 Emerging Cardiovascular Risk Biomarkers in type 2 Diabetic Patients with Subclinical Atherosclerotic Disease. Atherosclerosis Suppls 8(1): 157-158
Hallikainen, M.; Kolehmainen, M.; Schwab, U.; Uusitupa, M.; Miettinen, T.A.; Gylling, H. 2007: Po19-577 Serum Adipokines Are Associated with Cholesterol Metabolism in Metabolic Syndrome. Atherosclerosis Suppls 8(1): 158-159
Kaski, J.C.; Consuegra, L.; Fernandez-Berges, D.J.; Cruz-Fernandez, J.M.; Garcia-Moll, X.; Marrugat, J.; Mostaza, J. 2007: Po19-582 Elevated Serum Neopterin Levels Predict Adverse Cardiac Events in Patients with Non-St-Segment Elevation Acute Coronary Syndromes. The Siesta Study. Atherosclerosis Suppls 8(1): 159-160
Mortensen, E.S.; Rognum, T.O.; Straume, B.; Jørgensen, L. 2007: Po19-586 Evidence at Autopsy of Spasm in the right Distal Coronary Artery in Cases of Coronary Heart Disease with Sudden Death. Atherosclerosis Suppls 8(1): 160-161
Naumov, V.G.; Ezhov, M.V.; Raimbekova, I.R.; Orlova, E.M.; Sumarokov, A.B.; Samko, A.N.; Masenko, V.P.; Kuharchuk, V.V. 2007: Po19-591 Interleukin 6 is Associated with Restenosis after Implantation of Both Bare-Metal and Drug-Eluting Coronary Stents. Atherosclerosis Suppls 8(1): 161-162
Passaro, A.; Dalla Nora, E.; Vigna, G.B.; Volpato, S.; Marcello, C.; Mari, E.; Candiotto, M.; Fellin, R. 2007: Po20-595 Short Term effect of four different Macronutrient Oral Loads on Metabolic Profile and Flow Mediated Vasodilatation in Healthy Young Men. Atherosclerosis Suppls 8(1): 162-163
Gallego de la Sacristana, A.; Paniagua, J.A.; Romero, I.; Sanchez, M.E.; Vidal-Puig, A.; Latre, J.M.; Berral, F.; Perez-Martinez, P.; Lopez-Miranda, J.; Perez-Jimenez, F. 2007: Po20-600 Mufa-Rich Diet Prevents Central Body Fat Distribution and Decreased Posprandial Adiponectin Expression induced by Carbohydrate-Rich Diet. Atherosclerosis Suppls 8(1): 163-164
Athyros, V.G.; Liberopoulos, E.N.; Mikhailidis, D.P.; Papageorgiou, A.A.; Ganotakis, E.S.; Tziomalos, K.; Kakafika, A.I.; Karagiannis, A.; Hatziolios, A.; Elisaf, M. 2007: Po20-609 Association of Drinking Pattern with the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke and Peripheral Arterial Disease. Atherosclerosis Suppls 8(1): 165-166
Kozirog-Kolacinska, M.; Broncel, M.; Koter-Michalak, M.; Duchnowicz, P.; Chojnowska-Jezierska, J. 2007: Po20-613 the Pleiotropic effects of Anthocyanins from Chokeberry in Patients with Metabolic Syndrome. Atherosclerosis Suppls 8(1): 166-167
Accinni, R.; Sedda, V.; Dellanoce, C.; Rosina, M.; Speciani, A.F.; Perrone, G.; Ostan, B.; Vietti, D. 2007: Po20-617 effects of Ferrosuper (Driatec) Supplementation on Lipid and Redox Parameters in Healthy Subjects. Atherosclerosis Suppls 8(1): 167-168
Nakandakare, E.R.; Charf, A.; Santos, F.C.; Nunes, V.S.; Ortega, K.; Lottenberg, A.M.; Mion, D.; Nakano, T.; Nakajima, K.; Quintao, E.C.R. 2007: Po20-621 Dietary low Sodium Increases Plasma Inflammatory Markers in Hypertensive Patients. Atherosclerosis Suppls 8(1): 168-169
Salvanos, L.; Kamaratos, A.; Katsanaki, A.; Belos, G.; Koutsoukou, E.; Avramopoulou, T.; Anagnostopoulos, S.; Kokkoris, S.; Lentzas, I. 2007: Po21-638 the Metabolic Syndrome is Associated with Early Mortality in Acute Coronary Syndrome. Atherosclerosis Suppls 8(1): 172-173
Bilianou, H.; Ntellos, C.; Kardoulas, A.; Tsiribis, V.; Fountakis, G.; Patsourakos, N.; Thoma, M.; Anastasiadis, F.; Foussas, S. 2007: Po21-647 Waist Circumference like a Childhood Obesity Index. Atherosclerosis Suppls 8(1): 174-175
Kuryata, O.V.; Mitrohina, O.S. 2007: Po21-652 the Body Mass Index as Predictor of Poor Outcomes in Chronic Heart Failure Patients and Preserved left Ventricular Systolic Function. Atherosclerosis Suppls 8(1): 175-176
Simeunovic, S.; Milincic, Z.; Nikolic, D.; Simeunovic, D.; Novakovic, I.; Nedeljkovic, S.; Vukotic, M. 2007: Po21-656 Evaluation of Anthropometric Parameters as Risk Factors for Atherosclerosis in Children. Atherosclerosis Suppls 8(1): 176-177
Atamer, A.; Selek, S.; Kocyigit, Y.; Ilhan, N.; Sen, T.; Atamer, Y. 2007: Po22-689 effects of Rosiglitazone on the Serum Paraoxonase Activity and Metabolic Parameters in Patients with type 2 Diabetes. Atherosclerosis Suppls 8(1): 184-185
Kunsch, C.; Qiu, F.H.; Suen, K.L.; Shao, N.; Simmons, L.K.; Weingarten, M.D.; Smith, J.; Cook, C.K.; Small, R.; Xu, X.C.; Scott, R.A. 2007: Po22-693 Inhibition of Plasma Oxidation and Reduction of Leukotriene B4 Release after Oral Administration of Agi-1067, a Novel Anti-Atherosclerotic Agent. Atherosclerosis Suppls 8(1): 185-186
Dadashova, G.M.; Bakhshaliyev, A.B. 2007: Po22-714 the effect of Moxonidine in Comparison with Prestarium on Parameters of Lipid Metabolism in Postmenopausal Women with Hypertension. Atherosclerosis Suppls 8(1): 190-191
Ikeda, H.; Nkamura, Y.; Minamikawa, J.; Honjo, S.; Hamamoto, Y.; Wada, Y.; Nabe, K.; Koshiyama, H. 2007: Po22-718 Comparison of effects of Amlodipine and Angiotensin Receptor Blockers on the Intima-Media Thickness of Caroitd Arterial Wall (Aaa Study: Amlodipine Vs Arb in Atherosclerosis Study). Atherosclerosis Suppls 8(1): 191-192
Guerin, M.; LeGoff, W.; Duchene, E.; Julia, Z.; Nguyen, T.; Thuren, T.; Shear, C.; Chapman, M.J. 2007: Po22-722 Pharmacological Inhibition of Cholesteryl Ester Transfer Protein Attenuates Atherogenic Features of Postprandial Lipemia in type Iib Hyperlipidemia. Atherosclerosis Suppls 8(1): 192-193
Guyton, J.R.; Weinstock, R.S.; Mazzone, T.; Goldberg, R.B.; Polis, A.; Rosenberg, E.; Tershakovec, A.M. 2007: Po23-734 Influence of Age, Gender, and Ethnicity on Treatment effects in the Vytal Trial of Ezetimibe/Simvastatin Vs. Atorvastatin in type 2 Diabetics. Atherosclerosis Suppls 8(1): 195-196
Rosenson, R.S.; McTaggart, F.; Stalenhoef, A.F. 2007: Po23-738 effects of Rosuvastatin and Atorvastatin on Low-Density and high Density Lipoprotein Particle Concentrations in Patients with Metabolic Syndrome. Atherosclerosis Suppls 8(1): 196-197
Lindgren, P.; Jonsson, B. 2007: Po23-742 Trial Based Economic Evaluation of Intensive Atorvastatin Compared to Standard Simvastatin in the Ideal Trial. Atherosclerosis Suppls 8(1): 197-198
Schick, B.A.; Laaksonen, R.; Frohlich, J.J.; Paiva, H.; Lehtimaki, T.; Humphries, K.H.; Cote, H.C. 2007: Po23-750 Decreased Skeletal Muscle Mitochondrial DNA in Patients Treated with High-Dose Simvastatin. Atherosclerosis Suppls 8(1): 199-200
Ose, L.; Shah, A.K.; Davies, M.J.; Mitchel, Y.B. 2007: Po23-760 effect of Ezetimibe plus Simvastatin (Eze/Simva) on Attainment of Ldl-C Treatment Targets in Hypercholesterolemic Patients. Atherosclerosis Suppls 8(1): 202-203
Vertkin, A.L. 2007: Po23-767 the effect of Atorvastatin Treatment on Serum Levels of Lipids and C-Reactive Protein in Patients with Acute Coronary Syndrome. Atherosclerosis Suppls 8(1): 204-205
Farnier, M.; Roth, E.M.; Perevozskaya, I.T.; Davies, M.J.; Kush, D.; Mitchel, Y.B. 2007: Po23-775 effect of Co-Administration of Ezetimibe/Simvastatin and Fenofibrate on Apolipoproteins (A-I, B, and Ciii) in Patients with Mixed Hyperlipidemia. Atherosclerosis Suppls 8(1): 206-207
Akhvlediani, M.; Vorobiova, E.; Emukhvari, M.; Balavadze, M.; Vakhtangadze, T. 2007: Po23-784 effects of Prolonged Treatment with Atorvastatin and Rosuvastatin on Intima Media Thickness and Interleukins, C-Reactive Protein, D-Dimers and Protein-C. Atherosclerosis Suppls 8(1): 208-209
Farnier, M.; Perevozskaya, I.T.; Taggart, W.V.; Kush, D.; Mitchel, Y.B. 2007: Po23-788 effects of Co-Administered Ezetimibe/Simvastatin and Fenofibrate on Lipoprotein Subclasses and Ldl Size Pattern in Patients with Mixed Hyperlipidemia. Atherosclerosis Suppls 8(1): 209-210
Christoffersen, C.; Jauhiainen, M.; Moser, M.; Porse, B.; Ehnholm, C.; Fassler, R.; Dahlback, B.; Nielsen, L.B. 2007: Yi-793 effect of Apolipoprotein M on Modulation of Hdl in Apom Transgenic and Apom Deficient Mice. Atherosclerosis Suppls 8(1): 211-212
Capati, E.; Bruni, F.; Pasqui, A.L.; Pastorelli, M.; Ciani, F.; Palazzuoli, A.; Auteri, A.; Puccetti, L. 2007: Yi-797 Lectin-Like Oxidized-Ldl Receptor-1 (Lox-1) and Nitric Oxide Sinthase (Nos) Polymorphisms Influences Atorvastatin Antithrombotic Action and Cardiovascular Event Rate. Atherosclerosis Suppls 8(1): 212-213
Alves, A.C.; Rato, Q.; Furtado, A.; Bourbon For The Portuguese Fam, M. 2007: Yi-806 Pcsk9 Gene Analysis in Portuguese Patients with Familial Hypercholesterolemia. Atherosclerosis Suppls 8(1): 214-215
Keranen, M.A.I.; Nykanen, A.I.; Krebs, R.; Sandelin, H.; Tuuminen, R.; Koskinen, P.K.; Lemstrom, K.B. 2007: Yi-810 Alloimmune Response Induces Hif-1 Activation in Vascular and Inflammatory cells of Transplanted Hearts Possible Link to Cardiac Allograft Vasculopathy. Atherosclerosis Suppls 8(1): 215-216
Moisenovich, M.; Khapchaev, S..; Pustovalova, O.; Andrianova, I.; Orekhov, A. 2007: Yi-814 Non-Typical Antigen-Presenting cells in Subendothelial Intima of Human Aorta. Atherosclerosis Suppls 8(1): 216-217
Rubba, F.; Mattiello, A.; Trimarco, V.; Cuccaro, P.; Della Vecchia, A.; Scafarto, M.V.; Quagliata, L.; Novellino, E.; DiRenzo, G.; Triassi, M.; Panico, S. 2007: Yi-822 Ebm Based Approach to Angiotensin Ii Receptor Evaluation and Management. Atherosclerosis Suppls 8(1): 218-219
Karacaglar, E.; Bozbas, H.; Yildirir, A.; Demir, O.; Ulus, T.; Pirat, B.; Eroglu, S.; Atar, I.; Aydinalp, A.; Ozin, B.; Muderrisoglu, H. 2007: Yi-843 Patients with Metabolic Syndrome Have Higher Serum Gamma-Glutamyltransferase Activity. Atherosclerosis Suppls 8(1): 223-224
Ooi, E.M.M.; Barrett, P.H.R.; Chan, D.C.; Nestel, P.J.; Watts, G.F. 2007: Yi-851 Dose-Dependent effect of Rosuvastatin on Apolipoprotein B-100 Kinetics in the Metabolic Syndrome. Atherosclerosis Suppls 8(1): 225-226
Tziakas, D.N.; Chalikias, G.K.; Stakos, D.A.; Tentes, I.K.; Kortsaris, A.X.; Kaski, J.C. 2007: Lb-Po-852 Free Cholesterol Content of Erythrocyte Membranes is increased in Patients with Acute Coronary Syndrome. An Additional Detrimental effect of Erythrocyte Derived Cholesterol that Triggers Plaque Instability?. Atherosclerosis Suppls 8(1): 228-229
Velagapudi, V.R.; Yetukuri, L.; Westerbacka, J.; Sysi-Aho, M.; Bergholm, R.; Taskinen, M.R.; Yki-Järvinen, H.; Orešič, M. 2007: Lb-Po-860 Comprehensive Metabolomic Characterisation of Lipoprotein Fractions Reveals Differential Lipoprotein-Specific Regulation of Xenobiotic and Pro-Inflammatory Metabolites in Patients with Metabolic Syndrome. Atherosclerosis Suppls 8(1): 230-231
Lee, M.R.; Jeon, H.J.; Yoo, J.Y.; Song, C.K.; Park, J.G.; Lee, M.N.; Kim, B.; Jung, I.H.; Jeong, S.J.; Oh, G.T. 2007: Lb-Po-868 Anti-Atherogenic Potential of Relm Alpha Anti-Inflammatory Properties. Atherosclerosis Suppls 8(1): 232-233
Brollo, L.; Mazzaro, C.D.L.; Manzoli, M.T.N.B.; Hirai, A.; Harima, H.; Póvoa, R.M.S. 2007: D 004 Cardiac Alterations in Japanese-Brazilians with Diabetes and Metabolic Syndrome. Atherosclerosis Suppls 8(3): 1-2
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2007: H 004 Fluvastatin Attenuates Blood Pressure Responses to Exercise but not in Abpm in Hypertensive and Dyslipidemic Subjects. Atherosclerosis Suppls 8(3): 5-6
Galil, A.G.S.; Rocha, L.M.; Bastos, M.G. 2007: H 007 Metabolic Syndrome in a high Cardiovascular Risk Outpatient Clinic. Atherosclerosis Suppls 8(3): 6-7
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2007: H 011 Metabolic effects of Antyhypertensive Agents in Normoglycemic, Normolipidemic Hypertensive Patients. Atherosclerosis Suppls 8(3): 7-8
de Azevedo, R.E.U.; de Sousa, J.M.A.; Ferreira, M.D.C.; Mussi, A.; de Lima, N.C.B.S.; Stefanini, E.; de Camargo Carvalho, A.C. 2007: H 018 Chronic Kidney Disease is an Independent Predictor of In-Hospital Death in Patients with Myocardial Infarction. Atherosclerosis Suppls 8(3): 9-10
Toledo, J.C.Y.; DeSouza, L.A.; Girioli, S.U.; Nakazone, M.A.; Pinheiro, A.; Martin, J.F.V.; Moreno, H. 2007: H 036 Cardiovascular Risk Stratification in Patients with Refractory Arterial Hypertension. Atherosclerosis Suppls 8(3): 14-15
Sposito, A.C.; Santos, R.D.; Moreira, A.; Lima, J.C.; Abdalla, D.S.P.; Martinez, T.L.R.; Pereira, A. 2007: H 040 Plasma Cholesterol is an Independent Modulator for the Rest Blood Pressure Regulation in Children and in Identical Twins. Atherosclerosis Suppls 8(3): 15-16
Continentino, M.A.; Gadelha, E.B.; Papelbaum, B.B.; Araújo, P.F.; Faludi, D.B.; Zatz, A.A.; Bertolami, H.P.; Marcelo, C. 2007: L 008 Achievement of Target Ldl-Cholesterol Levels in a Tertiary Hospital Outpatient Clinic. Atherosclerosis Suppls 8(3): 18-19
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2007: L 015 low Titers of Human Antioxidized Ldl Autoantibodies Are Associated with Unstable Coronary Disease. Atherosclerosis Suppls 8(3): 20-21
de Gabriel e Dorighello, G.; de Oliveira, H.C.F. 2007: L 019 Ldl Receptor Deficient Mice Develop Atherosclerosis Independently of high Fat and high Cholesterol Diets. Atherosclerosis Suppls 8(3): 21-22
Szuster, E.; Barbosa, M.R.; Marinho, G.E.M.; Correa, L.C.T.; de Souza, A.C.; de Albuquerque, G.O.; Viegas, F.R.; de Oliveira Carvalho, G.; Vrandecic, E.C. 2007: L 027 Percutaneous Coronary Intervention in 2006: Private X Public System Analyzes. Atherosclerosis Suppls 8(3): 23-24
dos Santos, P.L.; Noronha, F.; de Albuquerque, E.M.; Grotto, H.Z.W. 2007: L 034 Evaluation of Reticulated Platelets and Platelet Activation in Patients with Dyslipidemia. Atherosclerosis Suppls 8(3): 25-26
de Oliveira, R.T.D.; Mamoni, R.L.; Ferreira, M.C.; Longui, L.N.A.; Souza, J.R.M.; de Lara Fernandes, J.; Menezes, F.H.; Blotta, M.H. 2007: L 038 Atherosclerotic Lesions Express Mrna For Il-17, Il-17R, Il-23 And Il-23R. Atherosclerosis Suppls 8(3): 26-27
Gomes, G.B.; Zazula, A.D.; Shigueoka, L.S.; Fedato, R.A.; Neto, J.R.F. 2007: L 042 Plant Sterols Have Additional effects to Ezetimibe on Reducing Ldl Cholesterol of Coronary Patients Already Taking Statins but not Reaching Lipid Goals. Atherosclerosis Suppls 8(3): 27-28
Martinez, L.R.C.; Miname, M.; Bortolotto, L.A.; Chacra, A.P.M.; Filho, W.S.; Rochitte, C.E.; dos Santos Filho, R.D. 2007: L 046 Subclinical Atherosclerosis Markers do not Correlate among Themselves in Familial Hypercholesterolemia Subjects without Use of Statin. Atherosclerosis Suppls 8(3): 28-29
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2007: L 053 Characterization of Oxidized Ldl by the Z-Scan Technique in Patients with Metabolic Syndrome after an Acute Coronary Event. Atherosclerosis Suppls 8(3): 30-31
Rosa, T.T.; Moura, E.L.R.; de Oliveira, M.C.; Veiga, J.P.R. 2007: L 057 Higher Uric Acid Was Detect in Female Ambulatory Patients with Laboratorial Exams Which Indicate the Presence of Metabolic Syndrome. Atherosclerosis Suppls 8(3): 31-32
Nascimento, H.; Denardin, O.; Almeida, G.; Martinez, T. 2007: L 065 Comparison of the Lipid Profile of Women during the Pre-And Post-Menopausal Period. Atherosclerosis Suppls 8(3): 33-34
Rozenberg, I.; Akhmedov, A.; Kouroedov, A.; Mocharla, P.; Watanabe, T.; Boren, J.; Odermatt, B.; Luescher, T.F.; Tanner, F.C. 2008: Histamine H1 Receptor is Required for Atherogenesis. Atherosclerosis Suppls 9(1): 1-2
Beltowski, J.; Lowicka, E.; Jamroz-Wisniewska, A.; Wojcicka, G. 2008: Effect of Experimental Hyperleptinemia on Plasma Paraoxonase 1 (Pon1) Activity toward Homocysteine Thiolactone and N-Homocysteinylation of Plasma Proteins. Atherosclerosis Suppls 9(1): 2-3
Hernandez-Vera, R.; Vilahur, G.; Pena, E.; Ferrer, R.; Badimon, L. 2008: The Prothrombotic Phenotype Observed in Niddm is Independent of Blood Glucose Levels. Atherosclerosis Suppls 9(1): 3-4
Tian, F.; Zhou, X.; Larsson, E.; Boren, J.; Akyurek, L.M. 2008: Endothelial cells Are Activated during Hypoxia via Endoglin/Alk-1/Smad1/5 Signaling in Vivo and in Vitro. Atherosclerosis Suppls 9(1): 4-5
Ciftci, O.; Gullu, H.; Erdogan, D.; Caliskan, M.; Topcu, S.; Yildirir, A.; Muderrisoglu, H. 2008: Association between Serum Gamma-Glutamyltransferase Levels and Coronary Microvascular Function. Atherosclerosis Suppls 9(1): 6-7
Shepherd, J.; Wenger, N.K.; Carmena, R.; Deedwania, P. 2008: Intensive Lipid Lowering with Atorvastatin is Associated with Significant Cardiovascular Benefits in Coronary Patients with Diabetes and Chronic Kidney Disease. Atherosclerosis Suppls 9(1): 8-9
Yang, P.Y.; Lu, X.; Rui, Y.C. 2008: N-Myc Downstream-Regulated Protein 2 Modulates Pdgf-Aa Production in Macrophage Foam cells via Inhibition on Activation of Extracellular Signal-Regulated Kinase. Atherosclerosis Suppls 9(1): 9-10
Schaefer, E.J.; Ai, M.; Otokozawa, S.; Asztalos, B.F.; White, C.C.; Demissie, S.; Cupples, A. 2008: Small Dense Ldl Cholesterol, Hdl Particles, Insulin, Adiponectin, and Glycated Albumen as Prospective Chd Risk Factors in the Framingham Study. Atherosclerosis Suppls 9(1): 10-11
Tejero, M.E.; Ebbesson, S.E.O.; Lopez-Alvarenga, J.C.; Ebbesson, L.; Howard, B.V.; Fabsitz, R.; Comuzzie, A.G. 2008: Associations among Fatty Acids in Red Blood cells and Components of the Metabolic Syndrome. Atherosclerosis Suppls 9(1): 11-12
Tamura, Y.; Sugimoto, M.; Murayama, T.; Kita, T.; Yokode, M.; Arai, H. 2008: Pharcological Blockade of Ccr2 Inhibits the Development of Insulin Resistance and Hepatic Steatosis in Db/Db Mice. Atherosclerosis Suppls 9(1): 12-13
Robenek, H.; Hofnagel, O.; Buers, I.; Severs, N.J. 2008: A New Hypothesis of Lipid Droplet Biogenesis. Atherosclerosis Suppls 9(1): 13-14
Kwon, Y.-G.; Maeng, Y.S. 2008: A Novel Role For Igf2/Igf2R Signaling In Homing Of Endothelial Progenitor Cells. Atherosclerosis Suppls 9(1): 14-15
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2008: Effects of Tirofiban on Angiographic Measures, St Resolution, and Clinical Outcome following the Primary Coronary Intervention in Patients with Stemi. Atherosclerosis Suppls 9(1): 16-17
Yamada, Y.; Eto, M.; Ito, Y.; Nomura, M.; Ota, H.; Son, B.; Ogawa, S.; Iijima, K.; Akishita, M.; Ouchi, Y. 2008: Endothelial Nitric Oxide Synthase in Adipocytes Has an Anti-Lipolytic Action. Atherosclerosis Suppls 9(1): 18-19
Holmes, E.; Davies, I.; Lowe, G.; Ranganath, L. 2008: Transport of Ghrelin and Obestatin in Plasma. Atherosclerosis Suppls 9(1): 26-27
Masuda, D.; Hirano, K.; Oku, H.; Sandoval, J.; Kawase, M.; Yamamoto, K.; Koseki, M.; Matsuura, F.; Tochino, Y.; Kawase, R.; Takada, M.; Yamashita, Y.; Kawamoto, T.; Nishida, M.; Ishigami, M. 2008: Chylomicron Remnants Are increased in Cd36 Deficiency at Postprandial State. Atherosclerosis Suppls 9(1): 27-28
Petraki, M.P.; Chroni, A.; Tselepis, A.D. 2008: Recombinant Paf-Acetylhydrolase Enhances the Cholesterol Efflux from Macrophages induced by Reconstituted high Density Lipoprotein or Apolipoprotein A-I. Atherosclerosis Suppls 9(1): 29-30
Hergenc, G.; Onat, A.; Agirbasli, M.; Kaya, Z.; Can, G.; Erginel Unaltuna, N. 2008: Preheparin Serum Lipoprotein Lipase Mass in Metabolic Syndrome and Coronary Heart Disease: Interaction with Gender, Gene Polymorphism and Smoking. Atherosclerosis Suppls 9(1): 30-31
Viiri, L.E.; Viiri, K.M.; Ilveskoski, E.; Huhtala, H.; Tienari, P.J.; Perola, M.; Lehtimaki, T.; Karhunen, P.J. 2008: Apoe Genotype-By-Smoking Interactions and Early Atherosclerotic Lesions. Atherosclerosis Suppls 9(1): 32-33
Koniari, E.; Laios, E.; andrikopoulos, G.; Richter, D.; Gialafos, E.; Manolis, A.; Chrousos, G.; Drogari, E. 2008: Identification 0F Six Pcsk9 Snps In The Greek General Population And Greek Familial Hypercholesterolemic Patients. Atherosclerosis Suppls 9(1): 34-35
Cazita, P.; Barbeiro, D.; Moretti, A.; Quintão, E.; Soriano, F. 2008: Human Cetp Expression Enhances the Mouse Survival Rate by Lowering the Systemic Inflammatory Response. Atherosclerosis Suppls 9(1): 35-36
Scheja, L.; Heeren, J.; Toedter, K.; Seedorf, K.; Beisiegel, U. 2008: Substantial Alterations in Lipid Metabolism Occur Early in the Development of Insulin Resistance in Mice as Revealed by Metabolic Profiling. Atherosclerosis Suppls 9(1): 36-37
Naumann, A.; Heeren, J.; Bruns, O.T.; Thiery, J.; Teupser, D.; Merkel, M. 2008: Apoprotein A5 (Apoa5) Reduces Atherosclerosis in Mice. Atherosclerosis Suppls 9(1): 37-38
Wijk, J.van; Hoepelman, I.; Rabelink, T.; de Koning, E.; Cabezas, M.C. 2008: Differential effects of Rosiglitazone and Metformin on Postprandial Lipemia and Fatty Acid Metabolism in Hiv-Lipodystrophy. Atherosclerosis Suppls 9(1): 39-40
Cai, L.; Ji, A.; Li, Y.; deBeer, F.; Tannock, L.; vander westhuyzen, D. 2008: The Hdl Receptor Sr-Bi Plays an Important Role in Inflammation and Protects against Endotoxemia in Mice. Atherosclerosis Suppls 9(1): 42-43
Pang, D.; Smith, A.; Talmud, P.; Humphries, S. 2008: Do Common Intronic Variants In Tcf7L2 Result In Differential Splicing Or Expression?. Atherosclerosis Suppls 9(1): 43-44
Arutyunov, G.P.; Kafarskaya, L.I.; Bylova, N.A. 2008: Role of Endotoxin in Systemic Inflammation and Development of Atherosclerosis. Atherosclerosis Suppls 9(1): 46-47
Peeters, W.; de Kleijn, D.P.; Moll, F.L.; Hellings, W.E.; Vons, K.; Velema, E.; deVries, J.P.; Pasterkamp, G. 2008: Acetylsalicylic Acid Use is Associated with increased Cytokine Expression in Atherosclerotic Carotid Plaques. Atherosclerosis Suppls 9(1): 47-48
Leonarduzzi, G.; Gamba, P.; Gargiulo, S.; Sottero, B.; Poli, G. 2008: Tgf-Beta1 Signaling in Human Promonocytic cells induced by 9-Oxononanoyl Cholesterol, a Major Cholesteryl Ester Oxidation Product. Atherosclerosis Suppls 9(1): 54-55
Almeida, C.; Solano, T.; Bulgareli, A.; Valduga, C.; Maranhão, R. 2008: Uptake Of [14C]Cholesteryl Oleate And [3H]-Cholesterol Of The Nanoemulsion By Endothelial Cells In Presence Of Hdl And Ldl. Atherosclerosis Suppls 9(1): 55-56
Ozsarlak-Sozer, G.; Gokce, G.; Oran, I.; Topcu, Z.; Kerry, Z. 2008: Telomere Length Regulation of Vascular Smooth Muscle cells in a Balloon Injury Model: Effects of Oxidative Stress. Atherosclerosis Suppls 9(1): 56-57
Dunér, P.; Bengtsson, E.; To, F.; Alm, R.; Goncalves, I.; Fredriksson, G.N.; Björkbacka, H.; Nilsson, J. 2008: Immune Responses against Fibronectin Modified by Reactive Aldehydes Released during Lipoprotein Oxidation Affects the Development of Atherosclerosis. Atherosclerosis Suppls 9(1): 57-58
Gokce, G.; Ozsarlak-Sozer, G.; Oran, I.; Oktay, G.; Ozkal, S.; Kerry, Z. 2008: The Role of Oxidative Stress on Intimal Hyperplasia: Modulation of Lox-1 Expression by Taurine. Atherosclerosis Suppls 9(1): 58-59
Dembinska-Kiec, A. 2008: Angiogenesis in Adipogenesis. Atherosclerosis Suppls 9(1): 60-61
Turan, R.G.; Brehm, M.; Yokus, S.; Koestering, M.; Zeus, T.; Bartsch, T.; Aktug, O.; Steiner, S.; Schannwell, C.M.; Strauer, B.E. 2008: Influence of Ptca on Mobilization of Bone Marrow Derived Circulating Progenitor cells in Peripheral Blood. Atherosclerosis Suppls 9(1): 61-62
Kim, T.; Han, H.; Im, J.; Hwang, B.; Yun, Y. 2008: The Antiproliferative Mechanism of Cudraflavone B on Rat Arotic Smooth Muscle cells. Atherosclerosis Suppls 9(1): 64-65
Philippova, M.; Ivanov, D.; Joshi, M.B.; Rupp, K.; Erne, P.; Resink, T. 2008: Gpi-Anchored T-Cadherin is Shed from Endothelial cells and is Transferred to Lipoproteins: New Implications for Signaling Mechanisms and Clinical Practice?. Atherosclerosis Suppls 9(1): 65-66
Stathopoulou, E.M.; Roufou, C.E.; Koloka, V.N.; Tellis, C.C.; Sakarellos, C.; Sakarellos, M.; Tsikaris, V.; Tselepis, A.D. 2008: Inhibitory effects of Synthetic Peptide Analogues of the Human Platelet Integrin Alphaiibeta Subunit on Rabbit Platelet Aggregation. Atherosclerosis Suppls 9(1): 67-68
Karadag, B.; Kucur, M.; Isman, F.K.; Duman, D.; Baskurt, M.; Aliyev, F.; Vatan, B.; Firinciogullari, H.; Vural, V.A. 2008: Association of Plasma Hyaluronidase Activity with Atherosclerosis in Patients with Coronary Artery Disease. Atherosclerosis Suppls 9(1): 68-69
Nikitidou, O.K.; Daskalopoulou, E.G.; Vlachogiannis, E.G.; Kosmidou, E.K.; Mastrogiannidou, E.K.; Papagianni, A.A.; Dombros, N.V. 2008: Endothelial Dysfunction Markers before and after Cpap Treatment in Patients with Obstructive Sleep Apnea Syndrome. Atherosclerosis Suppls 9(1): 69-70
Filiopoulos, V.; Koutis, I.; Malegos, I. 2008: Subclinical Atherosclerosis is increased in type 2 Diabetic Patients with Microalbuminuria Evaluated by Intima- Media Thickness and Pulse Wave Velocity. Atherosclerosis Suppls 9(1): 71-72
Valdivielso, P.; Puerta, S.; Rioja, J.; Ariza, M.; Hornos, A.; Garcia-Arias, C.; Sanchez-Chaparro, M.; Gonzalez-Santos, P. 2008: Fasting and Postprandial Apo-B48 Are increased in Patients with type 2 Diabetes with Atherosclerosis. Atherosclerosis Suppls 9(1): 72-73
Maurantonio, M.; Simonini, M.; Giannico, I.; Pellegrini, E.; Carulli, L.; Ganazzi, D.; D'Amico, R.; Bertolotti, M.; Carulli, N. 2008: Cardiovascular Risk in a Local Population of Diabetic Subjects. Atherosclerosis Suppls 9(1): 73-74
Xanthis, A.; Hatzitolios, A.; Befani, C.; Koliakos, G. 2008: Soluble Receptor of Advanced Glycation End Products is Inversely Related to Coronary Atheromatosis in Diabetics. Atherosclerosis Suppls 9(1): 74-75
Azarpazhooh, M.R.; Eatemadi, M.M.; Farzadfard, M.T.; Panahandeh, M.; Kiani, R.; Ghaior Mobarhan, M. 2008: Mashhad Stroke Incidence Study. Atherosclerosis Suppls 9(1): 77-78
Weihrauch, G.; Dobnig, H.; Scharnagl, H.; Stojakovic, T.; Maerz, W. 2008: Association of Cystatin C with Mortality: Data from the Luric Study. Atherosclerosis Suppls 9(1): 78-79
Yildiz, A.; Okcun, B.; Peker, T.; Cakar, M.A.; Biceroglu, S.; Kurtoglu, T.; Baskurt, M.; Uzunhasan, I. 2008: Prevalance and Outcomes of Coronary Artery Anomalies in 12,457 Adult Patients Underwent Coronary Angiography. Atherosclerosis Suppls 9(1): 79-80
Park, C.; Suh, S.; Na, J.; Choi, C.; Kim, J.; Kim, E.; Rha, S.; Seo, H. 2008: Doca-Salt Hypertensive Apo e Ko Mice; effect of high Bp on Aherosclerosis. Atherosclerosis Suppls 9(1): 81-82
Juenger, C.; Bestehorn, K.; Senges, J.; Gitt, A.K. 2008: Ldl Goals Of German Practice-Based Cardiologists For Patients With Chd/Chd Risk Equivalents And Ldl 100 Mg/Dl: Results Of The 2L-Register. Atherosclerosis Suppls 9(1): 82-83
Eremic, N.; Djeric, M.; Kojic-Damjanov, S. 2008: A Novel Bioindexes for Evaluation of Lipid Risk Factors for Atherosclerosis in Chronically Hemodialyzed Patients. Atherosclerosis Suppls 9(1): 83-84
Triantafyllou, K.; Symeonides, P.; Angelidou, D.; ElAli, M.; Theodoridis, T.; Kokkinou, V.; Papapanagiotou, A.; Nounopoulos, C.; Kalofoutis, A.; Koulouris, S. 2008: Oxidized Ldl Outperforms other Lipid Markers and is Comparable to Carotid Intima-Media Thickness in Predicting Extensive Premature Coronary Atherosclerosis. Atherosclerosis Suppls 9(1): 84-85
Nilsson, G.; Hedberg, P.; Jonason, T.; Lonnberg, I.; Ohrvik, J. 2008: Low Hdl Cholesterol is Associated with Poor 10-Years Survival in Men but not in Women among the Elderly. Atherosclerosis Suppls 9(1): 86-87
Tint, D.; Stanescu, C.; Pamfil, G.; Radoi, M. 2008: Prognostic Implications of Erectile Dysfunction as Early Sign of Atherosclerosis. Atherosclerosis Suppls 9(1): 91-92
Milincic, Z.; Nikolic, D.; Simeunovic, S.; Novakovic, I.; Vukotic, M. 2008: Glycemia Trends in School Children in Serbia. Atherosclerosis Suppls 9(1): 95-96
Aytekin, S.; Catakoglu, A.; Sener, M.; Kurtoglu, H.; Celebi, H.; Demiroglu, I.; Aytekin, V. 2008: Do low Hdl Cholesterol Levels Have Role in Aspirin Resistance?. Atherosclerosis Suppls 9(1): 96-97
Piwonska, A.; Piotrowski, W.; Piwonski, J. 2008: Individual Global Risk Of Polish Population And It'S Relation To Medical Care. Results Of National Multicenter Health Survey (Wobasz). Atherosclerosis Suppls 9(1): 97-98
Rosety-Rodriguez, M.; Rosety, I.; Gomez, F.; Meletis, J.; Rosety, M.A.; Rosety, M.; Ordonez, F.J. 2008: Regular Exercise Reduced Plasmatic Levels of Il-6 Inwomen with Metabolic Syndrome. Atherosclerosis Suppls 9(1): 99-100
Santiago, F.; Kaplan, D.; Schreiber, R.; dos Santos, J.; deFaria, E. 2008: Similarities Of Hepatic Lipase -514C/T And Cholesteryl Ester Transfer Protein I405V Polymorphisms In Brazilian Hyperalphalipoproteinemics. Atherosclerosis Suppls 9(1): 106-107
Leigh, S.E.; Whittall, R.A.; Hubbart, C.S.; Humphries, S.E. 2008: Update and Analysis of the Ucl low Density Lipoprotein Receptor Gene (Ldlr) Familial Hypercholesterolemia (Fh) Database. Atherosclerosis Suppls 9(1): 107-108
Coban, N.; Poda, M.; Horgusluoglu Guner, E.; Can, G.; Onat, A.; Humphries, S.; Erginel-Unaltuna, N. 2008: The Gender Limited effect Usf1 Gene Polymorphisms in the Turkish Adult Risk Factor (Tarf) Study. Atherosclerosis Suppls 9(1): 108-109
Polisecki, E.; Shepherd, J.; Ford, I.; Muallem, H.; Maeda, N.; Schaefer, E.J. 2008: Variation at the Ldlr Gene is Associated with Plasma Lipid Levels and Chd in the Prosper Study. Atherosclerosis Suppls 9(1): 109-110
Ariza, M.J.; Hornos, A.; Requena, G.; Rioja, J.; Roman-Garcia, J.; Valdivielso, P.; Sanchez-chaparro, M.A.; Gonzalez-Santos, P. 2008: Association Of Apo A5 Variants -1131T/C And S19W With Hypertriglyceridemia In A Mediterranean Spanish Working Population. Atherosclerosis Suppls 9(1): 111-112
Junyent, M.; Gilabert, R.; Nunez, I.; Pocovi, M.; Mallen, M.; Zambon, D.; Jarauta, E.; Civeira, F.; Vega, J.; Almagro, F.; Ros, E. 2008: Impact of Low-Density Lipoprotein Receptor (Ldlr) Mutational Class on Carotid Atherosclerosis in Patients with Familial Hypercholesterolemia (Fh). Atherosclerosis Suppls 9(1): 112-113
Bogavac-Stanojevic, N.; Jelic-Ivanovic, Z.; Spasojevic-Kalimanovska, V.; Spasic, S.; Memon, L. 2008: Impact of Apolipoprotein(A) Isoforms on Plasma Lipoprotein(A) Concentrations and their Association with Coronary Artery Disease. Atherosclerosis Suppls 9(1): 113-114
Kotrogiannis, I.; Chrysohoou, C.; Vasiliadou, C.; Papadimitriou, L.; Pounis, G.; Aggelopoulos, P.; Barbetseas, J.; Metallinos, G.; Pitsavos, C.; Stefanadis, C. 2008: The Role of Plasma Levels Interleukin-6 on Mortality in Non-Obese Patients with Newly Diagnosed Heart Failure, during 12-Months of Follow-Up. Atherosclerosis Suppls 9(1): 114-115
Pedersen, E.R.; Ebbing, M.; Midttun, O.; Ueland, P.M.; Vollset, S.E.; Schartum-Hansen, H.; Bleie, O.; Nordrehaug, J.E.; Nygard, O. 2008: B6 Vitamers as Predictors of Mortality in Stable Angina Patients. Atherosclerosis Suppls 9(1): 115-116
Stankiewicz, E.; Stepien, E.; Undas, A.; Zalewski, J.; Godlewski, J.; Zmudka, K. 2008: Platelet, Endothelial and Monocyte Microparticles Are Generated during Acute Myocardial Infarction and in Stable Angina. Atherosclerosis Suppls 9(1): 117-118
Santos, A.; Fischer, S.; Monteiro, A.; Sanches, E.; Monteiro, C.; Helfenstein, T.; Gidlund, M.; Brandao, S.; Oliveira, L.; Fonseca, F.; Izar, M. 2008: Low Titers of Human Anti-Oxldl Autoantibodies Are Associated with Unstable Coronary Disease. Atherosclerosis Suppls 9(1): 118-119
Vaverkova, H.; Jackuliakova, D.; Karasek, D.; Novotny, D.; Lukes, J. 2008: Association of Adiponectin with Insulin Resistance and Liver Enzymes in Dyslipidemic Subjects: Relationship to Nonalcoholic Fatty Liver Disease?. Atherosclerosis Suppls 9(1): 119-120
Ferraro, M.; Spagnuolo, V.; Mauro, G.F. 2008: Visceral Adiposity and Insulin Resistence in Nafald-Nash Subjects: Utility of Abdominal Ultrasound. Atherosclerosis Suppls 9(1): 120-121
Lagos, K.G.; Gazi, I.F.; Kostapanos, M.S.; Filippatos, T.; Kazakou, P.S.; Rizos, C.V.; Tselepis, A.D.; Elisaf, M. 2008: High-Density Lipoprotein Subclasses in Patients with or without the Metabolic Syndrome. Atherosclerosis Suppls 9(1): 126-127
Gamezardashvili, T.B.; Kipshidze, N.N.; Talakvadze, T.V.; Khosroshvili, L.B. 2008: Stady of Metabolic Disorders and Inflamatory Markers in Patients with Angina Pectoris and Metabolic Syndrome. Atherosclerosis Suppls 9(1): 127-128
Vecka, M.; Zak, A.; Tvrzicka, E.; Duffkova, L.; Stankova, B.; Zeman, M. 2008: Effect of Components of Metabolic Syndrome on Homeostasis of Cholesterol. Atherosclerosis Suppls 9(1): 129-130
Colina, I.; Araquistain, J.M.; Alberola, I.; Beloqui, O. 2008: Subclinical Atherosclerosis (Sa) and Metabolic Syndrome (Ms). Atherosclerosis Suppls 9(1): 130-131
Kim, B.; Oh, S.; Jeon, D.; Yoon, S.; Moon, Y.; Kim, K.; Jang, Y.; Cho, H.; Yang, J. 2008: Would Metabolic Syndrome affect the Patterns or Causes of Restenosis after Drug-Eluting Stent Implantation? An Intravascular Ultrasound Study. Atherosclerosis Suppls 9(1): 132-133
Derdemezis, C.S.; Filippatos, T.D.; Nakou, E.S.; Georgoula, M.; Kiortsis, D.N.; Tselepis, A.D.; Elisaf, M.S. 2008: Effects of Fenofibrate and Orlistat, Alone or in Combination, on Plasma Visfatin Levels in Subjects with Metabolic Syndrome. Atherosclerosis Suppls 9(1): 133-134
Ghayour-Mobarhan, M.; Esmaeili, H.; Azimi-Nezhad, M.; Shapouri-Moghaddam, A.; Parizadeh, S.; Safarian, M.; Kazemi-Bajestani, S.; Khodaei, G.; Hosseini, J.; Parizadeh, S.; Ferns, G. 2008: The Relationship between Estabilished Coronary Risk Factors and Serum Copper and Zinc Concentrations in a Larg Persian Population Sample. Atherosclerosis Suppls 9(1): 136-137
Adlouni, A.; Christon, R.; Cherki, M.; Khalil, A.; ElMessal, M. 2008: The Nutritional Benefits of Argan Oil in Obesity Risk Prevention. Atherosclerosis Suppls 9(1): 137-138
Safciuc, F.; Constantinescu, E.; Sima, A. 2008: The Hamster as an Experimental Model to Study the effect of the Hyperlipemic Diet on the Cerebral Circulation. Atherosclerosis Suppls 9(1): 138-139
Accinni, R.; Dellanoce, C.; Bianchi, M.; Guinea Montalvo, M.; Sedda, V.; Tonini, A. 2008: Effectiveness of a Food Supplement (Riducol) in Improving the Lipid Panel in Dyslipidaemic Subjects. Atherosclerosis Suppls 9(1): 139-140
Kulyk, O.; Mitchenko, O.; Romanov, V.; Belyaeva, T.; Yakuschko, L. 2008: Levels of Leptin and Soluble Leptin Receptors at Patients with a Metabolic Syndrome Depending on Carbohydrate Disoders. Atherosclerosis Suppls 9(1): 140-141
Hochner, H.; Friedlander, Y.; Meiner, V.; Manor, O.; Calderon-Margalit, R.; Wolff, Y.; Avgil, M.; Sharon, N.; Bravdo, R.; Rice, K.; Lumley, T.; Williams, M.; Siscovick, D. 2008: Maternal Obesity, Offspring Birth Weight and Offspring Blood Pressure at Age 17: The Jerusalem Perinatal Study. Atherosclerosis Suppls 9(1): 141-142
Heitmann, B.; Frederiksen, P.; Lissner, L. 2008: Low Hip Circumference and Early Cardiovascular Morbidity and Mortality among Men and Women. Atherosclerosis Suppls 9(1): 142-143
Alvarez-Llamas, G.; delaCuesta, F.; Darde, V.; Donado, A.; Padial, L.R.; Pinto, A.G.; Barderas, M.G.; Vivanco, F. 2008: Identification of Proteins Secreted by Artery Biopsies in the Search for Atherothrombotic Biomarkers. Atherosclerosis Suppls 9(1): 143-144
Undas, A.; Kolarz, M.; Kopec, G.; Tracz, W. 2008: Altered Fibrin Clot Properties and Cardiac Mortality in Patients on Long-Term Hemodialysis. Atherosclerosis Suppls 9(1): 144-145
Pojskic, B.; Buksa, M.; Dilic, M.; Macic-Dzankovic, A.; Kolenda, D.. 2008: What is the Better Predictor for Stroke at Hypertensive Patients: Intima Media Thickness or Dilatation of Carotid Arteries?. Atherosclerosis Suppls 9(1): 146-147
Dangardt, F.; Osika, W.; Gan, L.; Volkmann, R.; Mårild, S.; Friberg, P. 2008: Increased Vascular Diameter and Decreased Pulse Wave Velocity in Obese Children. Atherosclerosis Suppls 9(1): 148-149
Garcia Diaz, J.D.; Gaspar Blazquez, M.J.; Bienvenido Villalba, M.; Granizo Dominguez, V.; Jimenez Bustos, J.M. 2008: Relationship of Weight and Cord Blood Lipoproteins at Birth with Lipid Profile in Childhood. Atherosclerosis Suppls 9(1): 150-151
Ravaglia, G.; Forti, P.; Pisacane, N.; Rietti, E.; Lucicesare, A.; Bianchin, M.; Dalmonte, E. 2008: Association between Homocysteine and Depression: The Conselice Study of Brain Aging. Atherosclerosis Suppls 9(1): 151-152
Ito, Y.; Hirano, T.; Kinoshita, M.; Shiba, M.; Shoji, T.; Koba, S.; Ikewaki, K.; Yoshino, G. 2008: Diagnosis of Familiar Combined Hyperlipidemia by small Dense Ldl-Cholesterol. Atherosclerosis Suppls 9(1): 152-153
Gudnason, V.; Thorsson, B.; Aspelund, T. 2008: Equivalence of Subclinical Atherosclerosis Measurements to Cardivascular Death for Evaluating Risk Factor Impact. The Refine Reykjavik Study. Atherosclerosis Suppls 9(1): 153-154
Arslan, U.; Balcioglu, S.; Kocaman, S.A.; Timurkaynak, T. 2008: Five Year Results of the Treatment Strategy Based upon Fractional Flow Reserve Measurements in Patients with Borderline Coronary Artery Lesions. Atherosclerosis Suppls 9(1): 156-157
Nagaoka, K.; Sadamatsu, K.; Iwamoto, K.; Shikada, T.; Ohe, K.; Sagara, S.; Morishige, K.; Tanaka, E.; Yamawaki, T.; Tashiro, H. 2008: Fibrin Degradation Products in Acute Aortic Dissection. Atherosclerosis Suppls 9(1): 157-158
Oliveira, S.; Sousa, T.; Afonso, J.; Morato, M.; Pinho, D.; Marques-Lopes, J.; Albino-Teixeira, A. 2008: Arterial Hypertension, increased Vascular Nadph Oxidase Activity and Lipid Peroxidation in an Experimental Model of Atherogenesis. Atherosclerosis Suppls 9(1): 158-159
Ozgul, A.; Ozgul, E.; Polat, E.; Sade, L.; Yilmaz, M.; Aydinalp, A.; Yildirir, A.; Ozin, B.; Muderrisoglu, H. 2008: Relation between Carotid Intima Media Thickness and Extent of Coronary Artery Disease in Patients with Acute Coronary Syndrome. Atherosclerosis Suppls 9(1): 164-165
Timurkaynak, T.; Kocaman, S.A.; Sahinarslan, A.; Cengel, A. 2008: Des, like Bms, do not Influence Systemic Inflammatory Status Related with Inflammatory cells after Pci in Stable Angina Pectoris. Atherosclerosis Suppls 9(1): 166-167
Chen, I.C.; Chao, T.H.; Chang, Y.T.; Kao, Y.H.; Tsai, H.S.; Li, Y.H.; Lin, L.J.; Tsai, L.M.; Chen, J.H. 2008: Clinical Significance of the Treatment Timing of Clopidogrel in Patients Undergoing Coronary Stenting. Atherosclerosis Suppls 9(1): 167-168
Blazek, M.; Blaha, M.; Maly, J.; Pecka, M.; Blaha, V.; Masin, V. 2008: Outcome Comparison to Take Advantage of Modified Platelets Aggregation and Pfa-100 Analysis to Rationalize Therapeutic Ldl-Apheresis Procedure. Atherosclerosis Suppls 9(1): 168-169
Hammami, S.; Barhoumi, A.; Kaoubaa, N.; Hamzaoui, A.; Nakbi, A.; Hammami, M.; Mahjoub, S. 2008: Lipid Profile And Hyperhomocyteinemia In The Active Stage Of BehEt' S Disease. Atherosclerosis Suppls 9(1): 173-174
Hamishayev, J.Z. 2008: Can Nt-Pro Bnp together with Doppler Tissue Imaging Predict Severity of Coronary Artery Disease in Patients with Acute Coronary Syndrome?. Atherosclerosis Suppls 9(1): 174-175
Labudovic, D.D.; Toseska Trajkovska, K.N.; Alabakovska, S.B.; Bogdanska, J.J.; Todorova, B.B.; Jovanova, S. 2008: The Role of Lp(A) Levels and Apoprotein(A Phenotype in the Development of Atherosclerosis in Patients with Cad. Atherosclerosis Suppls 9(1): 175-176
Franco-Espinoza, P.; Garcia de Alba, J.; Salcedo-Rocha, A.; Mendoza-Briseno, E.; Mendez-Verduzco, M. 2008: Blood Lipid Levels and Waist Circumference as Cardiovascular Risk Factors, Comparation between two Definitions. Atherosclerosis Suppls 9(1): 176-177
Truijers, M.; Kurvers, H.A.; Bredie, S.J.; Oyen, W.J.; Blankensteijn, J.D. 2008: In Vivo Imaging of Inflammation in the Wall of Abdominal Aortic Aneurysms. Atherosclerosis Suppls 9(1): 178-179
Franco, M.; Arroyo, J.; Geli, C.; Diaz, C.; Diaz-Torne, C.; Mestres, J.; Ordonez, J. 2008: Cardiovascular Risk Factors and Carotidal Ultrasonography Evaluation in Patients with Autoimmune Diseases. Atherosclerosis Suppls 9(1): 180-181
Gachechiladze, D.; Beraia, M.; Kahadze, S. 2008: The Cerebral Hemodinamic Status in Relaton to the type of Colateral Supply in Patients with Ica High-Grade Changes. Atherosclerosis Suppls 9(1): 181-182
Locsey, L.; Borbas, B.; Szlanka, B.; Menes, I.; Dan, A.; Szabo, L.; Asztalos, L. 2008: Relationship between Visceral Fat Surface and Cardiovascular Complications in Transplanted Patients. Atherosclerosis Suppls 9(1): 182-183
Brudi, P.; Massad, R.; Lantz, K.; Tershakovec, A.M. 2008: Patients Attaining European Guidelines Ldl-C Goal (<2 Mmol/L) in 3 Studies Evaluating Switch to Ezetimibe/Simvastatin versus Statin Dose Doubling. Atherosclerosis Suppls 9(1): 185-186
Brown, B.G.; Fazio, S.; Guyton, J.R.; Polis, A.; Tomassini, J.E.; Tershakovec, A.M. 2008: Time and Dose-Related effects on the Lipid Profile in Hyperlipidemia Patients following Triple Combination Therapy with Ezetimibe/Simvastatin + Niacin. Atherosclerosis Suppls 9(1): 186-187
Brudi, P.; Reckless, J.; Henry, P.; Pomykaj, T.; Lim, S.; Massaad, R.; Vandormael, K.; Johnson-Levonas, A.; Lis, K.; Allen, C. 2008: Lipid-Altering Efficacy Of Ezetimibe/Simvastatin 10/40Mg Compared To Doubling Statin Dose In Patients Admitted To The Hospital For Recent Coronary Event. Atherosclerosis Suppls 9(1): 188-189
Sampietro, T.; Puntoni, M.; Sbrana, F.; Bigazzi, F.; Calvaruso, S.; Toneatti, S.; Lusso, S.; Maffei, A.; Pennato, B.; Bionda, A. 2008: Apo-Ai Lipoproteins Are increased by Ezetimibe in Patients with Refractary Familiar Hypercholesterolemia. Atherosclerosis Suppls 9(1): 189-190
Fischer, S.; Santos, A.; Oliveira, L.; Brandão, S.; Monteiro, C.; Monteiro, A.; Sanches, E.; Helfenstein, T.; Izar, M.; Gidlund, M.; Fonseca, F. 2008: Ace-Inhibitors and Diuretics Reduce Titers of Antibodies Anti-Oxldl in Hypertensive Patients. Atherosclerosis Suppls 9(1): 190-191
Dobiasova, M.; Vrablik, M.; Stulc, T.; Dolezalova, R.; Kasalova, Z.; Zlatohlavek, L.; Ceska, R. 2008: Rosiglitazone and Fenofibrate Improve Hdl Metabolism Assessed by Ferhdl. Atherosclerosis Suppls 9(1): 191-192
Farnier, M.; Ducobu, J.; Bryniarski, L. 2008: Safety and Efficacy of Long-Term Administration of a Fenofibrate/Pravastatin Fixed Combination in high Risk Patients with Mixed Hyperlipidemia. Atherosclerosis Suppls 9(1): 192-193
McKenney, J.; Bays, H.; Koren, M.; Ballantyne, C.; Maccubbin, D.; Mitchel, Y.; Betteridge, A.; Kuznetsova, O.; Sapre, A.; Sisk, C.; Paolini, J. 2008: Safety Profile of Extended-Release Niacin/Laropiprant in Patients with Dyslipidemia. Atherosclerosis Suppls 9(1): 194-195
Elikir, G.; Hesse, E.; Sanchez, R.; Baglivo, H. 2008: Safety of Lipid-Lowering Treatment. Atherosclerosis Suppls 9(1): 195-196
Park, J.; Kim, Y.; Choi, J.; Kim, Y.; Hong, T.; Kim, D.; Kim, K.; Jeong, M.; Chae, J.; Oh, S.; Seong, I. 2008: Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome (Krest). Atherosclerosis Suppls 9(1): 196-197
Wu, Z.G.; Liang, C. 2008: Atorvastatin Inhibit Intimal Hyperplasia and Oxidative Stress of Rabbit Carotid Artery induced by Vascular Adventitial Injury. Atherosclerosis Suppls 9(1): 197-198
Busnelli, M.; Froio, A.; Giunti, M.; Cerrito, M.; Deleo, G.; Forni, M.; Leone, B.; Gentilini, F.; Ingra', L.; Giovannoni, R.; Bacci, M.; Biasi, G.; Lavitrano, M. 2008: Effects of Atorvastatin and Co in the Pathogenesis of Intimal Hyperplasia following Vascular Injury in Healthy and Hypercholesterolemic Pigs. Atherosclerosis Suppls 9(1): 198-199
Clearfield, M.B.; Sosef, F.; Palmer, M.; Melezínková, H. 2008: Efficacy of Rosuvastatin 10 Mg versus Atorvastatin 20 Mg in Patients with Diabetes: Subgroup Results from the Pulsar Study. Atherosclerosis Suppls 9(1): 199-200
Deedwania, P.; Grundy, S.; Kastelein, J.; Breazna, A. 2008: High-Dose Atorvastatin Attenuates Cardiovascular Risk Prediction of the Metabolic Syndrome Components: The Treating to New Targets Study. Atherosclerosis Suppls 9(1): 201-202
Tsoma, V.; Brel, U.; Chalabi, T.; Mazina, G.; Nedogoda, S. 2008: Comparative Effectiveness of Atorvastatin, Simvastatin, Lovastatin and Fluvastatin on Pulse Wave Velocity at Patients with Dislipidemia and high Cardiovascular Risk. Atherosclerosis Suppls 9(1): 202-203
Kosmidou, M.; Hatzitolios, A.; Adamidou, A.; Giannopoulos, S.; Raikos, N.; Parharidis, G.; Milionis, H. 2008: Effects of Atorvastatin on Red Blood cell Na+/Li- Countetransport in Hyperlipidemic Patients with and without Hypertension. Atherosclerosis Suppls 9(1): 204-205
Olsson, A.G.; Lindahl, C.; Holme, I.M.; Cater, N.B.; Faergeman, O.; Kastelein, J.; Tikkanen, M.J.; LytkenLarsen, M.; Pedersen, T.R. 2008: Ldl Cholesterol Goal Attainments in the Ideal Study. Atherosclerosis Suppls 9(1): 205-206
Peiro-Martinez, I.; Martinez-Martin, F.; Rodriguez-Rosas, H.; Macias-Batista, A.; Pedrianes-Martin, P.; Soriano-Perera, P.; Comi-Diaz, C. 2008: Marcador-2.Antiinflammatory and Antiatherothrombotic effects of a Combination of Manidipine + Lisinopril in Hypertensive Non-Diabetic Patients with Metabolic Syndrome. Atherosclerosis Suppls 9(1): 210-211
Teramoto, T.; Ikeda, Y.; Fujita, T.; Goto, Y.; Oikawa, S.; Shimada, K.; Uchiyama, S.; Yamada, N.; Yamazaki, T. 2008: Baseline Data of Jppp (The Large Randomized Controlled Trial of Primary Prevention by Enteric Coated Low-Dose Aspirin in Japan). Atherosclerosis Suppls 9(1): 213-214
Ozbay, Y.; Akbulut, M.; Kutlu, M.; Erdem, K.; Kobat, M.A.; Cekici, Y. 2008: The effect of Tirofiban on Qt Dispersion in Acute Coronary Syndromes. Atherosclerosis Suppls 9(1): 218-219
Kassner, U.; Steinhagen-Thiessen, E.; Vogt, A. 2008: Lipidscreening in Families of Patients at high Risk for Cardiovascular Disease. Atherosclerosis Suppls 9(1): 219-220
Franzini, M.; Corti, A.; Martinelli, B.; DelCorso, A.; Emdin, M.; Parenti, G.; Glauber, M.; Pompella, A.; Paolicchi, A. 2008: Gamma-Glutamyltransferase Deposits in Human Atherosclerotic Plaques: Potential Relationships with the Circulating Enzyme. Atherosclerosis Suppls 9(1): 220-221
Kuznetsova, T.; Gavrilov, D.; Kirillova, A.; Dudanov, I. 2008: The Effectiveness of Rosuvastatin in high Risk Patients Treatment. Atherosclerosis Suppls 9(1): 221-222
Zota, I..G.; Melnic, E.M.; Untesco, M.I. 2008: The Role of Endothelial cell in the Immune Inflamation Initiation during the Atherosclerosis. Atherosclerosis Suppls 9(1): 224-225
Cicek, D.; Vayisoglu, Y.; Gorur, K.; Camsari, A.; Ozcan, T.; Akcay, B.; Aksoy Kara, A. 2008: Is There Any relation between Coronary Atherosclerosis and Tympanosclerosis?. Atherosclerosis Suppls 9(1): 225-226
Yilmazkaya, B.; Circi, R.; Circi, U.; Gurkahraman, S.; Yondem, O.; Yukselen, M.; Tasdemir, O. 2008: Oronary Artery Endarterectomy in Patients with Long Segment In-Stent Restenosis. Atherosclerosis Suppls 9(1): 226-227
Turkyilmaz, E.; Tanboga, I.H.; Tokgoz, H.C.; Can, M.M.; Akgun, T.; Bezgin, T.; Karabay, C.Y.; Keles, N.; Ozkan, A.; Koca, F.; Sonmez, K.; Saglam, M.; Yaymaci, B.; Ozdemir, N.; Kaymaz, C. 2008: Serum Lipoprotein(A) and Homocysteine Levels Related to five Risk Scores for Coronary Artery Disease. Atherosclerosis Suppls 9(1): 229-230
Barylski, M.; Błaszczyk, J.; Banach, M.; Irzmański, R.; Kowalczyk, E.; Pawlicki, L.; Lewiński, A.; Kowalski, J. 2008: Estimation of Cardiovascular Complications in Subjects with Metabolic Syndrome and high Cardiovascular Risk. Atherosclerosis Suppls 9(1): 231-232
Hatzinikolaou-Kotsakou, E.; Beleveslis, T..; Bobotis, G.; Moschos, G.; Reppas, E.; Chantas, A.; Mavrogiani, A.; Tsakiridis, K. 2008: Atorvastatin effects on Inflammation and Platelet Activation Markers following Drug Eluting Stenting in Patients with Stable Coronary Artery Disease. Atherosclerosis Suppls 9(1): 233-234
Yildiz, M.; Kaptanoğullari, H.; Aygin, D.; Akduran, F. 2008: A Comparison of Parathormone, Ferritin and Echocardiographic Parameters in Differnet Body Mass Index Levels in Patients with Hemodialysis. Atherosclerosis Suppls 9(1): 235-236
Gavish, D.; Bruzgol, T.; Winder, A.; Herman, A.; Leibovitz, E.; Lichman, I.; Rachmilevitz, E. 2008: Coagulation Markers:D-Dimers And Fibrinogen During Acute Infection Predict Cardiovascular Events. Atherosclerosis Suppls 9(1): 236-237
Mylonopoulou, M.; Antonopoulos, S.; Mikros, S.; Katsaros, K.; Papadakis, G.; Melidonis, A.; Tentolouris, N.; Katsilambros, N. 2008: Lipidaemic Profile And Heart Rate Variability (Hrv) In Chronic Kidney Disease (Ckd) Patients With Or Without Type2 Diabetes Mellitus (T2Dm). Atherosclerosis Suppls 9(1): 237-238
Likidlilid, A.; Peerapatdit, T.; Chantawee, R.; Tresukosol, D.; Sriratanasathavorn, C.; Ratnamaneechat, S. 2008: Polymorphism of Angiotensinogen Gene and the Risk of Coronary Heart Disease in type 2 Diabetic Patients. Atherosclerosis Suppls 9(1): 238-239
Rasic-Milutinovic, Z.R.; Perunicic-Pekovic, G.; Cavala, A.; Gluvic, Z.; Bokan, L.. 2008: The effect of Epo Treatment on Insulin Resistance and Inflammatory Markers in Patients on Maintenance Hemodialysis. Atherosclerosis Suppls 9(1): 239-240
Ito, Y.; Koba, S.; Hirano, T.; Yokota, Y.; Tsunoda, F.; Ban, Y.; Sato, T.; Shoji, M.; Suzuki, H.; Geshi, E.; Katagiri, T. 2008: Significance of small Dense Low-Density Lipoproteins in Coronary Heart Disease. Atherosclerosis Suppls 9(1): 242-243
Demirbag, R.; Yildiz, A.; Sezen, Y.; Gur, M.; Bas, M.; Polat, M.; Yilmaz, R.; Cakir, H.; Ozcan, E. 2008: The Influence of Oxidative Parameters, Prolidase, Paraoxonase and Arylesterase Activities on mean Blood Pressure. Atherosclerosis Suppls 9(1): 244-245
Turemen, E.E.; çetinarslan, B.; Bıyıklı, Z.M.; Canturk, Z.; Tarkun, I.; Turgut, T. 2008: Endothelial Dysfunction and low Grade Chronic Inflamation in Subclinical Hypothyroidism. Atherosclerosis Suppls 9(1): 246-247
Chackathayil, J.; Panja, N.; Patel, J.; Gunarathne, A.; Dotsenko, O.; Abraheem, A.; Hughes, E.; Lip, G. 2008: Angiogenin, a Marker of Angiogenesis Increases with Coronary Heart Disease Severity. Atherosclerosis Suppls 9(1): 247-248
Kiselyova, T.Y..; Kuryata, O.V. 2008: Interrelation of Insulin-Resistance and over Body Weight in Males and Females with Ischemic Heart Disease. Atherosclerosis Suppls 9(1): 248-249
Garrido-Sanchez, L.; JimenezNavarro, M.; Perez Cabeza, A.I.; Fernandez Pastora, J.; Garcia Pinilla, J.; Cardona, F.; Garcia-Fuentes, E.; Tinahones, F. 2008: Anti-Oxidized Ldl Autoantibodies in Diabetic Persons Undergoing Percutaneous Coronary Revascularization. Atherosclerosis Suppls 9(1): 249-250
Garcia-Fuentes, E.; Garcia-Almeida, J.; Garcia-Serrano, S.; Soriguer, F.; Tinahones, F.; Garrido-Sanchez, L. 2008: Presence of Anti-Oxidized Ldl Antibodies in Morbidly Obese Persons and their Evolution following Bariatric Surgery. Atherosclerosis Suppls 9(1): 250-251
Berg, A.; Koenig, D.; Deibert, P.; Landmann, U.; Frey, I.; Kloock, B.; Gollhofer, A. 2008: Anti-Atherogenic effects of a 1-Yr Intervention Program in 50-65 Yrs-Old Overweight Women. Atherosclerosis Suppls 9(1): 252-253
Esmaeili Nadimi, A.E.; Jafarzadeh, A.J. 2008: Association of Helicobacter Pylori Seropositivity with Coronary Artery Disease. Atherosclerosis Suppls 9(1): 253-254
Li, W.; Lee, J.; Hsu, C.; Tsai, W. 2008: The Early Impact of Cardiac and Renal Influence before Exercise Intolerance in Middle-Aged Females. Atherosclerosis Suppls 9(1): 254-255
Hristova, K.; Milanov, S.; Filibev, I. 2008: Prevention on Sudden Cardiac Death in Patients with Acute Coronary Syndrom: Effect of Highly Purified Omega 3 Fatty Acid. Atherosclerosis Suppls 9(1): 256-257
Alizade, I.G.; Karayeva, N.T. 2008: Effect of Moxonidine on some Inflammatory Markers and T cell Repertoire in Essential Hypertension. Atherosclerosis Suppls 9(1): 259-260
Bohuslavova, R.; Kralova-Lesna, I.; Adamkova, V.; Lanska, V.; Hubacek, J.A. 2008: Association between Plasma Levels of C-Reactive Protein and Numbers of Children. Atherosclerosis Suppls 9(1): 261-262
Bergovec, M.; Reiner, Z.; Milicic, D.; Vrazic, H. 2008: Continental versus Mediterranean Differences in Risk Factors in Croatian Ischemic Heart Disease Patients - Taspic-Cro V Study. Atherosclerosis Suppls 9(1): 262-263
Abellan, R.; Martinez-Hervas, S.; Pedro, T.; Real, J.; Garcia-Garcia, A.; Chaves, F.; Saez-Merino, G.; Carmena, R.; Ascaso, J. 2008: Antioxidative Stress Systems in Subjects with Familial Hypercholesterolemia. Atherosclerosis Suppls 9(1): 265-266
Laghi, L.; Giovanetti, F.; Gargiulo, M.; D'Addato, S.; Maioli, F.; Ceccacci, T.; Stella, A.; Borghi, C. 2008: Influence of Lipoprotein(A) on Restenosis after Percutaneous Transluminal Angioplasty (Pta) in Patients with Peripheral Arterial Occlusive Disease (Pad). Atherosclerosis Suppls 9(1): 267-268
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 26 High-Dose Atorvastatin Provides Sustained Benefit in Reducing Risk of Cv Disease among Stable Chd Patients 65 Years. Atherosclerosis Suppls 10(2): e83-e84
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 31 Ezetimibe/Simvastatin (E/S) Vs Atorvastatin (A) in Metabolic Syndrome (Ms) Patients with Hypercholesterolemia (Hc). Atherosclerosis Suppls 10(2): e89-e90
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 65 Cholesterol-Lowering Therapy with the Cholesterol Absorption Inhibitor Ezetimibe Inhibits Plaque Destabilization and Rupture in the Brachiocephalic Arteries of Apoe-Deficient Mice. Atherosclerosis Suppls 10(2): e212-e213
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 508 Comprehensive Cardiac Rehabilitation Program Strongly Prevents New Onset of Myocardial Ischemia in Patients Received Percutaneous Coronary Intervention. Atherosclerosis Suppls 10(2): e254-e255
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 510 Impact of Smoking and High-Density Lipoproteins on Coronary Plaque Regression during Statin Therapy in Acute Coronary Syndrome; Sub-Analysis of Japan-Acs. Atherosclerosis Suppls 10(2): e257-e258
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 517 Efficacy and Safety of Fenofibric Acid in Combination with Atorvastatin and Ezetimibe in Patients with Mixed Dyslipidemia: A Phase 3 Study. Atherosclerosis Suppls 10(2): e262-e263
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1208 Relationship between Glycated Hemoglobin, Blood Pressure and Carotid Artery Atherosclerosis in Nondiabetic Patients. Atherosclerosis Suppls 10(2): e315-e316
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 573 Correlation of Non-Hdl-C and Ldl-C with Apob during Lipid-Lowering Therapy in Patients with Combined Hyperlipidemia (Hl). Atherosclerosis Suppls 10(2): e333-e334
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 581 Cholesterol Balance in the Presence of Inhibition of Intestinal Absorption and Endogenous Production by Ezetimibe And/Or Simvastatin in Men. Atherosclerosis Suppls 10(2): e340-e341
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 582 Attainment of Single/Dual Treatment Levels for Ldl-C and Non-Hdl-C, Apob, or Hs-Crp in Patients with Metabolic Syndrome (Ms): Ezetimibe(E)/Simvastatin(S) Vs Atorvastatin(A). Atherosclerosis Suppls 10(2): e342-e343
Wu, C.C.; Chen, M.F.; Horng, H.E.; Yang, S.Y.; Yang, H.C. 2009: Abstract: 609 Timing for Adequate Imaging the Vulnerable Aortic Lesions with Biofunctionalized Magnetic Nanoparticles. Atherosclerosis Suppls 10(2): e360-e361
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 610 Segment-Specific Response to Atherosclerosis within the Carotid Arteries Detected using Magnetic Resonance Imaging (Mri). Atherosclerosis Suppls 10(2): e362-e363
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 1006 Ezetimibe/Simvatastatin (E/S) plus Extended Release Niacin (N) in Hyperlipidemia (Hl) Patients with Diabetes (Dm) or Metabolic Syndrome (Ms). Atherosclerosis Suppls 10(2): e379-e380
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 1007 New Onset Diabetes Mellitus (Dm) in Patients with Hyperlipidemia (Hl) Taking Ezetimibe/Simvastatin (E/S) +/ Niacin (N). Atherosclerosis Suppls 10(2): e381-e382
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: 1071 Plasma Pentraxin 3 Levels Reflect Metabolic Syndrome in Patients with Coronary Artery Disease. Atherosclerosis Suppls 10(2): e420-e421
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P156 Cholesterol Lowering Inhibits Crystal Formation with Associated Plaque Disruption, Thrombosis and Inflammation. Atherosclerosis Suppls 10(2): e472-e473
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P182 Pitavastatin Incorporated Nanoparticle-Eluting Stent Attenuates In-Stent Stenosis, and Prevents Adverse effects of Silorimus-Eluting Cypher Stent in Porcine Coronary Artery Model. Atherosclerosis Suppls 10(2): e499-e500
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P184 small Arteries and Renal Medulla Are Major Targets of Antioxidant Enzyme Dysfunction in a Model of Atherogenesis. Atherosclerosis Suppls 10(2): e502-e503
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P285 Identification of Extremely High-Risk Plaques on the Basis of low Endothelial Shear Stress: Implications for Risk Stratification. Atherosclerosis Suppls 10(2): e592-e593
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P301 Association of Cigarette Smoking with Early Onset of Acute Coronary Syndrome and Lipid Disorder; Subanalysis of Japan-Acs. Atherosclerosis Suppls 10(2): e609-e610
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P359 the Impact of Diabetes on Major Cardiovascular Events in Patients with Familial Combined Hyperlipoproteinemia. Atherosclerosis Suppls 10(2): e668-e669
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P453 N-3 Polyunsaturated Fatty Acid Decrease Homocysteine via Regulating Mrna Expression of the Enzymes in Methionine Metabolsim in Hepg2. Atherosclerosis Suppls 10(2): e763-e764
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P485 Alkaloids Extracted from Lobelia Chinensis Lour Inhibited the Formation of Atherosclerosis Independent of Lipid Reduction and Apoe Presence. Atherosclerosis Suppls 10(2): e797-e798
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P764 the effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein(A). Atherosclerosis Suppls 10(2): e938-e939
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P773 Efficacy of Ezetimibe Added to Atorvastatin Vs Uptitration of Atorvastatin in the Elderly. Atherosclerosis Suppls 10(2): e948-e949
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P787 Resting Heart Rate Remains an Independent Risk Factor for Mortality in Healthy Subjects after Adjusting for Inflammatory Markers, the Copenhagen City Heart Study (Cchs). Atherosclerosis Suppls 10(2): e963-e964
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P790 a New Approach to Classifying Chd in Normolipodemic Individuals using high Performance Lipoprotein Density Profiling. Atherosclerosis Suppls 10(2): e967-e968
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P864 Genetic Analysis of Variants on Genes Influencing Inflammation and Insulin Resistance: Effect on Coronary Artery Disease. Atherosclerosis Suppls 10(2): e1008-e1009
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P903 Carotid Lumen and Vessel Diameters and their Relationships with Carotid Intima-Media Thickness (Imt) in four Ethnic Groups: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis Suppls 10(2): e1048-e1049
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P947 Ezetimibe/Simvastatin (E/S) and Atorvastatin (A) Treatment Modify Apob, Ldl-C, and Non-Hdl-C Correlations in Metabolic Syndrome (Ms) Patients at Moderately high Risk(Mhr)/High Risk(Hr) for Chd. Atherosclerosis Suppls 10(2): e1094-e1095
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P948 Ezetimibe(E)+Atorvastatin(A) Vs. A Up-Titration In Moderately High Chd Risk (Mhr) Or High Chd Risk (Hr) Patients: Effects Of Baseline Body Mass Index (Bmi), Fasting Blood Sugar (Fbs) And Hs-Crp. Atherosclerosis Suppls 10(2): e1096-e1097
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P949 Influence of Age, Gender, and Race on the Efficacy of Ezetimibe plus Atorvastatin Vs. Atorvastatin Uptitration in Moderately High/High Chd Risk Patients. Atherosclerosis Suppls 10(2): e1098-e1099
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P964 Impact of Statin Dose on Lipid Levels in Patients with Atherosclerotic Disease: Results from the Voyager Individual Patient Data Meta-Analysis. Atherosclerosis Suppls 10(2): e1114-e1115
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P965 Statin Dose effects on Lipid Levels in Patients with Diabetes Mellitus: Observations from the Voyager Individual Patient Data (Ipd) Meta-Analysis. Atherosclerosis Suppls 10(2): e1116-e1117
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P966 effect of Age/Gender/Race on Ezetimibe/Simvastatin Vs. Atorvastatin Efficacy in Metabolic Syndrome Patients with Moderately High/High Chd Risk. Atherosclerosis Suppls 10(2): e1118-e1119
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P967 Influence of Metabolic Syndrome (Ms) Factors and Insulin Resistance (Ir) on Ezetimibe (E)/Simvastatin (S) and Atorvastatin (A) Efficacy in Patients with Ms and Moderately high (Mh) or high (H) Chd Risk. Atherosclerosis Suppls 10(2): e1120-e1121
Huang, P.H.; Chen, J.W.; Lin, S.J. 2009: Abstract: P1166 Red Wine Increases the Number and Functions of Circulating Endothelial Progenitor cells. Atherosclerosis Suppls 10(2): e1192-e1193
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1167 C-Reactive Protein Predicts Functional Status and Correlates with left Ventricle Ejection Fraction in Patients with Chronic Stable Angina. Atherosclerosis Suppls 10(2): e1194-e1195
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P823 Ezetimibe (E) Added to Atorvastatin (A): Effect on Lipoprotein Subclass Cholesterol Content in Patients with Higher versus Lower Triglyceride Levels (Tg). Atherosclerosis Suppls 10(2): e1212-e1213
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1175 Relationship between Weight and Cardiovascular Risk Factors. Atherosclerosis Suppls 10(2): e1238-e1239
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1214 Microparticles before and after Angioplasty of Iliac Artery Stenosis. Atherosclerosis Suppls 10(2): e1268-e1269
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1308 Ezetimibe/Simvastatin (E/S) Vs Atorvastatin (A) in Patients with Hypercholesterolemia (Hc) and Metabolic Syndrome (Mets) Grouped by Presence of Atherosclerotic Vascular Disease (Avd). Atherosclerosis Suppls 10(2): e1364-e1365
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1318 Lipid Ratios and Risk for Metabolic Syndrome. Atherosclerosis Suppls 10(2): e1375-e1376
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1372 Mutations in Hfe Causing Hemochromatosis Are Associated with Primary Hypertriglyceridemia. Atherosclerosis Suppls 10(2): e1421-e1422
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: P1443 Long-Term Effect Of Combination Ezetimibe/Simvastatin + Extended-Release Niacin (E/S+N) On Lipoprotein Subclasses In Patients With Hyperlipidemia (Hl). Atherosclerosis Suppls 10(2): e1493-e1494
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: S2-12 Visualising Inflamed Endothelial Cells: Molecular Imaging using Mri and Targeted Uspios. Atherosclerosis Suppls 10(2): e1510-e1511
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: S2-15 Differential Atherogenic effect of low Endothelial Shear Stress in Plaque-Free Vs. Atherosclerotic Coronary Segments: A Serial Ivus Study. Atherosclerosis Suppls 10(2): e1514-e1515
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: S2-21 Calcification in an Atherosclerotic Plaque: Ultrastructural Insights. Atherosclerosis Suppls 10(2): e1521-e1523
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2009: Abstract: S3-29 Multiple Mutations Perturb a small Number of Pathways in an Hdl Mutagenesis Screen. Atherosclerosis Suppls 10(2): e1541-e1542
Braunwald, E. 2009: Abstract: 1051 Ongoing Clinical Trials of the Statin/Ezetimibe Combination. Atherosclerosis Suppls 10(2): e1620-e1621
Weber, C. 2009: Abstract: 559 Chemokines as Therapeutic Targets in Atherosclerosis. Atherosclerosis Suppls 10(2): e1627-e1628
Kastelein, J. 2009: Abstract: 22 Efficacy of Statins. Atherosclerosis Suppls 10(2): e1646-e1648
Bauer, M.; Hoffmann, B.; Möhlenkamp, S.; Lehmann, N.; Roggenbuck, U.; Schmermund, A.; Moebus, S.; Dragano, N.; Bröcker-Preuss, M.; Stang, A.; Mann, K.; Siegrist, J.; Jöckel, K.-H.; Erbel, R. 2010: W24 Carotid Intima-Media Thickness is not Independently Predictive for Hard Coronary Events in Men and Women the Heinz Nixdorf Recall Study. Atherosclerosis Suppls 11(2): 5-6
Ragino, Y.; Chernjavski, A.; Polonskaja, Y.; Volkov, A.; Semaeva, E.; Tcimbal, S.; Voevoda, M. 2010: W33 Changes of Proinflammatory Cytokines, Chemoattractants and Destructive Metalloproteinases Contents during Unstable Atherosclerotic Plaque Formation. Atherosclerosis Suppls 11(2): 7-8
Stender, S.; Frikke-Schmidt, R.; Sethi, A.A.; Nordestgaard, B.G.; Tybjærg-Hansen, A. 2010: W38 Genetic Variation in Liver X Receptor Alpha and Risk of Ischemic Vascular Disease in the General Population. Atherosclerosis Suppls 11(2): 8-9
Purroy, A.; Belzunce, M.; Orbe, J.; Barrenetxe, J.; Páramo, J.A.; Rodríguez, J.A. 2010: W43 Genetic Deficiency in Functional Mmp-10 Reduces Progression of Atherosclerosis in Apolipoprotein E-Knockout Mice. Atherosclerosis Suppls 11(2): 9-10
Engel, D.; Beckers, L.; Wijnands, E.; Daemen, M.J.A.P.; Stan, R.; Biessen, E.A.L.; Lutgens, E. 2010: W52 Protection against Atherosclerosis in Cav-1 is Due to Cav-1/ in Non-Hematopoietic cells. Atherosclerosis Suppls 11(2): 11-12
Chan, J.; Monaco, C.; Bhakoo, K.; Gibbs, R. 2010: L2 Visualising Inflamed Atherosclerotic Plaques: Molecular Imaging using Mri and Targeted Ultrasmall Superparamagnetic Particles of Iron Oxide (Uspio). Atherosclerosis Suppls 11(2): 13-14
Qin, S.; Linghong, S.; Ben, H. 2010: P19 Orphan Nuclear Receptor Nur77 Suppresses Inflammatory Response Partially Dependent on Cox-2 in Macrophages induced by Oxidized Low-Density Lipoprotein. Atherosclerosis Suppls 11(2): 20-21
Díaz Peromingo, J.A.; Fernández Villaverde, J.M.; Carballo Vicente, A.; Echebarrieta Gorostiaga, I.; Múgico Sánchez, G.; Parga García, V.; Pérez Llamas, M.A.; Rodríguez Blanco, M.; Pena Seijo, M.; Pose Reino, A. 2010: P24 effect of Telmisartan on the Arteriovenous Index in Retinal Microvascularization. Atherosclerosis Suppls 11(2): 21-22
Katsimpoulas, M.; Kadoglou, N.; Kapelouzou, A.; Moustardas, P.; Botis, I.; Dede, E.; Kostomitsopoulos, N.; Liapis, C.; Karayannacos, P. 2010: P29 the Role of Exercise and Endocannabinoid System in Atherosclerotic Plaque Stability Experimental Study. Atherosclerosis Suppls 11(2): 22-23
Dhawan, V.; Malik, N.; Shukla, A.; Sikand, K.; Bahl, A.; Kaul, D. 2010: P33 a Nutrigenomic Approach to Study the effect of Herbal Polyphenols on Atherogenic Transcriptome. Atherosclerosis Suppls 11(2): 23-24
Hof, D.; Decasper, S.; von Eckardstein, A. 2010: P38 Generation of Recombinant Antibodies to Nitrotyrosine to Facilitate the Identification of Novel Protein Biomarkers of Atherosclerosis. Atherosclerosis Suppls 11(2): 24-25
Li, S.; Sun, Z.; Wang, J.; Yang, T. 2010: P43 N-Terminal Pro-Brain Natriuretic Peptide but not High-Sensitivity C-Reactive Protein is Related to Severity of Coronary Stenosis in Acute Coronary Syndrome. Atherosclerosis Suppls 11(2): 25-26
Kraml, P.J.; Syrovátka, P.; Potočková, J.; Anděl, M. 2010: P48 Oxldl/beta2Gpi Complex As An Early Marker Of Atherosclerosis Initiation In Healthy Middle-Aged Men With Abdominal Obesity. Atherosclerosis Suppls 11(2): 26-27
Novakovic, A.; Gojkovic Bukarica, L.; Nezic, D.; Peric, M.; Kanjuh, V. 2010: P53 Cardioprotective effect of Red Wine. Atherosclerosis Suppls 11(2): 27-28
Mytrokhina, O.; Kuryata, O. 2010: P68 Simvastatin Retards Progression of Aortic Valve Stenosis in the Elderly Patients with Chronic Heart Failure and Preserved Systolic Function. Atherosclerosis Suppls 11(2): 30-31
Tian, G.; Xig, G. 2010: P73 Relationship between Lipoprotein-Associated Phospholipase A2 and Inflammation in Coronary Heart Diseases. Atherosclerosis Suppls 11(2): 31-32
Babes, E.E.; Babes, V.V.; Popescu, M.I.; Ardelean, A. 2010: P78 Metabolic Syndrome and Subclinical Atherosclerosis in Young Adults. Atherosclerosis Suppls 11(2): 32-33
Tudor, C.; Iana, A.; Jeberean, R.A.; Petrus, A.; Buzas, R. 2010: P83 Ldl-Cholesterol and Cardiovascular Events in Patients with Diabetes Mellitus type 2. Atherosclerosis Suppls 11(2): 33-34
Seldenrijk, A.; van Hout, H.; van Marwijk, H.; de Groot, E.; Gort, J.; Rustemeijer, C.; Diamant, M.; Penninx, B. 2010: P87 Carotid Atherosclerosis Associated with Late-Onset Depressive Disorders: Results from a Large Cohort Study. Atherosclerosis Suppls 11(2): 34-35
Ferré, R.; Aragonès, G.; Plana, N.; Merino, J.; Heras, M.; Coll, B.; Cos, R.; Masana, L. 2010: P92 Endothelial Function Assessed by Peripheral Artery Tonometry is a Determinant of Carotid Intimae-Media Thickness Regardless of Framingham Risk Score. Atherosclerosis Suppls 11(2): 35-36
Ergun Cagli, K.; Gurel, E.I.; Ozeke, O.; Seringec, N.; Yalcinkaya, A.; Kocabeyoglu, S.; Basar, F.N.; Sen, N.; Cagli, K.; Dikmenoglu, N. 2010: P97 increased Erythrocyte Aggregability in Patients with Slow Coronary Flow. Atherosclerosis Suppls 11(2): 36-37
Jensen, M.K.; Mukamal, K.J.; Girman, C.J.; Chen, C.; Handberg, A.; Rexrode, K.M.; Rimm, E.B. 2010: P102 Genetic Variation at the Cd36 Locus and Risk of Coronary Heart Disease in Women and Men. Atherosclerosis Suppls 11(2): 37-38
Wagner, A.; Freyer, J.; Medack, A.; Willenborg, C.; Loley, C.; Nahrstedt, J.; Preuss, M.; König, I.R.; Schunkert, H.; Erdmann, J. 2010: P107 Tnf-M-Ras-Lfa-1 Pathway Analysis in Genome-Wide Snp Data on Patients with Myocardial Infarction. Atherosclerosis Suppls 11(2): 38-39
Krobot, K.J.; Siebert, U. 2010: P116 First Application of Risk Advancement Periods to Lipid Ratios. Atherosclerosis Suppls 11(2): 40-41
Guo, Z.; Tang, T.; Lin, X.; Yang, H. 2010: P121 The Protective Role Of Specific Protein-1 Against Benzo(A)Pyrene-Induced Atherogenesis. Atherosclerosis Suppls 11(2): 41-42
Kim, C.S.; Ahn, C.W.; Cho, M.H.; Lee, E.J.; Park, S.W.; Kim, S.K.; Kim, S.H.; Han, S.J.; Lee, S.H.; Park, S.E.; Choi, Y.J.; Ji, S.H.; Huh, K.B. 2010: P130 Postprandial Beta cell Responsiveness does it Have a Protective Role in the Development of Diabetic Complication?. Atherosclerosis Suppls 11(2): 43-44
Rein, P.; Saely, C.H.; Vonbank, A.; Beer, S.; Aczel, S.; Jankovic, V.; Boehnel, C.; Risch, L.; Drexel, H. 2010: P139 the Association of Albuminuria with Angiographically determined Coronary Atherosclerosis. Atherosclerosis Suppls 11(2): 45-46
Shah, T.; Khan, T.; Hingorani, A.; Casas, J. 2010: P144 Apolipoprotein e Genotype, Cardiovascular Biomarkers and Stroke Risk: Systematic Review of 10,550 Stroke Cases and Pooled Analysis of 74,052 Individuals. Atherosclerosis Suppls 11(2): 46-47
Miller-Kasprzak, E.; Bogdanski, P.; Pupek-Musialik, D.; Jagodzinski, P.P. 2010: P149 does Insulin Resistance Influence Endothelial Progenitor cells in Obese Patients?. Atherosclerosis Suppls 11(2): 47-48
Norouzy, A.; Nematy, M.; Alinezhad-Namaghi, M.; Shakhskalaee, M.; Mozhdehifard, M.; Sajjadi, S.; Sabery, M. 2010: P155 effects of Ramadan Fasting on Cardiovascular Risk Factors. Atherosclerosis Suppls 11(2): 48-49
Okuyan, E.; Uslu, A.; Levent, O. 2010: P160 the Prevelance of Subclinical Hypothyroidism among Patients with Acute Myocardial Infarction. Atherosclerosis Suppls 11(2): 49-50
Mistrik, E.; Blaha, V.; Dusilova-Sulkova, S.; Safranek, R.; Sobotka, L. 2010: P165 Asymmetric Dimethylarginine (Adma) Predicts Skin Blood Flow during Hemodialysis (Hd). Atherosclerosis Suppls 11(2): 50-51
Medack, A.; Loley, C.; Nahrstaedt, J.; König, I.R.; Mayer, B.; Hengstenberg, C.; Stark, K.; Wichmann, H.-E.; Schreiber, S.; Meitinger, T.; Schunkert, H.; Erdmann, J. 2010: P170 Comparative Mapping of Linkage and Association Signals in Myocardial Infarction. Atherosclerosis Suppls 11(2): 51-52
Anderssohn, M.; Böger, R.H.; Endres, H.G.; Schwedhelm, E.; Darius, H.; Atzler, D.; Lüneburg, N.; von Stritzky, B.; Maas, R.; Thiem, U.; Benndorf, R.A.; Diehm, C. 2010: P174 Adma (Asymmetric Dimethylarginine) Predicts All-Cause Mortality and Cardiovascular Events in Patients with Peripheral Arterial Disease: The Getabi Study. Atherosclerosis Suppls 11(2): 52-53
Tarnoki, D.L.; Tarnoki, A.D.; Stazi, A.; Medda, E.; Cotichini, R.; Baracchini, C.; Meneghetti, G.; Fanelli, F.; Littvay, L.; Metneki, J.; Molnar, A.A.; Garami, Z.; Berczi, V.; Lazar, Z.; Horvath, I. 2010: P188 Association between Atherosclerosis and Lung Function Results from International Twin Study 2009. Atherosclerosis Suppls 11(2): 55-56
Tzanogiorgis, I.; Nikolaou, E.; Kogias, I. 2010: P193 Smoking Behaviors after Acute Coronary Syndromes (Acs) in Adult Male Smokers. Atherosclerosis Suppls 11(2): 56-57
Sotos-Prieto, M.; Ortega-Azorín, C.; Carrasco, P.; Sorli, J.V.; Guillem-Saiz, P.; Gonzalez, J.I.; Corella, D. 2010: P198 the Association between Variation in Negr1 Gene and Body-Weight is Modulated by Physical Activity in a high Risk Mediterranean Population. Atherosclerosis Suppls 11(2): 57-58
Millan, J.; Gonzalez-Juanatey, J.R.; Guijarro, C.; Alegria, E.; Lozano, J.V.; Gonzalez-Timon, B.; Vitale, G. 2010: P202 Persistent Lipid Abnormalities in Statin Treated Patients in Spain. The Dyslipidemia International Survey Study (Dysis-Spain). Atherosclerosis Suppls 11(2): 58-59
Scott, J.; Li, X. 2010: P217 Mouse Gene Expression Networks Indicate Mitochondrial Dysfunction Causes Metabolic Inflammation in Obesity: Validation by Human Gene Expression and Snp Analysis. Atherosclerosis Suppls 11(2): 61-62
Benlian, P.; Donadille, B.; Bouché, C.; Vincent Dejean, C.; Valero, R.; Dufernez, F.; Sapin, V.; Paye, F.; Bouchard, P. 2010: P222 Composite Deficiency of the Lipolytic Complex in Pregnancy-Induced Major Hypertriglyceridemia. Atherosclerosis Suppls 11(2): 62-63
Lupattelli, G.; Pirro, M.; Siepi, D.; Mannarino, M.R.; Roscini, A.R.; Vaudo, G.; Schillaci, G.; Mannarino, E. 2010: P227 Non-Cholesterol Sterols in Common Hypercholesterolemia and Familial Combined Hyperlipemia. Atherosclerosis Suppls 11(2): 63-64
Brügelmann, K.; Teupser, D.; Bartelt, A.; Gordts, P.; Heeren, J.; Merkel, M. 2010: P232 Ldl Receptor Related Protein 1 (Lrp1) is Necessary for Apolipoprotein A5 (Apoa5) Mediated Triglyceride Reduction. Atherosclerosis Suppls 11(2): 64-65
Fóris, G.; Sarang, Z.; Seres, I.; Paragh, G. 2010: P237 Hypercholesterolemia (Hc) Abrogates the Biphasic effect of Angiotensin Ii (Ang Ii) on Endogenous Cholesterol Synthesis in Human Monocytes. Atherosclerosis Suppls 11(2): 65-66
Rizzo, M.; Amann-Vesti, B.; Zwimpfer, C.; Spinas, G.; Berneis, K. 2010: P242 increased Plasma Resistin Concentrations Are Associated with Atherogenic Small, Dense Low-Density Lipoproteins in Patients with Type-2 Diabetes. Atherosclerosis Suppls 11(2): 66-67
Gouni-Berthold, I.; Rizzo, M.; Berthold, H.K.; Spinas, G.; Krone, W.; Berneis, K. 2010: P251 Ezetimibe with or without Simvastatin Increases small Dense Low-Density Lipoproteins in Healthy Men a Randomized Trial. Atherosclerosis Suppls 11(2): 68-69
Brown, W.; Foody, J.; Zieve, F.; Jones-Burton, C.; Dong, Q.; Tomassini, J.; Shah, A.; Tershakovec, A. 2010: P254 Inverse Relationship between Hdl-C Raising and Hscrp Reduction in Older Patients Treated with Lipid-Lowering Therapy in the Vyteld Study. Atherosclerosis Suppls 11(2): 69-70
Galyavich, A.; Salakhova, L. 2010: P258 the effects of Omega-3-Polyunsaturated Fatty Acids and Atorvastatin on Fatty Acid Status of Blood in Patients with Dyslipidemia. Atherosclerosis Suppls 11(2): 70-71
Nakamura, H.; Mizuno, K. 2010: P268 the beyond Cholesterol-Lowering Activity of Pravastatin. Analysis of three Overlapping Dose Groups. Atherosclerosis Suppls 11(2): 72-73
Werner, C.; Filmer, A.; Groenewold, S.; Fritsch, M.; Böhm, M.; Laufs, U. 2010: P291 Simultaneous Determination of Triglyceride and Glucose Tolerance by a Novel Sequential test Protocol in 511 Patients with Coronary Artery Disease. Atherosclerosis Suppls 11(2): 78-79
Sleep, D.J.; Mandair, I.S.; Setze, C.M.; Kelly, M.T. 2010: P296 effects of Fenofibric Acid in Combination with Statin Therapy on Low-Density Lipoprotein Particle Size in Patients with Mixed Dyslipidemia. Atherosclerosis Suppls 11(2): 79-80
Inagaki, M.; Nakagawa-Toyama, Y.; Kawase, R.; Nakaoka, H.; Nakatani, K.; Yuasa-Kawase, M.; Tsubakio-Yamamoto, K.; Sandoval, J.C.; Masuda, D.; Ohama, T.; Nishida, M.; Ishigami, M.; Yamashita, S. 2010: P300 effect of Probucol on an Antioxidant Property of Hdl in Patients with Heterozygous Familial Hypercholesterolemia. Atherosclerosis Suppls 11(2): 80-81
Sutti Nunes, V.; Leança, C.C.; Pnazoldo, N.B.; Correa, D.F.; Nakandakare, E.R.; de Faria, E.C.; Quintão, E.C.R. 2010: P309 Hdl-C Relates to Markers of Absorption but not of Synthesis of Cholesterol: Study in Subjects with low Vs. High Hdl-C. Atherosclerosis Suppls 11(2): 82-83
Uehara, Y.; Abe, S.; Yahiro, E.; Kawamura, A.; Iwamoto, T.; Miura, S.-I.; Saku, K. 2010: P314 Identification and Cloning of Novel Soluble and Membrane Bound Forms of Human Atp-Binding Cassette Transporter G4. Atherosclerosis Suppls 11(2): 83-84
Evans, D.; Azar, J.; Beil, F. 2010: P319 Resequencing the Lpl Gene in Patients with Various Hypertriglyceridemias to Determine the Relative Importance of Rare Alleles and Common Variants. Atherosclerosis Suppls 11(2): 84-85
Gordts, P.; Bartelt, A.; Nilsson, S.; Annaert, W.; Heeren, J.; Roebroek, A. 2010: P324 Perturbed Cellular Lrp1 Localization Leads to increased Hepatic Ldlr Expression with Atheroprotective Consequences. Atherosclerosis Suppls 11(2): 85-86
Aragones, G.; Beltrán-Debón, R.; Rull, A.; Fernández-Sender, L.; Camps, J.; Joven, J.; Alonso-Villaverde, C. 2010: P334 HIV Infection Induces Major Changes in Hdl Particle Size Distribution and Composition: The effect of Antiretroviral Treatment and Disease Severity. Atherosclerosis Suppls 11(2): 87-88
Baracco, V.; Abello, F.; Guardamagna, O. 2010: P339 Usefulness Of Intima Media Thickness, apoB And Non-Hdl-C In Primary Dislipidemic Children. Atherosclerosis Suppls 11(2): 88-89
Mollaki, V.; Progias, P.; Skouma, A.; Drogari, E. 2010: P348 Molecular Diagnosis of Familial Hypercholesterolemia (Fh) in Greece. Known and Novel Mutations in the low Density Lipoprotein Receptor (Ldlr) Gene. Atherosclerosis Suppls 11(2): 90-91
Delporte, C.; Van Antwerpen, P.; Zouaoui Boudjeltia, K.; Noyon, C.; Calay, D.; Reyé, F.; Rousseau, A.; Raes, M.; Vanhaeverbeek, M.; Ducobu, J.; Nève, J. 2010: P353 Specific Oxidation of Apolipoprotein-B-100 by Myeloperoxidase. Atherosclerosis Suppls 11(2): 91-92
Guadall, A.; Rodríguez-Calvo, R.; Aledo, R.; Calvayrac, O.; Martínez-González, J.; Rodríguez, C. 2010: P362 Hypoxia Up-Regulates Fibulin-5 in Endothelial cells through a Hif-1 Dependent Mechanism. Atherosclerosis Suppls 11(2): 93-94
Zhang, Y.; Zheng, J.-P.; Zhang, W.; Edvinsson, L.; Xu, C.-B. 2010: P367 Ldl Increases Vascular Etb2 Receptor Expression via Activation of Erk1/2 and P38 Mapk Pathways. Atherosclerosis Suppls 11(2): 94-95
Bonaterra, G.A.; Thogersen, J.; Zügel, S.; Bendner, G.; Vorwald, S.; Fey, J.; Traut, U.; Strelau, J.; Kinscherf, R. 2010: P377 Role of Growth-Differentiation Factor 15 (Gdf-15) in a Mouse-Model of Atherosclerosis. Atherosclerosis Suppls 11(2): 96-97
Lietz, M.; Berger, C.; Lammerich, H.-P.; Steffen, Y.; Stolle, K.; Lebrun, S.; Schueller, J.; Wallerath, T. 2010: P382 the Impact of Cigarette Smoke on the Adhesion Properties of Human Monocytes to Endothelial cells in Vitro. Atherosclerosis Suppls 11(2): 97-98
Hennig, B.; Majkova, Z.; Toborek, M. 2010: P387 Monocyte Chemoattractant Protein-1 (Mcp-1) is a Biological Marker for Vascular Inflammation induced by Environmental Toxicants. Atherosclerosis Suppls 11(2): 98-99
Dimitriou, A.; Mitsios, J.; Tselepis, A. 2010: P392 Interaction of Platelet-Derived Microparticles with Plasma Lipoproteins. Effect on Platelet Activation. Atherosclerosis Suppls 11(2): 99-100
Paulsson, J.; Moshfegh, A.; Dadfar, E.; Bygdén-Nylander, A.; Held, C.; Jacobson, S.; Lundahl, J. 2010: P397 Neutrophil Il-1R And Chemokine Expression Following In Vivo Extravasation In Patients With Coronary Artery Disease. Atherosclerosis Suppls 11(2): 100-101
Meyer dos Santos, S.; Klinkhardt, U.; Scholich, K.; Kuczka, K.; Harder, S. 2010: P402 The Cx3C Chemokine Fractalkine And Gpib Mediate Platelet Translocation On Von Willebrand Factor Under Physiologic Flow Conditions. Atherosclerosis Suppls 11(2): 101-102
Thomas, A.; Eijgelaar, W.; Daemen, M.; Newby, A. 2010: P411 Genomic Differences between Mouse Foamy and Non-Foamy Macrophages. Atherosclerosis Suppls 11(2): 103-104
Papadopoulos, T.; Katsiki, N.; Dadous, G.; Kanonidis, I.; Sakadamis, G. 2010: P416 Inflammatory Markers in Patients Undergoing Implantable Cardioverter Defibrillator Implantation for Life Threatening Ventricular Arrhythmias. Atherosclerosis Suppls 11(2): 104-105
França, C.; Pinheiro, L.; Izar, M.; Brunialti, M.; Salomão, R.; Fonseca, F. 2010: P421 Early effects of Atorvastatin and Clopidogrel Alone or Combined on Endothelial Progenitor cells and Microparticles in Subjects with Coronary Disease. Atherosclerosis Suppls 11(2): 105-106
Cromwell, W.; Santos, R.; Blom, D.; Marais, A.D.; Charng, M.-J.; Lachmann, R.; Gaudet, D.; Tan, J.-L.; Tribble, D.; Flaim, J.; Chasan-Taber, S.; Donovan, J.; Raal, F. 2010: P431 Mipomersen, An apo B Synthesis Inhibitor, Preferentially Reduces Small Ldl Particle Number And Increases Ldl Particle Size In HoFh Patients. Atherosclerosis Suppls 11(2): 107-108
Martinez-Hervas, S.; Ivorra, C.; Pedro, T.; Gonzalez-Albert, V.; Hilario, R.; Ascaso, J.F.; Carmena, R.; Real, J.T.; Chaves, F.J. 2010: Ms4 Chronic Inflammatory State Present in Familial Hypercholesterolemia is Reduced after a Fat Overload Rich in Unsaturated Fatty Acids. Atherosclerosis Suppls 11(2): 109-110
Agapakis, D.; Papagianni, M.; Katsiki, N.; Tziomalos, K.; Savopoulos, C.; Satsoglou, A.; Hatzitolios, A. 2010: Ms9 Effectiveness of Omacor Monotherapy in Severe Hypertriglyceridemia. Atherosclerosis Suppls 11(2): 110-111
Maeda, T.; Honda, A.; Mashimo, Y.; Takeoka, Y.; Yasuda, D.; Yoshimura, N.; Kusano, J.; Tsukamoto, K.; Ishikawa, T.; Kinoshita, M.; Matsuzaki, Y.; Teramoto, T. 2010: Ms14 Sex Differences In Effects Of Npc1L1 Gene Polymorphism On Cholesterol Absorption. Atherosclerosis Suppls 11(2): 111-112
Ageeva, E.; Frolova, Y.; Dizhe, E.; Vinogradov, A.; Denisenko, A. 2010: Ms17 the Role of Acylation Stimulating Protein in Genesis of Dyslipidemias and in Regulation of Triacylglycerol Synthesis: Clinical and Experimental Data. Atherosclerosis Suppls 11(2): 112-113
Drogari, E.; Progias, P.; Koniari, E.; Manolaki, N.; Christomanou, H. 2010: Ms26 Cholesteryl Ester Storage Disease (Acid Lipase Deficiency): Another Factor for Early Atherosclerosis Disease. Experience from the Greek Population. Atherosclerosis Suppls 11(2): 114-115
Kougialis, S.; Levisianou, D.; Skopelitis, E.; Nikolaou, S.; Kroustalis, A.; Gogalis, T.; Groumas, G.; Zervou, A.; Kosmas, N.; Iliopoulos, N.; Mpilinis, C. 2010: Ms31 Circulating Oxidized Low-Density Lipoprotein Levels may Serve as a Risk Marker for Carotid Stenosis during Statin Therapy. Atherosclerosis Suppls 11(2): 115-116
Tunceli, K.; Sajjan, S.; Ramey, D.; Neff, D.; Tershakovec, A.; Hu, H.; Foody, J. 2010: Ms45 Impact of Switching to Simvastatin on low Density Lipoprotein Cholesterol Goal Attainment. Atherosclerosis Suppls 11(2): 118-119
Nicholls, S.J.; Lundman, P.; Brandrup-Wognsen, G.; Palmer, M.; Barter, P.J. 2010: Ms48 effects of Age and Statin Dose on Lipid Levels: Results from the Voyager Individual Patient Data Meta-Analysis. Atherosclerosis Suppls 11(2): 119-120
Pennato, B.; Lionetti, V.; Bigazzi, F.; Puntoni, M.; Simioniuc, A.; Campan, M.; Recchia, F.; Sampietro, T. 2010: Ms53 low Hdl-High Inflammatory Markers in Heart Failure induced by high Frequency Pacing in Minipigs. Atherosclerosis Suppls 11(2): 120-121
Tanyanskiy, D.; Firova, E.; Shatilina, L.; Denisenko, A. 2010: Ms68 Atherogenic Dislipidemia in Metabolic Syndrome: Role of Insulin Resistance, Nonesterified Fatty Acids and Adipokines. Atherosclerosis Suppls 11(2): 123-124
Gkogkos, K.; Nikitidou, O.; Panara, E.; Siarkou, O.; Miggos, C.; Plougarlis, T.; Pavlidis, G. 2010: Ms73 Decrease Of Plasma Levels Of Lipoprotein A [Lp(a)] After Administration Of L-Carnitine. Atherosclerosis Suppls 11(2): 124-125
Santos, T.; Gaspar, A.; Gaspar, I.M.; Rato, Q.; Bourbon, M. 2010: Ms79 Molecular Study of Lpl, Apoaiv, Apoav, Apocii and Apociii Genes in Patients with Hypertriglyceridemia. Atherosclerosis Suppls 11(2): 125-126
Kassi, E.; Hroussalas, G.; Dalamaga, M.; Kazanis, K.; Merantzi, G.; Zachari, A.; Giamarellos-Bourboulis, E.J.; Dionyssiou-Asteriou, A. 2010: Ms90 Adipocyte Factors, hsCrp And Malondialdehyde Levels In Overweight Postmenopausal Women With Normal And Impaired Ogtt. Atherosclerosis Suppls 11(2): 127-128
Dembinska-Kiec, A.; Malczewska-Malec, M.; Roche, H.; Leszczynska-Golabek, I.; Hartwich, J.; Wybranska, I.; Kiec-Wilk, B.; Perez-Martinez, P.; Defort, C.; Wolkow, P.; Lopez-Miranda, J. 2010: Ms97 The Effect Of The n-3/n-6 Pufa Ratio On The Transformation Of Postprandial State Proatherogenic Ldl Phenotype And Oxidative Stress Parameters. Atherosclerosis Suppls 11(2): 129-130
Savchenko, A.; Inoue, A.; Ohashi, R.; Inoue, K.; Jiang, S.; Hasegawa, G.; Naito, M. 2010: Ms130 Expression Pattern of Long Pentraxin 3 (Ptx3) in Human Atherosclerosis. Atherosclerosis Suppls 11(2): 135-136
Yuan, Z.; Liu, X.; Liu, Q.; Liu, Z.; Tang, C.; Wang, Z.; Yi, G.; Liu, L.; Jiang, Z.; Yang, Y. 2010: Ms135 Adipophilin low Expression Reduce Cellular Lipid. Atherosclerosis Suppls 11(2): 136-137
Mata, K.M.; Prudente, P.S.; Rocha, F.S.; Prado, C.M.; Floriano, E.M.; Elias, J.; Rizzi, E.; Gerlach, R.F.; Metze, K.; Rossi, M.A.; Ramos, S.G. 2010: Ms145 a Novel Rat Experimental Model Confirms the Critical Role of Metalloproteinases-2 and -9 in the Development of Abdominal Aneurysms. Atherosclerosis Suppls 11(2): 138-139
Aslam, R.; Khan, K.; Shiwen, X.; Howat, S.; Tsui, J.; Baker, D. 2010: Ms150 Basement Membrane Adaptations in Critical Limb Ischaemia. Atherosclerosis Suppls 11(2): 139-140
Hosseinzadeh Attar, M.J.; Mazaherioun, M.; Golestan, B.; Vasheghany Farahany, A.; Hosseinnezhad, A. 2010: Ms155 to Determine Circulating Visfatin Levels in Patients with Myocardial Infarction and its Relationship with the Severity of Stenosis. Atherosclerosis Suppls 11(2): 140-141
Sato, Y.; Moriguchi-Goto, S.; Hatakeyama, K.; Marutsuka, K.; Asada, Y. 2010: Ms165 Decreased Expression of Cd39 in Symptomatic Carotid Artery Plaques. Atherosclerosis Suppls 11(2): 142-143
Udartseva, O.; Andreeva, E.; Buravkova, L.; Andrianova, I.; Tararak, E. 2010: Ms170 Low-Fluence Pdt Impairs Phagocytic Activity of Human Macrophages. Atherosclerosis Suppls 11(2): 143-144
Opstad, T.; Pettersen, A.Å.; Åkra, S.; Weiss, T.; Arnesen, H.; Seljeflot, I. 2010: Ms185 Tf and Tfpi Polymorphisms in Coronary Heart Disease and Diabetes type 2. Atherosclerosis Suppls 11(2): 146-147
Komurcu Bayrak, E.; Onat, A.; Yuzbasiogullari, B.; Mononen, N.; Laaksonen, R.; Hergenc, G.; Humphries, S.E.; Lehtimäki, T.; Erginel-Unaltuna, N. 2010: Ms194 the Influence of Apolipoprotein e Genetic Variants on Serum Lipids and Insulin Resistance in Tarf Study. Atherosclerosis Suppls 11(2): 148-149
Pitha, J.; Stanek, V.; Poledne, R.; Gebauerova, M.; Aschermann, M.; Skalicka, H.; Matouskova, J.; Kruger, A.; Penicka, M.; Hrabakova, H.; Veselka, J.; Hajek, P. 2010: Ms199 Impact of Maternal and Paternal History of Premature Myocardial Infarction on the Age of Manifestation of Acute Coronary Syndrome. Atherosclerosis Suppls 11(2): 149-150
Vonbank, A.; Saely, C.H.; Rein, P.; Aczel, S.; Beer, S.; Kiene, V.; Bochdansky, T. 2010: Ms204 Eccentric Endurance Exercise Significantly Improves Fasting Glucose and Glucose Tolerance in Non-Diabetic Subjects. Atherosclerosis Suppls 11(2): 150-151
Ioannidis, A.; Oikonomou, K.; Ntalapascha, M.; Karapatsoudi, E.; Karantoumanis, I.; Karali, K.; Makridis, P. 2010: Ms209 New Event of Myocardial Infarction (Mi) in Patients with past Mi: Age, Sex and Treatment Differences. Atherosclerosis Suppls 11(2): 151-152
Weiss, T.; Seljeflot, I.; Hjerkinn, E.; Arnesen, H. 2010: Ms239 Adipose Tissue Inflammatory Activity is Associated with Cardiovascular Disease. Atherosclerosis Suppls 11(2): 157-158
Charvat, J.; Chlumský, J.; Szabó, M.; Zamrazil, V. 2010: Ms244 the Prevalence of Masked Hypertension in Treated type 2 Diabetic Patients and its Association with Cardiovascular Target Organ Damage. Atherosclerosis Suppls 11(2): 158-159
García Anguita, A.; Riestra, P.; Garcés, C. 2010: Ms249 Association Of The Q223R Polymorphism In The Leptin Receptor Gene With Age At Menarche. Atherosclerosis Suppls 11(2): 159-160
Abou-Raya, A.; Abou-Raya, S.; Helmii, M. 2010: Ms254 Monocyte Chemoattractant Protein 1 (Mcp-1): The Link between Obesity and Atherosclerosis?. Atherosclerosis Suppls 11(2): 160-161
Beutner, F.; Teupser, D.; Tennert, C.; Scholz, M.; Gielen, S.; Sandri, M.; Schuler, G.; Thiery, J. 2010: Ms259 Relationship of Inflammatory Marker C-Reactive Protein, Lipid Markers and Conventional Cardiovascular Risk Factors in Subjects with Suspected Coronary Artery Disease. Atherosclerosis Suppls 11(2): 161-162
Nucci da Silva, L.; Timerman, L.; Simone, J.; Gun, C. 2010: Ms264 Framingham And Procam Score Plus Cd44L Show Strong Association Of Periodontal Disease Score. Atherosclerosis Suppls 11(2): 162-163
Aggarwal, A.; Dwivedi, S.; Dev, M. 2010: Ms274 Risk Factor Differences Predisposing to Recurrence And/Or Death in Young Early Onset Coronary Artery Disease Patients. Atherosclerosis Suppls 11(2): 164-165
Descamps, O.; Cooper, J.; Neil, A.; Humphries, S. 2010: Ms279 in Applicability of the Cardiovascular Risk Predictor Score to Patients with Familial Hypercholesterolemia (Fh). Atherosclerosis Suppls 11(2): 165-166
Altug Cakmak, H.; Karadag, N.; Karadag, B.; Cosansu, K.; Ongen, Z.; Vural, V.A. 2010: Ms284 the Frequency and Prevalence of the Coronary Heart Disease in Patients with Metabolic Syndrome. Atherosclerosis Suppls 11(2): 166-167
Emami Meybodi, T.; Emami, M.; Hasan Lotfi, M.; Mahdiye Namayande, S.; Mahmood Sad, S. 2010: Ms294 Most Important Cardiovascular Risk Factors in Prognosis of Patients with Myocardial Infarction 5 Year Follow up Study. Atherosclerosis Suppls 11(2): 168-169